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INTRODUCTION
ISBER BEST PRACTICES:  
RECOMMENDATIONS FOR REPOSITORIES
The availability of high-quality biological and environmen-
tal specimens for research purposes requires the develop-
ment of standardized methods for collection, handling, 
storage, retrieval, and distribution. The International 
Society for Biological and Environmental Repositories 
(ISBER) is the leading global forum for the development, 
management, and operations of repositories. One of the 
key objectives for ISBER is to share successful strategies, 
policies, and procedures on providing fit-for-purpose spec-
imens for research. For more information about ISBER see 
www.isber.org.
ISBER Best Practices: Recommendations for 
Repositories (Best Practices) is a guidance 
document that reflects the collective experience 
of its members and has received broad input 
from other repository professionals. 
Throughout this document, effective practices are pre-
sented for the management of specimen collections and 
repositories and the term “Best Practice” is used in cases 
where a level of operation is indicated that is above the ba-
sic recommended practice or more specifically designates 
the most effective practice. It is understood that physical 
location or financial constraints can make “Best Practices” 
difficult or impossible to attain. Repositories facing such 
challenges should decide how best to incorporate these 
recommendations. While adherence to ISBER Best 
Practices is voluntary, it is important to note that some 
aspects of specimen management are governed by na-
tional/federal, regional, and local regulations. The reader 
should refer directly to their own national/federal, region-
al, and local regulations and requirements, as appropriate. 
ISBER recognizes that the definition and subsequent use of 
the terms “specimen” and “sample” varies when used in 
a clinical versus biodiversity and/or environmental setting. 
Definitions for each context are provided in the glossary. 
While “specimen” is used predominantly throughout the 
document, it could be substituted for “specimens and/or 
samples” in most instances. 
ISBER has strived to include terminology associated with 
various specimen types covered under these practices, 
but here too, readers should take steps to ensure that 
recommendations are appropriate for their particular 
repository type. Important terms within the document are 
italicized when first used in a section and defined in the 
glossary. 
The ISBER Best Practices are periodically reviewed and 
revised to reflect advances in research and technology. 
The fourth edition builds on the foundation established in 
previous editions which were published in 2005, 2008, 
and 2012.
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SECTION A: REPOSITORY 
PLANNING CONSIDERATIONS
A1.  GENERAL 
A repository is defined as a formally managed physical or 
virtual entity that may receive, process, store, and/or distrib-
ute specimens and/or samples and their associated data as 
appropriate in support of current or future use.  A repository 
may be further defined by the collection of specimens as a 
biorepository if the specimens represent, or are biological 
specimens. Specimens may be collected for a variety of 
scientific purposes (e.g., basic, clinical, population, public 
health, environmental, agricultural, museum-based re-
search). The specimens may be stored whole, processed 
and aliquoted, derived, or be stored as reference speci-
mens from a study population (e.g., type specimen).
A repository may be physically or virtually developed for 
a single organization or its services may be contracted 
or outsourced to serve other organizations. All reposi-
tories should be planned, organized, and managed in 
accordance with applicable ethical and legal frameworks 
and comply with national/federal, regional, and local 
regulations.
Many issues briefly touched upon in this section have been 
explored more fully in subsequent sections of these Best 
Practices. The reader should refer to the Table of Contents 
to identify sections appropriate to their particular interests 
and needs. 
A2.  REPOSITORY GOVERNANCE
Repository governance is the implementation and over-
sight of policies and procedures that regulate operations. 
Governance structure, design, and complexity may vary 
greatly by repository size, purpose, source of support, 
and institutional affiliation. Governance structure should 
comply with applicable regulations, provide good stew-
ardship of repository specimen and data collections to 
include quality control through Quality Management 
System adherence (see Section D: Quality Management), 
and be part of a business plan that addresses long-term 
sustainability (see Section A3.1. Organizational Planning 
Considerations). Governance oversight may be provided 
by a committee, board, or other group (governance over-
sight body) that serves to guide and advise the repository. 
A governance framework and/or policy should be devel-
oped to include a description of the governance oversight 
body’s composition and responsibilities.
Governance policies and procedures should be devel-
oped with the full repository lifecycle in mind (see Section 
M Specimen Access, Utilization, and Disposition). It is 
important that repository leadership, specimen, and data 
access review committees and repository operation poli-
cies be available to stakeholders. 
Transparency is the basis of repository stakeholder trust, 
including but not limited to that of donors, scientists, 
sponsors, and the general public. Information regarding 
the ethical, legal, and social foundations of the repository’s 
activities, repository governance, services provided, and 
fees assessed, if any, should be made available to stake-
holders. Consideration may be given to providing this 
information electronically through a publicly accessible 
website, which may also serve to inform the scientific com-
munity of the repository’s activities. 
Best Practice: A repository should have a governing body 
and written policies covering the full repository lifecycle.
Best Practice: Repository business plans should include 
terms and conditions of the repository governance over-
sight body. 
Best Practice: Information regarding the repository’s op-
erational and governance structures should be made avail-
able to stakeholders.
A2.1. Elements of a Repository Governance Plan
A written repository specimen and data gover-
nance plan should be made available to stakehold-
ers and should be incorporated in the repository 
business plan (see Section A3.1. Organizational 
Planning Considerations). Elements of a repository 
governance plan should include:
•	 Provisions for safekeeping of the collection(s) 
including maintenance, security, and integrity 
of specimens and data (see Section B: Facilities).
•	 A transparent policy regarding specimen and 
data access and use including applicable re-
quirements, limits, exclusions, and priorities 
(see Section M: Specimen Access, Utilization, 
and Disposition).
•	 Communication tools making general reposi-
tory operations and policies available to stake-
holders (see Section A3.4. Communication).
•	 A plan for appropriate physical and electronic 
management of specimens and data in the event 
of a collection’s utility end, resource constraints, 
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lapses in funding, donor withdrawal, dissolu-
tion of the repository, or disaster recovery (see 
Section M: Specimen Access, Utilization, and 
Disposition). 
Best Practice: A widely distributed, readily 
available, written specimen and data governance 
plan should be incorporated in the repository 
business plan.
A3.  REPOSITORY DEVELOPMENT 
A3.1. Organizational Planning Considerations 
A business plan is essential to the development of a 
repository. Business planning for the development 
of a repository should include identifying target 
customer(s) or business stakeholder needs, iden-
tifying the infrastructures (e.g., staffing, facilities, 
equipment) and services to serve the identified 
customer(s) and business needs, establishing pro-
active review of the repository’s ability to meet the 
needs, and a robust marketing plan to advertise 
the facilities and services within and outside the 
organization. The business plan should include a 
governance framework with transparent access 
guidelines and processes to support utilization 
of the repository collection(s). Considerations 
for termination of specific collections and/or the 
repository should also be included, as applicable.
When planning a repository, it is important that the 
vision and mission be clearly defined. The vision 
defines the direction of the repository. The mission 
should address the purpose of the repository and 
the entities served by the collections obtained. 
The vision and mission should be reviewed over 
time to ensure its appropriateness as conditions 
surrounding its implementation may change. It is 
also important that the governance, equipment, 
facilities, staffing, and funding for a repository be 
established according to a structure that will sup-
port its mission and activities during its anticipated 
lifetime. Policies should be created, enforced, and 
reviewed on a regular basis concerning repository 
operations from initiation to termination. 
Best Practice: A business plan should be devel-
oped for the lifetime of the repository and should 
be updated on a regular basis (e.g., every 2 years) 
or as requested.
A3.2. Determination of Specimens to be Collected 
and Storage Environment
The type of specimen that is best suited for a par-
ticular scientific investigation will depend on the 
goals of the particular research effort supported. 
Some material types are better suited than others 
for some kinds of analyses over others. Material 
type and quantity, specimen source, downstream 
testing plans, and financial constraints may in-
fluence decisions regarding specimen collection. 
Repositories should determine the most appropri-
ate storage environment for the particular types of 
specimens it holds together with their intended use 
and ensure that the sufficient equipment, facilities, 
and funding are in place to support the storage of 
these specimens until they are needed. 
Policies should be established for the acquisition of 
new specimens and for culling or deaccessioning 
of collections when specimens have fulfilled their 
original purpose, are no longer suitable for their 
intended purpose, or if participants request the 
withdrawal of their specimens (see Section M3. 
Specimen or Collection Disposition). 
Best Practice: The scientific purpose of the spec-
imen collection should be defined prior to initia-
tion to effectively plan for collection, processing, 
storage, and downstream uses. The plan should 
include exclusion criteria, if any, for specimens that 
prove difficult to collect. 
A3.3.  Determination of Customers Served 
Repositories should develop a clear understanding 
as to the identity and needs of the investigators 
and scientific clients it serves. Whenever possible, 
efforts should be made to understand the down-
stream use planned to ensure that specimens pro-
vided are collected and processed in a manner that 
is likely to benefit future research efforts. 
Best Practice: Repositories should create a plan to 
receive feedback from users to make sure that cus-
tomers’ needs have been satisfied to the greatest 
extent possible. This is one component of a total 
Quality Management System.
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A3.4.  Communication 
Transparent and effective lines of communication 
should be established among stakeholders, includ-
ing research participants, and should be part of a 
Standard Operating Procedure (SOP). Trust is an 
essential component among those donating, pro-
cessing, and storing specimens, as well as among 
the investigators who use the specimens to pursue 
a scientific endeavor. Efforts should be made to 
ensure that trust is developed and maintained and 
could include the engagement of advocates as 
part of the stakeholder community.
Best Practice: Prior to the initiation of collection 
efforts, stakeholders should gather to talk about 
communication strategies to ensure that expecta-
tions are satisfied and that transparency and trust 
can be firmly established. 
Best Practice: Repositories should develop clear 
guidance as to what services are provided, the 
costs for the provision of those services, the hours 
during which services are available, and contact 
information appropriate for each category of stake-
holder for regular hours as well as for after-hour 
emergencies. 
A3.5. Establishing Repository Models 
The collection and storage of specimens of various 
types (e.g., human, animal, plant, environmental, 
bacterial) may be performed in support of a variety 
of scientific endeavors. Specimens may be collect-
ed as a part of prospective or retrospective studies 
and the methods of collection, processing, and 
distribution of these specimens may depend on 
resource constraints, legal constraints, and the par-
ticular scientific inquiry under consideration. Several 
models exist for how specimens may be procured, 
stored, and prepared for subsequent use that may 
be impacted by such constraints. A repository may 
take advantage of a single approach or multiple ap-
proaches to achieve its mission. Once a repository is 
established in support of a model, it may be possible 
to join with additional models, as appropriate. This 
approach prevents duplication of effort and allows 
more efficient utilization of resources. Regardless 
of the model employed, specimens should always 
be collected and processed according to the most 
current methods supported by scientific data and 
best practices, where possible. 
A3.5.1.  Investigator-driven and Institutional  
 Collections 
The collection of specimens and utilization of a 
repository can be driven by a single investigator 
or group within an institution. These specimens 
may be available through collaboration or for 
general use. Repositories that store specimen 
collections obtained for defined study pur-
poses may serve a single facility or provide 
centralized storage and processing for a large 
number of studies as part of a centralized re-
pository service, acting as the custodian of the 
collection(s). Decisions about which specimens 
and data are collected are typically made by an 
individual investigator or team of investigators 
and are defined by study goals. Specimens are 
obtained and processed by trained field staff, 
clinical sites, or hospitals according to SOPs 
(see Section D: Quality Management). These 
repositories may be operated by institutional 
staff or through contracted repository services. 
A3.5.2. Federated Collections 
Federated collections (e.g., networks) are creat-
ed when specimens are collected, processed, 
and stored at physically separated sites, while 
related data are managed or duplicated through 
a central database. Each site functions as the 
specimen custodian for its local collection. 
Specimens are requested through the central 
database and distributed by the site custodians. 
Federated network participation may require 
that a portion of each custodian’s collection be 
made available to other network participants. 
This federated model may increase utilization of 
network collections. 
A3.5.3.  Virtual Collections 
Virtual collections are virtual representations of 
specimens (e.g., digital pathology images, he-
matoxylin and eosin (H&E) stained slides, slides 
of tissue prepared for immunohistochemical 
analysis, digital images of specimens, molecular 
data) that are housed and analyzed elsewhere 
or represent catalogs of specimens stored 
elsewhere. Virtual representations allow for 
new scientific questions to be addressed using 
specimens that have already been processed 
(e.g., slides containing tissues prepared for im-
munohistochemical analysis, digital images of 
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specimens, molecular data). Publicly-available 
data from Genome-Wide Association Studies 
would be included in this category. 
Catalogs of physical specimens and associated 
data allow investigators to access these pre-
viously collected resources. Various formats 
exist, including those that document single 
organization resources, multiple organization 
resources, or even multiple catalogs. Utilization 
of human specimens may be based on the relat-
ed research protocol and consent provided by 
donors. Information about available specimens 
is often provided in the form of a searchable 
electronic inventory that can be used to iden-
tify the desired specimens. The catalog may 
provide contact information for a requestor to 
communicate directly with the collection cus-
todian to learn of access policies required for 
the actual sharing of specimens and associated 
data. Catalogs allow investigators to identify 
resources that are currently available rather than 
having to initiate new and sustained collection 
efforts that can be time-consuming and costly. 
A3.5.4.  Biodiversity and Environmental  
 Biobanks 
Biodiversity biobanks and environmental speci-
men banks (ESBs) are often attached to natural 
history collections, universities, or environmen-
tal or agricultural organizations. Specimens 
and data may have been collected by individ-
ual scientists specifically for their own research, 
through surveys, or as part of generic collecting 
expeditions, and may pass through a registrar’s 
office. The collections usually provide material 
to the wider scientific community, safe-guard 
biodiversity, and document environmental 
change. Depending on size, organisms may be 
stored whole or as a portion (e.g., tissue, blood, 
leaf sections) of the original specimen.
A3.6.  Determination of Services to be Provided 
Repositories should determine the services to 
be provided and put into place the appropriate 
infrastructure necessary to ensure that high-quality 
specimens will be available for future research. The 
infrastructure not only includes equipment and 
supplies but also the trained personnel to perform 
these services as needed. Services may include 
specimen collection, receipt into the repository, 
processing, quality control, storage, and distribu-
tion. Multiple processing pathways may need to be 
developed within the repository to meet business 
needs and investigators’ requirements. 
There are a number of services that a repository 
may provide in addition to the collection and 
storage of specimens. Examples of these include 
feasibility assessments to assist investigators with 
study planning and proposal submissions, the 
provision of letters of support or the establishment 
of collaborative relationships with investigators, the 
identification and/or consenting of participants, 
batching of specimens, and inclusion of quality 
control specimens for specimens destined to 
be sent to a laboratory for testing, histology ser-
vices, micro-dissection, nucleic acids extraction 
and analysis, etc. All services offered should be 
well-defined. Consideration should be given to 
fees-for-service where appropriate, to support 
sustainability. Fee schedules should be established 
and posted prior to provision of service, when 
applicable. Consistency and transparency should 
exist in the application of service fees (see Section 
A4. Funding and Other Financial Considerations).
A3.6.1.  Procurement Service 
A repository that provides procurement ser-
vices, or request-based services, collects and 
processes specimens for specific requests on 
an ‘‘as-needed’’ basis. Investigators state what 
specimens they are seeking and frequently 
supply the protocol for collection, handling, 
and storage. The repository attempts to col-
lect specimens specifically for that request 
and processes them according to the inves-
tigator’s specifications. The service provider 
should be prepared to share guidance per 
evidence-based collection practices for the 
material type being requested. A repository 
based on this model will most likely not re-
quire long-term storage if the specimens will 
be entirely transferred to requestors within a 
short time after collection. The service provider 
should have a way to track specimen inventory 
and data moving into and out of the repository. 
Initial data collected with the specimens should 
be transferred to the requestor according to the 
protocols under which the data and specimens 
were collected and will be received, but this 
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model does not facilitate long-term follow-up 
data associated with the collections. 
A3.6.2  Banking Service 
Banking involves the storage of specimens 
in anticipation of current and future needs. 
Investigators seeking a particular type of speci-
men can approach a repository that has banked 
specimens to see if the desired specimens 
are available among the existing collections. 
Banked specimens may be received into the re-
pository from a variety of sources including, but 
not limited to, agreements with clinical sites, 
hospitals, institutions, or for biodiversity and 
environmental banks from staff or researchers 
who collect specimens during their field work. 
Specimens are subjected to identical process-
ing procedures using pre-defined protocols to 
ensure standardized practices. Data associated 
with banked specimens may be limited to what 
is available at the time of collection. 
One particular type of bank, a disease-focused 
bank, may be initiated by advocacy groups, 
to advance for research a particular disease or 
syndrome. Donors and families may request 
that hospitals and other clinical sites send 
their specimens to these banks or specimens 
may be donated through specimen collection 
kits sent from the donor’s residence (termed a 
donor’s ‘‘self-collected’’ specimen). Advocacy-
oriented banks often have associated registries 
containing detailed clinical and follow-up infor-
mation. These resources can be a rich source of 
material and data for research. Specimens and 
information from family members may also be 
associated with these banks. 
A4.  FUNDING AND OTHER FINANCIAL  
  CONSIDERATIONS 
The cost for specimen collection, processing, 
storage, quality control, and distribution can be 
considerable and it is important for repositories to 
develop a financial plan for the expected lifetime of 
the specimen storage and handling activities. Plans 
should be reviewed on a regular basis and adjusted 
as needed. See Section H: Cost Management for a 
full review of financial considerations when starting 
and implementing a repository. 
A5.  REPOSITORY PERSONNEL 
Repository staff varies according to the needs of the 
organization and the services provided and may 
be composed of managerial staff, technical staff, 
administrative personnel, and/or support staff. 
Personnel should be adequately trained to perform 
the tasks required by their particular position de-
scription and should follow all repository policies 
and applicable national/federal, regional, and local 
regulations.
Best Practice: An organizational structure and 
clear job descriptions with lines of reporting should 
be documented for each role in the repository. 
A5.1.  Director 
The individual(s) responsible for oversight of 
repository management (i.e., Director, Head, 
Curator, Manager) is referred to in this document 
as the Director. The Director should be qualified by 
training and experience to direct and manage the 
scope of activities conducted by the repository. 
A5.1.1.  General Operations 
The Director should implement policies of the 
organization and should be responsible for all 
operations including compliance with current 
international, national/federal, regional, and 
local regulations. Depending upon organiza-
tional structure of the repository, the Director 
may have other responsibilities including: 
•	 Ensuring the repository operates within 
budget.
•	 Ensuring the repository has adequate fund-
ing for operations which may require the 
development of cost-recovery strategies 
to ensure the repository’s short and long-
term financial stability.
•	 Ensuring that an adequate policy is in place 
for access to the specimens stored in the 
repository and that requests for specimens 
are met in a timely fashion.
•	 Serving as a liaison to key stakeholders.
•	 Ensuring that activities are within national/
federal, regional, local, and internation-
al ethical, legal, and social norms, as 
applicable.
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•	 Ensuring confidentiality of data.
•	 Ensuring that SOPs and best practices are 
in place and in general use as part of a 
Quality Management System. 
A5.1.2.  Personnel Supervision 
The Director should construct and maintain 
an organizational chart that delineates the 
functional relationships within the repository. 
Candidates for the supervisory and technical 
staff should be approved by the Director. The 
Director should also approve and maintain job 
descriptions and document staff responsibili-
ties. The Director should ensure that personnel 
responsible for performing repository activities 
are adequate in number and experience and 
have assigned responsibilities commensurate 
with their capabilities. 
The Director should also be responsible for de-
veloping and reviewing employee training pro-
grams. They should ensure that the repository 
is in alignment with applicable ethical and legal 
frameworks and is compliant with national/fed-
eral, regional, and local regulations. 
A5.1.3.  Quality Management System 
The Director and/or the Quality Manager should 
ensure that a Quality Management System 
(QMS) is in place to ensure that operations fol-
low the repository’s manual of operations and 
SOPs and comply with applicable requirements 
of governmental and regulatory organizations. 
The Director should require regular, document-
ed, internal reviews or audits to ensure compli-
ance with SOPs and regulations and to satisfy 
end-user requirements (see Section D: Quality 
Management). If deviations from SOPs or qual-
ity indicators are identified, the Director should 
ensure that appropriate corrective action is 
undertaken successfully and documented (see 
Section D4.3.3. Non-conformities). 
A5.2.  Technical Staff 
The scope of activities carried out by the repository 
technical staff may include, but not be limited to, 
specimen collection, processing, quality control, 
shipping and receiving, storage, data management, 
or facility and equipment management. Managers 
and staff should possess sufficient educational 
background, experience, and training to ensure that 
assigned tasks are performed in accordance with 
the repository’s established SOPs. Technical staff 
should be responsible for adherence to policies and 
SOPs as established by the Director. Duties of each 
staff member should coincide with written job de-
scriptions. Staff should demonstrate competency in 
operations for which they have received training and 
to which they are assigned. Authority and reporting 
relationships for each member of the staff should be 
clearly described. 
Best Practice: An organizational structure and 
clear job descriptions with lines of reporting should 
be documented for each role in the repository.
A6.  CONTRACTED LABORATORY SERVICES  
  AND CONSULTANTS
Careful planning during the development phase is critical 
to quality and cost-efficiency. Where internal resources 
are not sufficient to provide all necessary expertise, either 
during development or as a repository evolves, a reposi-
tory may seek assistance from qualified experts and con-
sultants. Consultants should have documented successful 
experience (similar to that which would be sought for inter-
nal staff) in the area for which they are retained. Repository 
consultants may provide expertise in areas such as strategic 
planning; equipment selection; and decisions surround-
ing automation, SOP development, vendor selection, 
grants and cost recovery, contract management, quality 
assurance, and regulatory affairs. Similarly, the repository 
may have contractual relationships with other institutions 
or service providers that provide access to facilities or 
services not available at its own location or through other 
departments within a parent institution (when applicable). 
In all of these situations, the Director should have clear 
documentation of the relationships, rights, and obligations 
of all parties. 
Best Practice: Repositories that contract for services 
should retain records pertaining to the name and address 
of the contracted facility, the name and contact informa-
tion for key personnel at the location where the services 
are being provided, documentation of the inclusive dates 
of the contract or agreement period, and copies of the 
contract as well as any accompanying documentation. The 
scope of work for all contract services should be clearly 
articulated. 
Best Practice: Repositories should perform supplier eval-
uation when contracted services are required. 
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SECTION B: FACILITIES
B1. GENERAL
An efficient repository has many particular location and 
design elements to ensure the safe-keeping of the material 
stored, support the equipment employed, and provide a 
safe and effective working environment for the repository 
staff. In planning the design of a repository, it is necessary 
to know the types of material being stored, the required 
storage and handling conditions, the projected retention 
periods, projected growth of the specimen numbers, and 
the projected use of the materials. The design should 
include sufficient space to accommodate the material 
planned for initial, future, and backup storage and also 
provide for the safe movement of people, equipment, and 
specimens, as needed, or as required by law and/or other 
regulatory agencies. 
Best Practice: Planning for a repository within a facility 
should take into account the environmental conditions 
experienced by the region where it is located (e.g., fire, 
flooding, high winds, earthquake, tsunami) and availabil-
ity of resources (e.g., access to chilled water, stable elec-
tricity, liquid nitrogen). A disaster recovery plan should be 
established for the repository per Section B8. Emergency 
Preparedness.
B2. HEATING, VENTILATION, AND AIR  
  CONDITIONING
B2.1. Temperature 
In most repositories it is critical to maintain ambient 
temperature within defined limits. Sufficient heat-
ing capacity should be provided to prevent the 
freezing of water in drain lines. Likewise, sufficient 
air conditioning should be provided to prevent 
excess load on the compressor systems of me-
chanical freezers and refrigerators that may result in 
excess wear and early failure. 
Best Practice: For optimal life of mechanical 
refrigeration equipment, repository ambient tem-
peratures should be monitored and controlled 
following the manufacturers’ instructions for tem-
perature and humidity. This is particularly critical for 
rooms containing multiple mechanical units. 
B2.2. Air Flow, Circulation, and Humidity
Sufficient air circulation should be provided to 
prevent excess moisture and condensation. Excess 
humidity can lead to fungal growth if left un-
checked, which may affect specimen integrity and 
cause health problems for staff. Sufficient space 
for air circulation is required especially in areas 
where freezers and refrigerators are employed to 
prevent excess heat accumulation which may neg-
atively affect compressor function (see Section C3. 
Mechanical Freezers). Adequate ventilation and 
monitoring are also critical in repositories where 
liquid nitrogen and dry ice are used to ensure that 
sufficient oxygen levels are maintained (see Section 
C2.5.1 Oxygen Sensors). Similarly, when services 
are performed in which potentially harmful vapors 
are generated (e.g., formaldehyde) the ventilation 
system should ensure that personnel are protected 
and that national/federal, regional, and local reg-
ulations for the removal of specific harmful vapors 
are met.
Best Practice: Appropriate monitoring devices 
(e.g., oxygen and/or CO2 monitors), preferably with 
auditory and visual alarms, should be combined 
with a dedicated exhaust system and installed 
within areas where low oxygen level might develop 
or harmful gases might accumulate. This system 
provides a sufficient amount of recirculating air to 
replace the air volume of a room according to the 
local regulations. The extracted gases are vented 
to the outside of the building, according to regula-
tions, and never to the interior areas of the building. 
Best Practice: Repositories located in areas where 
humidity is high (e.g., coast) should employ a 
de-humidification system to ensure optimal opera-
tion of the equipment.
B3. LIGHTING
B3.1. General Lighting
Lighting in a repository should be sufficient to 
provide a safe working environment and to allow 
materials to be accurately stored and retrieved. 
The lighting levels required will depend on the par-
ticular spatial environment where the samples are 
stored, the type of activity that is being performed, 
the volume and specimen type, and the labeling/
identification system employed. 
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Lighting may be both general and task-focused, 
depending on the situation. Some repositories may 
contain materials or specimens which are sensitive 
to light levels or to particular frequencies of light. 
Best Practice: Appropriate lighting should be 
planned for and used during the storage and han-
dling of materials or specimens determined to be 
sensitive to certain lighting conditions. 
B3.2. Task Lighting
Task lighting may be necessary to have sufficient 
illumination for tightly packed materials, reading 
labels, or where overhead lighting is impaired. In 
situations where task lighting is employed, care 
should be taken that the lighting method does not 
adversely affect the sample integrity and the stor-
age conditions. For example, the heat from incan-
descent lighting placed too close to stored material 
may cause a sample to thaw, partially thaw, or melt. 
Consider using Light Emitting Diodes (LEDs), given 
this type of lighting is more energy efficient, cost 
effective, and easier to produce directed beams of 
light for work stations.
Best Practice: LED lighting or another type of light-
ing that does not create a source of heat should be 
used in task lighting near work areas used to handle 
specimens.
B3.3. Emergency Lighting
In case of power loss, it is critical that emergency 
lighting be available to indicate exit routes from 
the repository and to provide an illuminated, safe 
environment to aid in monitoring equipment 
and responding to the needs of the emergency. 
Emergency lighting should have battery backup 
support and should be tied to backup generators. 
It may be beneficial to use small night lights that 
plug into outlets that have a battery component 
for low-level illumination. Repositories should also 
have portable lighting (e.g., flashlights) on hand to 
use as focused light sources, as needed. Focused 
light sources can be essential during an emergency 
for use in equipment diagnosis and repair. 
Best Practice: Emergency lighting should be test-
ed on a regular basis and batteries checked on an 
annual basis and replaced as needed as a part of 
the overall operating procedures.
B4. FLOORING 
Flooring surfaces used in repositories should be appro-
priate for the equipment and refrigerants used in daily 
repository activities. Flooring should be easy to clean and 
facilitate the movement of equipment when circumstanc-
es warrant. Special consideration should be given to the 
flooring in regions where liquid nitrogen is used, as vinyl 
tile will crack and cause a hazard if liquid nitrogen is spilled 
directly onto it. Repositories should consider providing 
anti-fatigue mats for staff in areas where personnel stand 
for prolonged periods of time.
Due to the high weight of storage and other equipment 
(e.g., freezers, liquid nitrogen units, heavy cabinets), con-
sideration of the combined weight of the equipment must 
be taken into account when locating the repository within 
a building or when designing a new facility.
B5. BACKUP POWER
Repositories that store specimens in constant temperature 
environments will use some equipment that require a 
source of constant and stable (e.g., consistent voltage per 
manufacturers’ instructions) electrical power. Given that all 
commercial power is likely to be interrupted at some time, 
a backup power system is strongly recommended. 
Best Practice: Repositories should be aware of the loca-
tion of their building generators and confirm that they are 
on the backup system.
B5.1. Uninterruptible Power Supply 
An uninterruptible power supply (UPS) is inserted 
between the source of power (typically commercial 
utility power) and the load it is protecting. When a 
power failure or abnormality occurs, the UPS will ef-
fectively switch from utility power to its own power 
source almost instantaneously to provide a continu-
ous supply of electric power during transition to an 
alternate power source or orderly shut-down.
Best Practice: Computer systems and electronic 
systems such as environmental monitoring systems, 
safety systems (e.g., oxygen sensors, ventilations 
systems), and controllers for liquid nitrogen freez-
ers should be protected by a UPS. UPSs used in 
repositories should be tested on an annual basis to 
ensure their proper backup capabilities.
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B5.2. Generators
The most common type of backup power is a motor 
generator. Generators have automatic controls that 
cause them to produce electricity when commer-
cial power is interrupted and are typically fueled by 
diesel, natural gas, or propane. The actual backup 
system employed should be determined based 
upon a risk management assessment of the facility, 
region, and resources.
Dual fuel generators that can run on more than one 
type of fuel (e.g., natural gas, propane) provide 
a high level of flexibility for fuel supply sources. 
Manual transfer switches in addition to the auto-
matic transfer switches can be installed to allow for 
set up of quick disconnects which enable portable 
generators to be brought in and connected in a 
matter of minutes. Each outage scenario and de-
sired outcome needs to be evaluated in advance 
to ensure expected infrastructure is in place. For 
large repositories, risk assessment exercises will 
inform the decision to have one large generator or 
multiple smaller ones to support the facility.
Based on risk tolerance assessments and financial 
stewardship, it may be determined that a backup 
generator support only designated pieces of 
equipment deemed critical. 
Best Practice: A generator should have a fuel 
supply to run continuously for a minimum of 48 
hours and preferably a minimum of 72 hours, with 
an ability to re-fill fuel storage supplies. 
Best Practice: Repositories that utilize generators 
should have an established plan for sources to re-
plenish fuel supplies in case of an emergency. This 
plan should include lists of suppliers and backup 
suppliers committed to provide the fuel as needed. 
Best Practice: Repositories should contact suppli-
ers to be placed on a list as an entity that receives a 
quick response should an emergency situation arise.
B5.2.1. Generator Tests
To ensure the likelihood that backup power 
systems function reliably when needed, they 
should be routinely tested to ensure that the 
system starts on demand and carries the re-
quired load. Load tests should be performed 
to ensure that the generator functions within 
specifications under full load. Additionally, for 
facilities that have bulk diesel storage, annual 
testing and filtering of the fuel should be per-
formed to ensure that excessive water or bac-
terial build-up, which can affect performance of 
the generators, has not occurred.
Best Practice: The power generator system 
should be included in a frequent preventative 
maintenance plan which includes weekly 
testing for automatic starting and power gen-
eration and monthly load testing. If load testing 
places sensitive equipment at risk, the gener-
ator should be tested less frequently. Those 
systems that have an automatic transfer switch 
should also be tested on a periodic basis (e.g., 
every six months).
Best Practice: Repositories located in or 
associated with larger facilities (e.g., hospitals, 
universities) that automatically initiate backup 
power upon power interruption should link 
their freezers and other essential equipment 
into these emergency systems. The operational 
safety and testing should be performed by pro-
fessional caretakers of the larger infrastructure. 
Best Practice: For large facilities, staging of 
the sequence of start-up of mechanical freezers 
and other systems should be considered to 
ensure sufficient downtime to allow the com-
pressors to come to rest before restart.
Best Practice: Generator-dependent systems 
should be periodically checked to confirm 
automatic restart when the electric power 
fails. When possible, an attached alarm system 
(SMS, email, phone call, etc.) should be in place 
to manage the emergency response.
B6. SECURITY AND ACCESS
Repositories should be equipped with a system that ad-
equately limits access to appropriate staff and protects 
against physical intrusion from unauthorized individuals. 
Only persons assigned to repository operations should 
have access to the material stored within and records of 
access should be maintained. Freezers or environmental 
storage equipment that store valuable or sensitive speci-
mens should be individually locked. 
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B6.1. Security Systems
Every repository should employ basic security 
systems to ensure protection of the specimens 
and data stored therein. A responsible individual 
should be available at all times to take the neces-
sary action(s) to respond to an alarm in a time frame 
that prevents or minimizes loss or damage to the 
stored materials. Systems should initiate calls to 
other staff trained in emergency response when 
the first individual fails to acknowledge the alarm. 
Best Practice: Repository security systems should 
be monitored and personnel available to respond 
to alarms twenty-four hours per day and seven days 
per week. 
B6.2. Intrusion Detection Systems
When either the repository or the building in which 
it resides is not occupied by authorized personnel, 
a system should be in place to detect unauthorized 
entry. Motion detectors, glass break sensors, and 
door entry sensors should be integral components 
of the system. As appropriate, the system should 
accommodate changes to security codes and keys 
when individuals leave the organization. 
B6.3. Visitor Access Policy
An access policy should be developed for individu-
als visiting the repository. Where feasible and appro-
priate, sign-in sheets or log books should be used to 
record the name and affiliation of the visitor, purpose 
of the visit, as well as track the time at which the vis-
itor(s) enters and leaves the repository. Badges can 
be made available for the visitors that clearly indicate 
to staff that they have been formally received and 
their presence documented. Visitors should be ac-
companied by staff at all times during their visit. 
Best Practice: Written or electronic records of 
repository visitors should be maintained and the 
records maintained and archived according to the 
repository’s records management practices. 
B7. FIRE PREVENTION SYSTEMS
In many countries and municipalities, a fire prevention sys-
tem is required by building codes for newly constructed 
facilities and compliance with codes is usually required if a 
facility is being converted or renovated. 
B7.1. Fire Prevention Plan
Repositories should have a written fire prevention 
plan. The plan should address procedures for reg-
ular maintenance on equipment used to prevent or 
control sources of ignition or fires and name or job 
title of employees responsible for maintaining the 
equipment.
Best Practice: The fire prevention plan should 
include a list of major fire hazards, potential ignition 
sources, proper handling and storage procedures 
for hazardous materials, and the type of equipment 
necessary to control each major hazard.
B7.2. Detection Systems
Automatic fire detection systems are used to quick-
ly identify a developing fire and alert occupants and 
emergency response personnel before extensive 
damage occurs. Automatic fire detection systems 
do this by using electronic sensors to detect the 
smoke, heat, or flames from a fire and provide an 
early warning. Fire detection systems should be 
tested regularly to maintain proper reliability and 
operating condition by a trained person knowl-
edgeable in the operations and functions of the 
system. Fire detectors should be selected based 
on the burning characteristics of the materials pres-
ent and the nature of location they will be used to 
protect.
B7.3. Fire Extinguishing/Suppression Systems
B7.3.1. Sprinkler Systems
The most common type of fire suppression is a 
sprinkler system that sprays water upon activa-
tion. The standard system has water in the pipes 
at all times. Excess heat causes the system to 
activate, spraying water into the area. 
When computer equipment and electrical 
systems are in place, a “pre-action” sprinkler 
system can be employed. In such a system, the 
sprinkler pipes are dry until a fire is detected. 
This type of system prevents water damage 
from accidental activation of the sprinkler 
system. Special consideration should be used 
if sprinkler systems are deployed in proximity 
to cold rooms where slip hazards could be an 
issue.
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B7.3.2. Non-Water-Based Fire Retardants
Due to the nature of certain equipment and 
stored materials, water may be an unsuitable 
tool for fire suppression. In these instances, oth-
er chemicals may be employed. The chemicals 
used in these systems generally smother the fire 
by cutting off the supply of oxygen. While these 
systems can be very effective and may be crit-
ical for valuable collections adversely affected 
by exposure to water, they are costly and may 
present safety hazards. Although the majority 
of these suppressants do not represent a health 
risk to staff upon activation, personnel should 
receive appropriate safety training.
Most facilities provide dry chemical fire extin-
guishers. The suppressant is somewhat corro-
sive. If used in proximity of mechanical freezers, 
the dry chemical released can be pulled into the 
compressor area and damage the unit. There is 
also risk of specimen contamination as it is dif-
ficult to fully remove and clean up the powder 
in these areas. Other methods such as nitrogen 
gases may be considered to extinguish fires. 
Local authorities should be contacted to pro-
vide input into any restrictions for the methods 
that may be employed.
Best Practice: Use extinguishers that contain 
a non-corrosive gaseous suppressant in repos-
itory areas.
B8. EMERGENCY PREPAREDNESS
B8.1. Emergency Response Planning
An emergency response plan should be a compo-
nent of the disaster recovery plan. Emergencies 
can cover a wide range of natural and man-made 
disasters, all of which may have varying effects 
on the facility and on the ability of the repository 
to carry out its essential functions. The type and 
duration of disasters may depend on the geo-
graphic location at which the repository is located. 
Depending on the “value” and the ability to replace 
certain samples, some repositories may decide to 
divide collections and store them in different envi-
ronmental storage containers or even at different 
geographic locations so that a disaster affecting 
one component of the collection would not elimi-
nate the entire collection. 
Repositories should have a written disaster recov-
ery/incident response and business continuity plan 
for responding to a wide variety of emergency 
situations. This plan should be tested periodically 
(e.g., at least annually) to ensure that all personnel 
are trained and that the plan meets the anticipated 
needs. Copies of these plans should be distributed 
to all appropriate staff.
Key individuals should be identified who will serve 
as being “on call” or who will be able to respond to 
an emergency at the repository. Leave and vacation 
schedules should be monitored to ensure that cover-
age of essential responsibilities is in place should key 
individuals be unavailable. Emergency contact num-
bers should be posted in prominent locations in the 
repository and should be carried by staff members 
at all times who are “on call”. The contact information 
should be reviewed on a regular basis to ensure that 
the information contained therein is current.
Best Practice: The Director or appropriate staff 
member should communicate with local power 
providers before an emergency occurs to request 
that the repository be placed on a list of “high 
priority” users for power restoration following an 
emergency.
Best Practice: Repositories should have a check-
list of activities for “on call” staff to follow during 
an emergency. “On call” staff should be familiar 
with the location and operation of certain key 
equipment and controls (i.e., circuit boards) that 
may need to be checked during an emergency. 
Telephone numbers for professional assistance 
should be clearly posted in the repository and 
accompanying administrative areas (e.g., engineer-
ing or facilities personnel, power companies, fuel 
supply companies, transportation services).
Best Practice: Notification of security and environ-
mental monitoring systems should be verified on a 
routine basis. Where possible, emergencies should 
be simulated to ensure proper follow-through for 
the established emergency plan. 
 Best Practice: If repository inventory systems are 
housed on a server located away from the reposito-
ry, some consideration should be given to storing 
electronic inventory records on site to ensure that 
needed records are accessible in an emergency.
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Best Practice: In the event of an impending need 
for evacuation, repositories that utilize liquid nitro-
gen bulk tank(s) should arrange to have them filled. 
Best Practice: Duplication of specimen collec-
tions and data in distinct locations (e.g., including 
in different freezer units) is recommended to ensure 
preservation of the holding in the event of a cata-
strophic event. 
B9. PEST AND CONTAMINATION CONTROL 
Insects, rats, or other small animals may invade the re-
pository space, for example, through drainage systems, 
windows, etc. The invasion pathway(s) need to be blocked 
and an extermination company can be used to help with 
problem areas.
Consideration should be given into monitoring mold and mil-
dew contamination in high-humidity areas (e.g., facilities and 
controlled storage environments). A remediation plan should 
be established to address any contamination issues that arise. 
Best Practice: A plan for effective and environmentally 
sensitive approaches to pest and contamination manage-
ment should be maintained.
B10. RELOCATION OF A REPOSITORY
There are times that require repositories to relocate from 
one site to another. Such situations may be caused by 
the inability to renew a lease if repository space is leased, 
because the special requirements have changed either 
due to expansion or reduction of the collections housed 
within the repository, or due to an emergency situation. 
Since many considerations must be made to ensure an or-
derly transfer of equipment and supplies, planning should 
begin as early as possible to ensure the effective transfer. 
In preparation for an unanticipated emergency, a plan 
should be in place and tested in advance to ensure suc-
cessful implementation. Consideration should be given to 
whether the repository has sufficient staff and resources to 
conduct the relocation independently or if a commercial 
vendor providing such services should be utilized. 
The requirements for the new space should be well-
documented and complete and should meet the 
anticipated growth for the period of time for which it will 
be occupied. Stakeholders and staff should be included 
in discussions to ensure that all details are attended to and 
that all training needs are met for handling the collections 
in the new location. 
Relocation should be planned over a period of time that 
will allow for effective responses to any challenge that 
may arise. Empty environmental equipment for all storage 
temperatures reflected in the collection to be transported 
should be operational and stabilized to receive specimens 
in the event of a failure of a particular unit during transit. 
When dry ice bins or shippers are used, careful planning 
is needed to ensure the temperature and safety of the 
specimens is maintained during transport. Equipment 
maintenance professionals should be alerted to the date 
and time of the move to ensure the likelihood of their rapid 
response. To the greatest extent possible, repository staff 
should ensure that shippers, carriers, and drivers follow 
all regulations for movement of hazardous and infectious 
materials.
Best Practice: A map should be created for the new site 
that will indicate the location of all equipment and materials 
that will be transferred prior to the initiation of the move.
Best Practice: Planning should include review of current 
processes to ensure that they can be efficiently implement-
ed into the new space. 
Best Practice: When planning a large relocation, a mock 
or pilot relocation run (e.g., a partial movement of the back-
up systems of freezers and liquid nitrogen tanks) should be 
conducted in advance of the actual move to test the plan 
and make any necessary adjustments.
Best Practice: When large shipments are planned or 
repositories are relocated, the time of year and environ-
mental conditions (e.g., seasonal weather) should be con-
sidered to ensure the safe transport of the specimens and 
maintenance of cold chain. 
Best Practice: The details of how the relocation is to be 
accomplished (e.g., a description of the plan, timelines, 
roles of staff and contract support) should be documented 
to ensure that those involved are fully aware of schedules 
and costs and that the transition process is carried out 
effectively and appropriately.
Best Practice: Potential impacts of relocation on speci-
men quality should be recorded and documented. 
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SECTION C: STORAGE AND 
PROCESSING EQUIPMENT 
C1. GENERAL
The variety of storage systems available for specimen 
collections continues to increase as technologies advance. 
Storage equipment selections should be based on the 
type of specimens and/or samples to be stored, the an-
ticipated length of time the specimens will be stored, the 
intended use for the specimens, and the resources avail-
able for purchasing the equipment. Also important are the 
size and physical design of the repository and the number 
of specimens stored (as well as predictions for future 
growth in number of specimens stored). Some freezers 
and refrigerators now provide automated specimen entry 
and retrieval components which may reduce long-term 
costs for the repository and will maintain specimen quality 
more effectively as warming events of specimens can be 
avoided. Often these larger systems are accompanied by 
increased initial costs, which may be more than smaller 
repositories can support financially. Equipment selections 
should take into consideration staffing requirements, qual-
ity issues, estimated length of specimen storage, available 
resources, and equipment support and maintenance.
As costs for maintaining repositories have continued to 
rise, every effort should be made to keep the costs for op-
erating equipment to a minimum. Recent developments 
in energy-efficient equipment can generate significant 
savings on facility costs. Several manufacturers are making 
use of compressor systems that are cooled either by water, 
where available, or by placing condensers on the exterior 
of the building so that the heat released from equipment 
does not have to be counter-balanced by heavy Heating, 
Ventilation, and Air Conditioning (HVAC) requirements. In 
addition, there are now freezers with free-piston technolo-
gy that utilize less energy than compressor-based systems 
and reduce electric utility costs, heat output, and HVAC 
cost of operations. These systems may also be introduced 
into existing facilities that tend to have warmer indoor 
temperatures, without the need to modify HVAC systems. 
Energy-saving storage solutions are being introduced to 
repositories that allow for ambient storage for some ma-
terial types, eliminating the need for maintaining low-tem-
perature storage environments to ensure specimen 
integrity (C7. Ambient Temperature Storage). Repositories 
located in areas where humidity is high (e.g., coast, etc.) 
should employ a de-humidification system to maintain the 
preferred storage conditions and minimize the effects on 
the storage units. 
Temperature mapping is performed to ensure that spec-
imens are correctly handled and stored within their speci-
fied temperature range(s) and may include freezer rooms, 
cold rooms, and temperature-controlled storage areas. 
It is the process of mapping the differences and changes 
in temperature that occur due to influences like opening 
doors, proximity to cooling fans, personnel movement, 
and the quantity of materials being stored at any given time. 
Temperature mapping locates the points of greatest tem-
perature fluctuation and difference, analyzes the causes of 
these, and creates ‘worst case’ conditions to verify that a sys-
tem maintains the correct temperature levels in all situations 
when influenced by external factors such as weather, and 
internal factors such as airflow restrictions and the operation 
of the HVAC systems (see Appendix A: Internet Resources).
Best Practice: Repositories should have backup power 
and/or alternate cooling systems in place, as well as an 
emergency response plan (see Section B8.1. Emergency 
Response Planning).
Best Practice: Systems should be equipped with redun-
dant compressors that operate under an electrical alternat-
ing control system. 
Best Practice: Adequate signage should be used for 
appropriate storage. 
Best Practice: To prepare for the possibility of freezer 
contamination by blood or other fluids, decontamination 
equipment and procedures should be available in advance. 
Best Practice: Oxygen monitors/alarms should be used 
when liquid nitrogen, liquid CO2, and/or any other oxy-
gen-depriving compressed gases are used. 
Best Practice: Temperature mapping should be per-
formed to document and control the temperature distribu-
tion within a storage area upon installation and periodically 
at defined intervals.
C1.1. Personal Protective Equipment
Normal laboratory personal protective equipment 
(PPE) (e.g., closed-toed shoes, full cover of legs 
and feet, goggles) should be worn when han-
dling coolants. The use of protective equipment, 
goggles, and gloves should be mandatory when 
handling cryogenics and the equipment should 
be placed in an easily accessible and visible lo-
cation. Appropriate outerwear and shoes should 
be considered when working in walk-in systems 
that are maintained at cryogenic temperatures. 
Appropriate training in the safe handling of 
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cryogenics should be provided and included in an 
SOP, describing the potential health hazards and 
required safety precautions. Additional information 
about PPE can be found in Section F5. Personal 
Protective Equipment.
C.1.2. Identification of Specimen Storage 
Containers
The type of label/identifier utilized should be ap-
propriate for the storage equipment and needs to 
be able to withstand the temperature conditions of 
the system. A unique human-readable identifier that 
can be read electronically (e.g., barcode, Radio-
Frequency Identification [RFID]) should be on each 
specimen container. The container and identifier 
should meet the needs of the downstream pro-
cesses and end-user demands. See Section I2.13. 
Labels for additional information.
A pre-approved test plan for validating labels/iden-
tifiers should include evaluation for readability, abil-
ity to scan, stability of the identifier over time, etc., 
at the storage conditions used in the repository as 
well as known downstream applications (e.g., heat 
blocks, water baths, xylene, alcohol). Given there 
are low-cost solutions to identify and track speci-
mens, hand labeling is not recommended, as it is 
not compatible with automation or best practice 
given issues with legibility, permanency, etc. (see 
Appendix A: Internet Resources). 
Best Practice: The use of barcodes (e.g., 1D, 2D) is 
highly recommended to ensure accurate tracking 
of specimens. 
Best Practice: The particular type of label should 
be evaluated for its performance over a variety of 
conditions prior to use. 
C2. LIQUID NITROGEN STORAGE SYSTEMS
The use of liquid nitrogen (LN2) for long-term specimen 
preservation is optimal for the storage of some types of 
biological material. Cryogenic storage using LN2 is an 
effective long-term storage platform because on-site LN2 
supplies reduce reliance on mechanical freezers that use 
electrical power, especially in areas where power is unreli-
able and LN2 is available. 
Technological advances have led to the development of 
new systems that allow specimens to be handled either 
fully or semi-automatically while stored in the vapor phase 
of liquid nitrogen. Such systems provide areas for handling 
and retrieval that are cooled to ultra-low temperatures (be-
low -100°C) preventing cooling/re-warming cycles of the 
specimens.
When considering storing in LN2 vapor phase (≤ -150°C) 
vs. submersion in liquid phase (-196°C), vapor phase 
storage is preferred because it provides sufficiently low 
temperatures to maintain specimens below the Tg (Glass 
Transition Temperature; -132°C) while avoiding contami-
nation issues and safety hazards inherent in liquid phase 
storage. At temperatures below -132°C, the extreme cold 
arrests biological life and slows most chemical and physi-
cal reactions that cause specimens to deteriorate.
While LN2 storage has been traditionally reserved to 
containers that either hold LN2 in the base of the freezer 
or which hold enough liquid for specimens that are sub-
merged in LN2, equipment is now available that allows 
for LN2 to be used as a coolant to allow for storage tem-
peratures in the +4 to -80°C range. This type of cooling 
may have the advantage of being able to maintain the 
temperature of specimens in the event of a power failure. 
A comprehensive assessment of available choices in 
equipment design should be made prior to making any 
new purchases.
Best Practice: Any storage unit used at cryogenic tem-
peratures should be rated for these temperatures and 
have relief valves to evacuate over-pressures.
C2.1. Specimen Storage Containers
The liquid to gas expansion ratio of LN2 is 1:696 
when brought to a gaseous phase at room tem-
perature1. This situation may produce an explosion 
hazard. Glass, metal, and some plastic specimen 
containers (e.g., vials, tubes, straws) can crack and/
or explode if LN2 is trapped inside the specimen 
container when it is removed from the freezer. 
Certain containers, like cryogenic straws, are her-
metically sealed and specifically designed for the 
safe storage of specimens in the liquid phase of 
nitrogen.
Best Practice: Specimen containers selected for 
storage in LN2 should be tested prior to use given 
many commercially available specimen containers 
are penetrable by liquid nitrogen and can create an 
explosion hazard. 
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C2.2. Liquid Nitrogen Supply
Where LN2 refrigeration is employed, an adequate 
supply of LN2 should be maintained. For freezers 
filled from Dewars or supply tanks, a minimum 
three-day supply of LN2 at normal usage and re-
plenishment intervals should be maintained, with 
the assumption that a re-supply is readily available. 
Bulk supply systems should maintain at least three 
days’ working capacity. Bulk supplies should be 
checked for re-supply at least once a week. A te-
lemetry system may be installed to allow suppliers 
to monitor liquid levels in real time to ensure stocks 
do not drop below agreed-upon levels.
Bulk storage and piping systems require relief valves 
to prevent rupturing of the pipe and bulk tanks in 
the event of over-pressure. If relief valves trip un-
expectedly, a person near a valve can be sprayed 
with either the cold gas or the liquid. More likely, 
in the event of a blockage or excessive pressure, 
several relief valves may vent nearly simultaneously. 
This can cause a “whiteout” condition in a matter of 
a few seconds. Visibility can drop to near zero and 
oxygen levels in the area may become less than 
that necessary to sustain life. Under these circum-
stances, personnel should evacuate immediately. 
For this reason, O2 monitoring should be installed 
in any areas of the facility where LN2 is utilized (See 
Section C2.5.1. Oxygen Sensors). 
Best Practice: Daily LN2 usage per freezer should 
be recorded either by monitoring the display levels 
or by manual means as excessive LN2 usage can 
indicate problems with the vacuum component of 
the freezer. 
C2.3. Liquid Nitrogen Safety 
Additional safety precautions are needed when uti-
lizing LN2 freezers given the displacement of oxygen 
and extremely cold temperatures pose increased 
risk to personnel compared to other freezer systems 
(see Section F6.8. Liquid Nitrogen Safety).
C2.3.1. Oxygen Sensors
Because nitrogen displaces oxygen, care 
should be taken when LN2 freezers are em-
ployed. The risk is inversely correlated with the 
size of the room. Oxygen level sensors should 
always be employed when LN2 freezers are 
used in a repository. Normal levels of oxygen 
in ambient air should be ~21%. Most installed 
oxygen sensor units have batteries or sensor 
cells that should be replaced and re-calibrated 
as directed by the manufacturer. Consult the 
manufacturer for recommended requirements 
to determine the number of sensors needed 
based on the size of the room, to confirm the 
placement in the room, and height of wall 
mounting. Acoustic and visible alarms may be 
installed in and out of the room and dedicated 
exhaust ventilation may be used in coordina-
tion with the sensors. Rooms with LN2 freezers 
should have viewing window(s) to determine 
whether it is occupied during alarms.
Both fixed and mobile/personal monitors may 
be appropriate depending on the size of the 
facility. Even when installed units indicate an 
alarm condition, it may be useful to employ a 
personal monitor to enter the room carefully 
to validate the alarm condition if the area is not 
visible from outside the room. It may be more 
appropriate to use mobile oxygen monitors in 
a secure area where LN2 freezers operate be-
cause the sensors in installed units will degrade 
over time and sound false alarms. 
Best Practice: All monitoring systems for mea-
suring oxygen deficient atmospheres should be 
installed and evaluated per the manufacturer’s 
instructions. Staff should carry personal oxygen 
monitors when safety conditions warrant it.
Best Practice: Duplicate systems (e.g., wall 
system, automatic emergency fans, automatic 
door opening, personnel monitoring system) 
should be employed to ensure the highest level 
of personal protection.
C2.3.2. Personal Protective Equipment
In addition to the oxygen deficit risks described 
under Section C2.5. Liquid Nitrogen Safety, 
use of LN2 as a refrigerant poses special safety 
problems because of its low temperature and 
rate of expansion when placed at ambient 
conditions. Eye protection is mandatory every 
time LN2 is handled to protect against splashes 
that inevitably occur. Face and eye protection 
is recommended when handling vials removed 
from a LN2 freezer or when dispensing LN2 from 
low-pressure lines. Heavy gloves (appropriate 
for LN2 use) should be worn to protect hands 
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when handling specimens stored within the 
liquid phase or when transferring LN2 or other 
coolants to Dewar flasks. 
C3. MECHANICAL FREEZERS
Mechanical freezers are employed in a variety of storage 
temperature ranges and come in a wide variety of sizes, 
configurations, and electric voltages. Because these are 
devices attached to commercial power systems, a back-
up power plan and emergency response plan should be 
in place (see Section B8. Emergency Preparedness). The 
length of time that results in the significant warming of the 
stored material will vary by the properties of the stored ma-
terial, the temperature of the material stored in the freezer, 
the ambient conditions, and the design and maintenance 
of the unit. Chest systems maintain better cold retention 
upon opening while uprights typically provide more effi-
cient compartmentalized storage. It is the responsibility 
of the facility operator to establish and enforce the critical 
temperatures and response times to alarms. 
Some mechanical freezers are equipped with emergency 
backup systems that automatically cool their contents with 
either LN2 or liquid carbon dioxide (CO2) in the event of an 
extended power loss. Any freezer implementing this type 
of emergency backup cooling system should be specifi-
cally designed to accommodate whatever coolants are 
utilized and adequate supplies of refrigerant gas should 
be kept on hand at all times to operate the system. Safety 
precautions with the backup system (O2 or CO2 monitoring 
systems) should be taken into consideration in the event of 
an emergency. Precautions should be taken to maintain 
the safety of personnel in the areas where compressed 
gases such as CO2 or LN2 are used (see Section F6.2.2. 
Compressed Gases).
Independent of backup cooling solutions, efforts should 
be made to ensure that freezers (as well as refrigerators) 
are positioned in repositories to allow for adequate airflow. 
Insufficient distance between units or between units and 
walls may lead to overheating of compressors, shortening 
compressor life. In addition, inadequate air circulation may 
lead to the growth of mold and other harmful microbial 
contamination situations. HVAC systems are more efficient 
than simple ventilation systems at maintaining tempera-
tures and humidity.
A cascade freezer system is a series of storage units that are 
connected to a central cooling unit. The benefit of cascade 
systems is greater storage capacity in a smaller footprint with 
greatly reduced energy consumption over stand-alone units. 
In addition, the mechanical cooling systems may be placed 
in areas external to the sample storage reducing heat and 
noise in the storage/work area. The upfront cost is typically 
greater than stand-alone units, but the reduced footprint and 
energy consumption can pay for this upfront cost over time 
in the right situation. Cascade freezer systems are available 
in a wide variety of configurations, including size, number of 
chests, temperature ranges, and voltage requirements. The 
systems should be designed with full redundant cooling sys-
tems to mitigate failure and allow for maintenance of the sys-
tem while online. The systems can be scheduled to run in al-
ternation so that both units do not wear out at the same time. 
The system can be configured with one or multiple chest or 
upright configurations. A typical installation example can 
have ten storage units with the capacity of 30 stand-alone, 
large, uprights in less than half of the area. A cascade system 
should be configured with the ability to manually control 
cooling and to isolate individual containment areas, as well 
as the ability to replace individual storage units if possible. 
It is recommended to have independent alarms systems for 
the units and it is the responsibility of the facility operator to 
establish and enforce the critical temperatures during access 
of the individual units and response times to alarms. 
C4. AUTOMATED STORAGE SYSTEMS
Automated specimen storage and retrieval systems keep 
specimens at their required storage temperature while 
minimizing temperature fluctuations. It is important for 
the specimen storage temperature and the specimen 
retrieving temperature to be as close as possible to pre-
vent warming events. Other considerations for the use of 
automated specimen storage are the specimen tracking 
capability, audit trail, and maximization of the storage ca-
pacity. Most systems can consolidate empty positions of 
stored racks (defragmentation). Some systems provide the 
ability to store multiple labware types. 
Automated specimen storage solutions are available in 
various temperature settings (e.g., ambient, -20oC, -80oC, 
and -150oC) and various size solutions for collections rang-
ing from thousands to millions. Many systems can be ex-
panded as the collection grows. In addition, most auto-
mation systems have lower energy requirements, smaller 
footprints, and require lower HVAC output than individual 
storage units. 
C4.1. Specimen Storage Containers
The first step in considering automation of any 
repository should be the labware type utilized. 
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The choice of labware size and manufacturer is 
optional, but at a minimum, a unique identifier that 
can be read electronically (barcode, RFID, etc.) 
should be on each specimen as many downstream 
processes can only be automated if the specimens 
have a barcode label. Although this may be a more 
expensive option, legacy collections without these 
barcodes are not automation friendly. Hand label-
ing is not recommended as it is not compatible with 
automation or best practice given issues with leg-
ibility, permanency, etc. See Section I2.13. Labels 
for additional detail.
C5. REFRIGERATORS
Refrigerators are commonly employed where the longev-
ity of the material being stored is enhanced by storage 
below ambient temperature. This is the preferred storage 
medium when the material should be kept cool but does 
not require freezing. Refrigerators may also be used for 
short-term storage of media and additives based on expi-
ration dates. It is important to ensure that the temperature 
is maintained within the specified operating range, not just 
below a maximum temperature. Some high value materi-
als should be maintained precisely between 2°C and 8°C. 
C6. WALK-IN ENVIRONMENTAL STORAGE  
  SYSTEMS
C6.1. Design 
Walk-in refrigerators and freezers should be 
equipped with redundant compressors that oper-
ate under an electrical alternating control system. It 
is important to consider noise reduction strategies 
when employing units with compressors. To de-
crease the noise in the rest of the repository, it may 
be important to isolate the compressors in their 
own enclosure within the facility. Rusting of the 
metal parts in freezers can be a serious issue during 
long-time storage. Care should be taken to reduce 
the moisture content of the air inflow to freezers in 
high-humidity environments. 
When evaluating whether to use mechanical or 
walk-in freezer systems, a consideration in the 
decision-making process is the lower cost of oper-
ation of walk-in freezers compared to stand-alone 
mechanical freezers. In addition, most walk-in 
systems have lower energy requirements, smaller 
footprints, and require lower HVAC output. 
Best Practice: To inhibit the rusting of metal parts, 
repositories should apply anti-rust coatings and 
install dehumidification systems. 
C6.2. Safety 
In most countries building codes require that 
walk-in units have internal safety releases to pre-
vent a person from being trapped within a unit 
by the accidental closing of doors (e.g., interior 
door release mechanism). Because of the special 
hazards involved in personnel working in a -20°C 
or colder walk-in environment, it is desirable that 
some form of monitoring system be employed and 
that consideration is given to the amount of time it 
is safe to work inside the system. This is especially 
applicable if only one person is working in the 
freezer; however, most repositories employ a bud-
dy system. Multiple technologies to detect motion 
of personnel working in the system are available 
such as wearable devices commonly employed 
by firefighters and other emergency personnel 
or motion detectors permanently installed in the 
system. Walk-in freezers should be kept free of dry 
ice (i.e., the solid phase of CO2). Carbon dioxide 
can rapidly build-up, displace the oxygen in the 
room, and cause personnel working in the units to 
lose consciousness. Where dry ice is employed, 
there should be adequate ventilation to ensure that 
sufficient air or oxygen levels exist. In these circum-
stances, it is recommended that walk-in freezers 
have both oxygen and CO2 monitors as well as an 
automatic emergency exhaust fan. Similarly, it is not 
appropriate to use scientific cold rooms to store 
hazardous or flammable material or food.
Moisture within walk-in systems can generate slip-
ping and falling hazards if water condenses on the 
floor. Freezers can occasionally create ice or water 
on the floor if the unit is defrosting. Some type of 
rubberized mat or grate should be placed in front 
of these types of units to prevent slipping.
Best Practice: For a -20°C or colder walk-in envi-
ronment, engineering controls may be designed 
to support an audible alarm system coupled with 
a safety procedure to allow for the safest operating 
conditions.
Best Practice: A warning sign should be posted at 
the entrance of walk-in cold storage areas advising 
that the area may be slippery.
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C7. AMBIENT TEMPERATURE STORAGE 
While formalin-fixed, paraffin-embedded (FFPE) tissues 
have been stored at room temperature for centuries, 
recent developments have allowed for the identification 
of biological storage matrices that allow for long-term 
maintenance of additional biological components at 
room temperature. These matrices have been used for the 
storage of dry blood spots, isolated RNA and DNA, and 
for other biological materials. They may be helpful when 
mechanical or cryogenic equipment is not available or 
may serve as an alternative method for backup storage for 
some material types2. Prior to implementation, all matrices 
should be evaluated to be sure that they are appropriate 
for downstream purposes and applications. See also 
Section E1. Validation of Sample Processing Methods. 
Storage cabinets for ambient temperature storage of 
specimens can be equipped with passive or active humid-
ity controls. These storage cabinets can be fully integrated 
with automation and robotic controls as well as tracking 
and specimen management software.
C7.1. Storage of FFPE Tissue Blocks and Slides
FFPE tissue blocks and slides are stored in a vari-
ety of ways. Many are stored in cabinets or other 
manual storage systems. This includes manual 
placement, sorting, and retrieval of tissue blocks 
and slides. Sorting of specimens should be done 
chronologically or study-based to ensure the 
increased efficiency of locating the specimen. It 
is a good idea to place a marker in the position of 
the removed specimen to allow ease of returning 
the specimen to the original location, when ap-
propriate. Regardless of the storage system used, 
FFPE specimen storage at room temperature (20 
– 25°C) should be in a controlled low-humidity 
environment3.
Manual handling of FFPE specimens is associated 
with major drawbacks, including: (1) manual label-
ing of specimens can be ambiguous and may lead 
to misidentification; (2) returning a specimen to a 
different storage location can lead to “disappear-
ance” of the specimen; and (3) difficulty in con-
trolling incoming and outgoing specimens, may 
result in challenges in running a proper database 
of specimens stored in the archive.
New technologies for automating FFPE storage 
are being developed. Semi-automated systems 
using barcoded blocks and slides (2D barcodes are 
preferred) not only reduce the work load of the re-
pository personnel but also increase the reliability 
of inventory control by scanning of each incoming 
and outgoing specimen. It is recommended that 
automation be implemented when either col-
lection size or activity level increases to the point 
where efficient retrieval and organization become 
a bottleneck to the repository.
Best Practice: FFPE blocks stored at room tem-
perature (20 – 25°C) should be under controlled 
low humidity.
Best Practice: Specimen quality is maintained 
optimal when the FFPE blocks are stored at 
-20°C to 4°C. Repositories should validate the fit-
ness-for-purpose of the paraffin they use to sub-ze-
ro temperatures.
Best Practice: Barcodes (e.g., 1D, 2D) should 
be used to ensure accurate tracking of FFPE 
specimens. 
C8. CONTAMINATION ISSUES
Every effort should be made to avoid contamination of 
specimens. Contamination by fungus can frequently de-
velop in cold storage rooms (2 – 8°C), refrigerators, or 
at ambient temperatures. It is important to periodically 
survey areas to eliminate factors (e.g., damp, unclean ar-
eas, cardboard boxes) that can facilitate fungal growth. 
Periodic monitoring should be encouraged to visually 
monitor for fungal contamination and for items that may be 
inappropriately stored. Repositories should consider the 
use of dehumidification systems.
C9. BACKUP STORAGE CAPACITY
Adequate backup capacity for low-temperature units 
should be maintained in anticipation of possible equip-
ment failure. If space and funds allow, backup storage 
for each storage condition should be available within 
the repository. Where this is not possible, repository staff 
should identify backup space in a nearby facility to allow 
for transfer of specimens in case of an emergency. When 
colocation is not possible, LN2, dry ice, and/or portable 
freezers should be available at the facility to maintain 
specimens during transfer to the backup units offsite in the 
event of an emergency. Additional backup power should 
also be available. Refer to Section B: Facilities for additional 
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details on emergency preparedness and relocation of a 
repository. 
Best Practice: Extra-capacity equipment should be equal 
to the capacity of the largest single storage unit and should 
be maintained in reserve at operating temperature. The 
total amount of backup storage required for large repos-
itories should be determined empirically.
Best Practice: Repositories should have a written proce-
dure for transferring specimens from a failed or malfunc-
tioning unit (one that has exceeded or is on the verge of 
exceeding its acceptable operating temperature range or 
become over-filled) and for the return of the specimens to 
their original location once it is considered safe to do so. 
The procedure should include the freezer or refrigerator 
name or number as well as the location within the freezer 
where the specimens have been relocated.
C10. ENVIRONMENTAL MONITORING  
  SYSTEMS
Acceptable temperature ranges should be determined for 
any specimen storage equipment that is designated for 
operation at a specific temperature before the equipment 
is put into service. Temperature ranges allow for normal op-
erating variations and provide some variation for warming 
when the material is accessed. It is important to understand 
that temperature probes measure the temperature where 
the probes are located; therefore, different locations in the 
equipment might exhibit different temperatures depending 
on the size and age of the unit as well as other factors. Also, 
note that freezers and refrigerators that are full will likely dis-
play temperature readings that are different from readings 
taken when the equipment is empty.
Once placed in service, daily and continuous monitoring 
practices and systems should be used for evaluating 
the performance of all fixed-temperature storage units. 
Storage units with defined environmental conditions 
should have temperature-monitoring devices that can be 
visually inspected on a regular basis. 
In addition to regular temperature-monitoring activities 
performed by repository staff, an automatic tempera-
ture-monitoring system should be utilized that continually 
monitors temperatures of all critical equipment and other 
important parameters, creates logs, generates audit 
trails, and generates alarms to notify personnel trained in 
emergency preparedness to respond. An option to have 
an audible alarm for those individuals physically present in 
the repository can be beneficial as well.
The alarm notification system should call or page the indi-
vidual “on call” (or should activate the “on call” list) rather 
than simply providing passive notification (e.g., provide 
computer-generated notification which has to be moni-
tored by staff; see also Section B6.1. Security Systems).
Depending on the size of the repository and number of staff 
available, more than one individual should be available at 
all times, in case the first individual is in a location where he 
or she cannot receive or respond to the notification. Alarm 
conditions should be responded to in a timeframe that 
minimizes the likelihood of damage to the stored material. 
Repository management should ensure that personnel 
with adequate training who can take corrective action 
should be available or reachable 24 hours per day, seven 
days per week (see Section C12. Equipment Maintenance, 
Repair, and Replacement).
One additional method for automated temperature mon-
itoring involves the connection of thermocouple wires 
from the “dry” temperature contacts to the building secu-
rity system that allows identification of individual storage 
units in alarm. 
Visual inspection of room and storage equipment tem-
peratures should be performed regularly (at least three 
times a week) and a record kept of the temperatures ob-
served. Temperature records should be verified monthly 
by supervisors. In addition to monitoring the current room 
and storage equipment conditions, regular recording and 
review of temperatures (preferably daily) provides a way to 
spot trends, which may provide an indication of degraded 
performance or incipient failure.
Temperatures should be monitored during extended 
periods of freezer access to ensure that safe temperature 
ranges are not exceeded. Attention should be given to the 
fact that closing the freezer or refrigerator warming may 
not immediately reverse warming.
Best Practice: Environmental monitoring systems should 
be qualified prior to and periodically during use as required 
by business need (also see Section C12.2. Verification of 
Equipment Functionality). 
Best Practice: In repositories where specimens are stored 
in the vapor phase of liquid nitrogen, staff should regularly 
employ a technique whereby a physical measurement 
of the liquid nitrogen level is taken with a tool such as a 
dipstick to confirm the liquid nitrogen level. Alternatively, 
probes may be placed at various levels in the freezer to 
monitor liquid nitrogen levels (e.g., temperatures below 
 196°C indicate that the probe is submerged in liquid ni-
trogen and temperatures warmer than -196°C indicate that 
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the probes are in the vapor phase of the chamber). If a tool 
is used to measure liquid levels, it should be treated with 
ethanol, bleach, or other disinfectants to disinfect the tool 
before and after it is used. 
Best Practice: Alarms should be tested on a regular basis 
(e.g., weekly or monthly) to ensure proper functioning and 
call-out to pagers and other notification devices used by 
staff that are “on call”.
Best Practice: In repositories that use an automated en-
vironmental monitoring system, periodic review of tem-
perature profiles or trends should be employed to ensure 
consistency between the controller display values and the 
environmental monitoring system values. This practice will 
allow staff to proactively evaluate each unit’s performance 
and determine if any maintenance work is needed.
C11. AUTOMATED LIQUID-HANDLING  
  ROBOTICS
Automated liquid-handling robots can provide increased 
throughput, improved precision, and fewer errors than man-
ual manipulation and pipetting tasks. Most liquid-handling 
robots incorporate barcode scanners to accurately track 
their specimen processing. This ensures proper specimen 
tracking for all downstream processing and applications.
There are two main types of pipetting robots: air dis-
placement and liquid displacement systems. Like manual 
pipettes, air displacement systems use air/vacuum to 
dispense or withdraw liquids. The liquid displacement 
systems use syringe pumps to move liquid through flexible 
tubing to displace the appropriate volume of the request-
ed specimen. Either system is acceptable if there is a pro-
cedure for calibration and validation of both the instrument 
and their associated methods. Methods used to calibrate 
for accuracy and precision of the pipetting process in-
clude gravimetric and spectrographic techniques. These 
procedures should be done once per year at a minimum 
and more often based upon the use of the liquid handler.
Automated liquid-handling robots come in a variety of 
sizes and functionality. Liquid-handling applications that 
may be performed with automated liquid handlers include 
blood fractionation (separation of serum, peripheral blood 
mononuclear cells, red blood cells [RBCs]), nucleic acid 
extraction, aliquoting, DNA normalization, etc. Additional 
hardware options such as cooled plates, shakers, heaters, 
and incubators can be included. These systems utilize 
disposable tips. Filter tips can be used to prevent cross 
contamination of biological specimens. 
Additional automated processing systems which can 
help assist laboratories in the performance of their daily 
operations include automated weighing stations, tube 
sorters, and detection systems for quantification. As with 
any automated specimen processing system, a validated 
Laboratory Information Management System should be 
employed to track and register all specimens being pro-
cessed. The use of 1D barcodes are required and 2D bar-
coded tubes are highly recommended to ensure the high-
est level of compatibility with automation. 
C12. EQUIPMENT MAINTENANCE, REPAIR,  
  AND REPLACEMENT
A system for preventative maintenance and repair of stor-
age equipment, supporting systems, and facilities should 
be in place. System maintenance should be performed at 
regular, established intervals per manufacturer’s recom-
mendation and as determined as fit for purpose aligned 
with the repository’s practices. Equipment exposed to 
infectious (or potentially infectious) materials should be 
properly disinfected. The choice of disinfectant to be used 
depends on the situation. Some disinfectants have a wide 
spectrum (kill many different types of microorganisms), 
while others kill a smaller range of disease-causing organ-
isms but are preferred for other properties (they may be 
non-corrosive, non-toxic, or inexpensive). For example, 
bleach should not be used on stainless steel as it can result 
in pitting of the metal and damage to the equipment.
C12.1. Calibration
A system for the calibration of all instruments should 
be in place. Any device that provides analog or dig-
ital measurements is considered an instrument and 
requires calibration. Calibration should be done 
annually or per manufacturer’s recommendation. 
Best Practice: Calibration records should include 
the appropriate standard readings taken both be-
fore and after calibration.
Best Practice: A log of calibration records should 
be kept that includes the date of the calibration, the 
name of the individual performing the calibration, 
the name/serial number of the device used against 
which the instrument is calibrated, and a reference 
to the standard operating procedure used to per-
form the calibration. 
Best Practice: Instruments used for calibra-
tions should be ‘verified’ against an approved, 
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recognized calibrator source (e.g., NIST [National 
Institute of Standards and Technology]).
C12.2. Verification of Equipment Functionality
The proper performance of all equipment and relat-
ed software should be verified or qualified prior to 
use or following repairs that affect the instrument’s 
operating capabilities. Documentation of the test-
ing should be maintained and made available for 
audits. The repository Director should ensure that 
all required regulatory practices are implemented.
Best Practice: Freezer and refrigerator units 
should be qualified prior to and periodically during 
use by performing temperature mapping with 
multiple thermocouples placed throughout the 
storage unit to evaluate consistency of tempera-
ture. This temperature profile should be performed 
prior to its initial use so that warm and cold spots 
that could be problematic for material storage can 
be identified.
Best Practice: The entire system should be re-vali-
dated when any changes are made to the software 
and/or automation equipment.
C12.3. Equipment Preventative Maintenance and 
Repair
Essentially all equipment composed of multiple 
components wears out with time and exposure to 
various environmental conditions. Performing rou-
tine assessments and modifications to the equip-
ment per the manufacturer’s specifications may 
significantly extend the duration of the lifetime for 
equipment used in the repository. For mechanical 
freezers, this may include a periodic changing out 
of fluids, cleaning of filters, calibration of probes, or 
manually removing ice from the tops and sides of 
the interior chamber of the freezer. Routine main-
tenance recommendations should be determined 
before a piece of equipment is put into service. 
Frost-free freezers should not be used for reposito-
ry storage, since the daily heating cycle built into 
the doors of these models gradually causes dete-
rioration/desiccation of specimens stored near the 
doors and walls of the unit. Maintenance records 
should provide a description of the maintenance 
performed, date of maintenance, and indication of 
personnel performing the maintenance.
Repair records should provide a description of the 
cause of the equipment failure (where possible), 
the date on which the incident occurred and 
was observed (these performed to verify proper 
functioning of the equipment), and the results 
compared to available standards and manufacturer 
recommandations. Equipment taken out of use 
should be labeled appropriately and the event re-
corded (include a record of the date when returned 
to service, if applicable).
Best Practice: Properly trained personnel with 
expertise in monitoring and repairing repository 
equipment (especially freezers and refrigerators) 
should be used for regular and emergency repairs. 
These trained technicians may be on the repository 
staff, may be on staff within the larger organization 
within the institution in which the repository re-
sides, may be available through a “fee for service” 
arrangement with a commercial entity with this 
expertise, or repair services may be obtained from 
a similar entity on a retainer basis. 
Best Practice: Repositories should maintain spare 
parts for critical equipment, especially for aging 
equipment for which parts may not be readily 
available. 
C12.4. Repair vs. Replacement
While most manufacturers of repository equipment 
offer projections for the expected lifetime of that 
equipment, actual lifetimes vary depending on a va-
riety of factors including preventative maintenance, 
availability of replacement parts, environmental con-
ditions in the area in which the equipment is located, 
etc. For example, manufacturers of mechanical 
freezers offer projections of lifetimes that range from 
8-12 years, but actual lifetimes might run for a period 
of 5 to 15+ years. Liquid nitrogen freezers may have 
lifetimes extending through 10 to 35 years. 
Long-range plans should be made to address the 
possible repair and replacement of equipment 
essential to the functioning of the repository. When 
multiple repairs are required, the additional cost of 
making those repairs may lead to a decision to have 
the unit replaced. Since replacement of freezers 
and refrigerators can be expensive, it is best to 
anticipate these costs and have some financial re-
serves available to address this when decisions to 
replace equipment are made.
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Best Practice: Repositories should plan for the or-
derly replacement of equipment. If multiple pieces 
of the same equipment need replacement at one 
time, it might be best to use interim equipment 
or backup equipment while introducing the new 
equipment in over time. This allows for a gradual 
introduction of new equipment so that likely re-
pair and replacement schedules are likely to be 
staggered. 
Best Practice: Resources for equipment repair 
and replacement should be identified when the 
repository is being established before an emer-
gency is experienced. These resources should be 
reviewed on an annual basis.
Best Practice: Before new equipment is pur-
chased, an evaluation should be performed to 
identify the most energy-efficient equipment that 
effectively addresses the need(s) for that equip-
ment. Attention should be given to the expected 
life of the equipment (e.g., mean time between 
failures, experience with the equipment in other 
installations).
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SECTION D: QUALITY 
MANAGEMENT
D1. GENERAL
The purpose of a repository is to supply specimens and 
their associated data in a form that meets specific quality 
criteria and is provided in compliance with all necessary 
regulatory and statutory obligations. Therefore, aQMS 
that includes Quality Assurance (QA) and Quality Control 
(QC) programs should cover the full spectrum of a reposi-
tory’s operations. The implementation and maintenance of 
a QMS contributes to the long-term sustainability of repos-
itories. These systems support the delivery of high-quality 
services to end-user communities and in doing so sustain 
the business, utility, and research viability of collections. 
Quality Assurance is an integrated system of management 
activities involving planning, implementation, documen-
tation, assessment, and improvement to ensure that a 
process is of the type and quality needed for the project. 
Quality Control is the system of technical activities that 
measures the attributes and performance of a process or 
product against defined standards to verify that the stated 
requirements are fully met. The QC process also confirms 
the authenticity of a collection’s holdings (e.g., reference 
strains and cell lines). 
Each repository should have a QMS or adhere to the QA 
program of the organization with which the repository is 
associated. The program should describe the repository’s 
commitment to its QA and QC programs and describe 
approaches for ensuring that the requirements of these 
programs are met. An essential component of quality 
management is a formal system for documentation and re-
cord-keeping (see Sections D4. Documents of the Quality 
Management System and D5. Records Management).
If it is not possible to have a formal QMS with dedicated 
staff, then a procedure should be in place to review doc-
uments and records to assess the efficacy and quality of 
repository operations. This review should be conducted 
at least on an annual basis1,2.
D2. BEST PRACTICES 
Best practices are used to maintain quality as a comple-
ment to mandated or regulated standards. A best prac-
tice is generally accepted as a technique, procedure, or 
method that produces superior results to those achieved 
by other means. Best practices are established through 
experience and research that have been proven to lead to 
a desired and often evidence-based result. Best practices 
go above and beyond standard recommendations and 
may be cost-prohibitive in some cases. Repository man-
agement and other staff should decide which practices to 
adopt that best support their particular circumstances and 
include it in their SOPs. 
D2.1.  Relevant Best Practices
•	 ISBER Best Practices: Recommendations for 
Repositories
•	 Consensus Best Practices for Biological Resource 
Centers in OECD Countries 
•	 Council of Europe Recommendation Rec 
(2006)4 of the Committee of Ministers to mem-
ber states on research on biological materials of 
human origin
•	 Laboratory Medicine Best Practices sponsored by 
the Centers for Disease Control and Prevention’s 
(CDC) Division of Laboratory Systems 
•	 National Cancer Institute Best Practices for 
Biospecimen Resources (“NCI Best Practices”) 
D3. STAFF RESPONSIBILITIES
Overall responsibility for quality management should 
be assigned to the Director or Quality Manager whose 
responsibility is to ensure repository staff are trained to 
comply with quality standards and to provide regular 
guidance and instruction to all personnel. All staff should 
exercise collective responsibility for assuring compliance 
with SOPs, policies, and regulatory requirements. QMS 
staff should have the responsibility and authority to inspect 
and approve specimen handling, processing, and storage 
practices, as well as discontinue processing and/or re-
lease of specimens when errors warrant. 
A repository should have a clear policy and create a system 
for reporting, documentation, and follow-up of any devia-
tion, incident, or failure and personnel should be trained 
and encouraged to report deviations as learning oppor-
tunities supporting quality improvement. QMS personnel 
should be responsible for implementing both audits and 
accreditation or certification processes. To ensure consis-
tency across staffing, training, and competency, assess-
ment programs should be established as an important 
component of any QMS. 
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D4. DOCUMENTS OF THE QUALITY  
  MANAGEMENT SYSTEM
A repository should create a series of documents, includ-
ing a quality manual, which make a clear quality statement 
and describe the roles and responsibilities of staff within 
and connected to the repository’s operations. The docu-
ments of the quality management system ensure that the 
biorepository infrastructure is in compliance with regula-
tory and safety obligations. The quality manual may refer-
ence all the procedures which are required to ensure that 
QA/QC objectives are fulfilled and be commonly accessi-
ble in working areas. 
D4.1.  STANDARD OPERATING PROCEDURES
SOPs serve as the description of how tasks pertain-
ing to repository operations should be handled by 
staff assigned to those specific responsibilities. SOPs 
allow for uniformity and reproducibility in specimen 
handling. SOPs should be written by an individual or 
group of individuals with experience in successfully 
performing the processes described and should be 
managed in a document management system. Draft 
SOPs should be reviewed before they are finalized. 
Personnel should be trained in the use of the SOPs 
which should be reviewed on a regular and routine 
basis or in response to accidents, incidents, and 
failure to conform to the QA/QC system.
Essential components of an SOP are listed below:
•	 Title – a unique name which captures the es-
sence of the practice described.
•	 Number – a unique number that can be used for 
easy reference. 
•	 Date – date the procedure was first introduced 
as well as the date of the most recent version.
•	 Version Reference – system for tracking version 
number and/or date to ensure the most recent 
version is used. 
•	 Department/Division/Staff Covered – individu-
als to whom the SOP will apply.
•	 Purpose – brief description of the utility of the 
process(es) described in the SOP.
•	 Protective Wear – protective equipment that 
should be worn by staff when performing the 
procedure described.
•	 Equipment – list of the equipment needed to 
perform the procedure. The SOP may direct the 
user to maintain a list of equipment(s) utilized 
by the repository; the equipment record may 
include but is not limited to the name, model, 
date of purchase, serial number, asset tracking 
number, and manufacturer.
•	 Supplies – all materials and supplies needed to 
perform the procedure should be recorded. The 
SOP may direct the user to maintain a record of the 
vendor, catalog number, lot number, and expira-
tion dates for the materials and supplies utilized.
•	 Step-by-Step Guidance – the procedure should 
be written in specific detail to ensure that it can 
be repeated in a reproducible fashion to include 
the order of steps that should be followed, the 
times allowed for each step (as needed), and 
the temperatures at which the steps are to be 
performed.
•	 Safety – describes any safety steps or references 
to any relevant SOPS and addresses appropriate 
regulatory compliance (i.e., institution and/or 
country-specific) associated with the proce-
dures. Careful review and inclusion of Safety Data 
Sheets (SDS)/Material Safety Data Sheets (MSDS) 
or similar globally accepted regulation such as 
the Globally Harmonized System of Classification 
and Labeling of Chemicals is also recommended 
(see Appendix A: Internet Resources). 
D4.1.1.  Implementation
Either the repository Director and/or the indi-
vidual responsible for the Quality Management 
Program (i.e., Quality Manager) should review 
and approve all SOPs and associated process 
validation studies prior to release and imple-
mentation. Upon implementation, all SOPs 
should be followed as written.
D4.1.2.  Modifications
Each repository should have document con-
trol policies in place that govern document 
and SOP management including creation, 
revision, review, authorization, publishing, and 
archiving. Changes should be clearly marked 
in the new version of the document versus 
the previous version. Prior to implementation, 
each modification should be approved by the 
Quality Manager or Director. Implementation 
dates should be recorded for all procedures.
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A system should be in place to ensure that only 
current versions of documents are available for 
use and that previous versions are removed 
when new revisions are issued. Old versions of 
documents should be removed and archived 
when new revisions are issued.   
D4.1.3.  Review of Standard Operating  
 Procedures
SOPs should be reviewed regularly to ensure the 
current policy and/or method for performing the 
procedure is described. A system should be in 
place to document the revision number and date 
of release of the revised document.
Best Practice: SOPs should be reviewed an-
nually and/or when policy or methods change.
D4.1.4.  Staff Access and Review
Current controlled copies of the SOPs should 
be stored in designated locations and available 
to the staff at all times. New and revised policies 
and procedures should be read by the staff 
prior to implementation. 
Best Practice: A system should be in place to 
document staff review of the most recent ver-
sions of an SOP. 
Best Practice: Training associated with SOPs 
should be maintained in a training record (see 
Section G2.7. Training Records).
D4.2. Types of Documents of the Quality 
Management System
A repository should develop and maintain an 
Operating Manual which contains procedures, 
instructions, and guidance for use by repository 
personnel. An Operating Manual should specifi-
cally include, but not be limited to, SOPs and other 
documents regarding the following:
Administrative Policies
•	 Organizational chart, personnel policies, staff 
and director responsibilities, delegation of 
functions, compliance with regulations, and 
introduction of new personnel.
•	 Customer relations, forms, and agreement 
templates.
•	 Project-specific SOPs (e.g., it is the responsibility 
of the repository to follow sponsored/investi-
gator initiated studies when it differs from their 
standard procedures). Conflicts should be 
resolved.
Specimen Handling
•	 Collection, labeling, transport, receipt, 
quality control, processing, distribution, and 
disbursement.
•	 Shipping and receiving.
•	 Relocation of specimens within a repository as 
equipment and environmental needs warrant.
•	 Laboratory procedures for specimen aliquoting 
or other specimen processing.
•	 Laboratory procedures for tests performed 
in-house.
•	 Where appropriate, human subjects protection 
documentation, including policies/procedures 
on informed consent; privacy and confidentiality 
protections; animal welfare-related documents; 
and other legal, ethical, and cultural issues. 
•	 Procedures on access and sharing of specimens 
and associated data.
•	 Where appropriate, procedures on the disposal 
of specimen of participants who have requested 
the withdrawal from a study.
Facilities and Equipment Management
•	 Repository security.
•	 Maintenance of essential support systems (e.g., 
liquid nitrogen supplies, electricity, extra power 
supply, temperature control system).
•	 Environmental monitoring and alarm systems.
•	 Equipment qualification, maintenance, repair, 
calibration, upgrading, and replacement.
Quality Assurance (see Section D4.3.)
•	 Policies for performing validation/qualification 
of instruments, reagents, labels, and processes 
employed in specimen collection, processing, 
storage, and retrieval.
•	 Policies for quality metrics, handling non-confor-
mities, performing corrective actions.
Safety
•	 General safety policies including chemical, bio-
logical, and fire safety.
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•	 Safety programs including documentation of 
staff ergonomics, management of safety-related 
incidents, injuries and exposure to potential 
human pathogens, and notifiable animal/plant 
pathogens and agents under biological control.
•	 Emergency preparedness and response 
procedures.
•	 Disposal of medical and other hazardous waste.
Training and Competency
•	 Policies and procedures relating to personnel 
education, training, and competency programs.
Information Technology (See Section I: 
Repository Information Management 
Systems)
•	 Procedures for validation and documentation of 
the information technology (IT) system including 
backup routines.
•	 Audit trail.
•	 Software bug tracking, troubleshooting/help 
desk functions, and resolution procedures.
•	 IT security and access policies and procedures.
D4.3.  Quality Assurance
D4.3.1.  Validation/Qualification 
A validation process to ensure accuracy, reli-
ability, and consistent intended performance 
should be employed prior to implementation 
of (and after changes to existing) instruments, 
reagents, labels, and processes employed in 
specimen collection, processing, storage, and 
retrieval. 
D4.3.2.  Key Performance Indicators (KPI) 
Repository leadership should periodically 
review the overall effectiveness of their quality 
management system. For example, the identifi-
cation of a specific set of performance metrics, 
tracked over time, may serve as an indicator of 
overall effectiveness of the quality management 
program. Such metrics could include:
• Percentage of correctly located specimens 
during quarterly inventory audit.
• Percentage of specimens received in the 
repository that are acceptable and/or 
appropriately labelled.
• Percentage of repository-shipped spec-
imens received within the expected/
acceptable temperature range. 
In these examples, higher percentages are bet-
ter, and repository leaders could set thresholds 
requiring corrective action (see Corrective and 
Preventive Actions, below). The selected KPIs 
can evolve over time. 
D4.3.3.  Non-Conformities 
A process for documenting deviations from 
established policies and procedures should be 
established. A complete “incident reporting 
system” may be instituted whereby situations 
(e.g., lost or damaged specimens, client com-
plaints, adverse safety occurrences) are docu-
mented and investigated to:
• Facilitate “root cause analysis” for the 
event.
• Identify trends based on operational com-
ponents (i.e., failing equipment, bad lots of 
reagents or consumables, an inappropriate 
SOP).
• Prevent such episodes from reoccurring. 
D4.3.4.  Corrective and Preventive Actions 
A process centered on development, imple-
mentation, and documentation of actions to 
correct an incident when it has already occurred 
(Corrective Action) or to avoid its occurrence 
before it has occurred (Preventive Action). 
These actions help leadership determine and 
implement the appropriate response to correct 
the initial undesirable situation.
Best Practice: Repositories should utilize a 
quality metric system as a way to measure the 
effectiveness of the quality assurance program 
and have plans to address deficiencies that may 
arise.
D5. RECORDS MANAGEMENT
Records (historical footprints) comprise information com-
piled as registered and recorded evidence that is perma-
nent and traceable. Records maintained may include but 
are not limited to: training documents, informed consent 
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documentation, procurement records, processing re-
cords, assay reports, equipment maintenance records, 
audit/review reports, specimen storage location informa-
tion, material transfer agreements, specimen distribution, 
quality control records, and all relevant forms. Records 
should be created and maintained in a manner that allows 
steps to be clearly traced and enable sample chain of cus-
tody. Security systems should be adequate to ensure the 
confidentiality and security of all stored records. Access to 
records should be on a “need to know” basis.
Best Practice: Repositories should develop a complete re-
cords management system to track all repository operations. 
D5.1. Recordkeeping
A repository may develop a variety of template 
forms and spreadsheets to allow for effective re-
cordkeeping. Uniform systems of documentation 
improve consistency in the tracking and monitoring 
of repository activities. Examples of forms include 
those to monitor equipment operations and repair, 
nonconformity or incident reports, and periodic 
equipment maintenance and calibration. 
Forms should have a unique number and a distinct 
title and include the date that the version of the 
form was created (i.e., version tracking). The forms 
should be easily accessible and saved in an elec-
tronic shared file system. 
Best Practice: Forms or spreadsheets to record 
the most important pre-analytical data that may 
affect the quality of the biospecimens should be 
developed and maintained in the repository’s re-
cords management system.
Best Practice: Forms should have a unique num-
ber and a distinct title and include the date that 
the version of the form was created (i.e., version 
tracking). 
D5.2. Record Corrections and/or Amendments
Corrections or amendments (changes) to a hard 
copy record should be made in ink with a single 
line drawn through the altered text. Corrections 
should be initialed and dated by the individual 
making the correction or amendment. Corrections 
in electronic records should be noted and tracked. 
Amendments tracked should include the name of 
the individual making the amendment, the time 
and date at which the amendment was made, and 
the reason for the amendment. Inventory systems 
that have the ability to maintain an audit trail are 
recommended. 
Best Practice: Follow Good Documentation 
Practices as per the appropriate Quality 
Management System and regulatory requirements 
(e.g., College of American Pathologists (CAP), 
Good Clinical Practice (GCP), Good Manufacturing 
Practice (GMP)). Dates should implement a format 
that is unambiguous and follows the country’s con-
ventions for designating dates (examples: ddmmyy 
or ddMonyyyy; where dd stands for day, mm or 
Mon stands for month, and yy or yyyy stand for 
year). 
D5.3. Record Retention
Unless otherwise specified by contract, corporate 
or government policy, or other agreement, each 
repository should specify the length of time for 
retention of each type of record in its policies. 
Additionally, the repository’s policy should indicate 
how records that are no longer needed should be 
destroyed or transferred. For example, a repository 
may archive equipment maintenance and repair 
records following the retirement of the equipment. 
Retention of records for specimens or collections 
that are no longer active (e.g., closed) or when sam-
ples have been destroyed or transferred from the 
repository may or may not require further retention, 
depending on the type of repository and its quality 
management system and policy requirements. In 
some instances, repositories may specify in their 
policies that information pertaining to collections 
that are inactive or specimens that have been 
removed from the repository should be retained 
in the repository database for tracking and docu-
mentation purposes.
For natural history collections, data and metadata 
(and to the extent known, all other data related to 
the use of the specimen) should be stored indefi-
nitely, unless otherwise dictated by the agreements 
with the country of origin.
D5.4. Data Security
Data integrity as well as access control have to be 
considered. Electronic records should be backed 
up daily on a network or remote secure server. Data 
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may or may not be sensitive and require protection. 
This may differ between data regarding human 
subjects (including under any data protection 
laws operating in the repository’s country) and 
non-human specimens. In the latter case, data are 
generally regarded as less sensitive and may be 
open-access. In some cases, provider countries 
may require detailed distribution data of specimens 
be kept secure to minimize threats to endangered 
species.
A repository should develop a system for archiving 
records that are not currently needed for daily 
activities but need to be retained as described 
in Section D5.3. Record Retention. This system 
should allow all archived records to be accessible 
for audits and inspection as defined in Section D7. 
Internal Audits.
Best Practice: Arrangements should be made to 
store all critical records at a remote location, poten-
tially with an off-site data security company. 
Best Practice: Physical and electronic access to 
records and documents should be restricted and 
assigned based on roles; authorizations for access 
should be documented and available for audit.
Best Practice: Any physical documentation held 
onsite that contains sensitive information, (e.g., con-
fidential donor/client information such as Personally 
Identifiable Information [PII] or Institutional Animal 
Care and Use Committee [IACUC] sensitive infor-
mation) should be locked in secure fire and water 
proof enclosures with controlled access.
Best Practice: When records are stored for 
prolonged periods or stored remotely, a periodic 
recall of a portion of the electronic data should be 
performed to verify the integrity of stored records. 
The frequency for performing this test should be 
defined in an SOP.
D5.5. Availability for Inspection
Records should be readily accessible for inspection 
by authorized personnel from regulatory agencies 
(these may vary for each country or state, depend-
ing on the regulatory agencies with jurisdiction 
over those activities) and Quality Assurance per-
sonnel. Access to privacy records or confidential 
client information should be restricted to limited re-
pository staff members authorized to grant access 
to inspectors from regulatory agencies and other 
approved auditors. 
D6. QUALITY STANDARDS 
A variety of standards exist to allow for confidence and 
reproducibility in repository practices. While each of the 
standards described below can be implemented to sup-
port various repository activities, there are costs involved 
in the attainment of each standard and all the standards 
may not be appropriate for every repository.
D6.1. Good Practices 
Good Practices (GP) are regulatory guidelines that should 
be interpreted by the repository to fit its particular circum-
stances. GP may be preclinical (Good Laboratory Practice 
[GLP]) or clinical (GCP) and GMP may be more relevant to 
industry repositories. Academic and other small reposito-
ries may wish to aim toward GP guidelines to instill con-
fidence in the implementation of their SOPs. Generally, 
these standards are interpreted as follows: 
•	 The facility is in a secure, locked area with limited ac-
cess for unauthorized persons.
•	 Personnel should be trained in all procedures and 
successful completion of such training is documented 
with evidence of updates, if required, on a periodic 
basis.
•	 The facility is subject to internal QA audits and/or site 
visits by external clients and agencies, as appropriate. 
The agencies that audit vary by local, state, national/
federal, or international regulations. 
•	 Procedures are documented in SOPs that are ap-
proved by appropriate personnel and are changed or 
updated only under strict document control rules.
•	 Records are maintained with respect to the purchase 
of new equipment, maintenance, and repair activities, 
as well as equipment disposal. Examples of informa-
tion tracked may include but are not limited to the 
name and model number for the equipment, name of 
manufacturer and contact information, serial number, 
date of acquisition, maintenance and repair, etc. 
•	 Maintenance of records for critical materials and 
reagents used by the repository. Examples of informa-
tion tracked may include but not be limited to: the item 
name, company from which the item was purchased, 
date of purchase, expiration date, and all related SDS.
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•	 Deviation reports are produced for all events that fall 
outside SOPs.
D6.2.  International Organization for 
Standardization
The International Organization for Standardization 
(ISO) is a worldwide federation of national stan-
dards with headquarters in Geneva, Switzerland. 
The organization was founded in 1946 to develop a 
common set of standards for manufacturing, trade, 
and communications organizations.
ISO/DIS 20387:2017(E) Biotechnology Biobanking 
General Requirements for Biobanking has been 
developed to enable biobanks to demonstrate 
operational competency and that they can provide 
biological resources (materials and data) of appro-
priate quality. It specifies general requirements 
including quality control requirements for the com-
petence, impartiality, and consistent operation of 
biobanks to ensure appropriate quality of sample 
collections. This is a working document, foreseen 
to be published in 2018.
Additional relevant ISO standards:
•	 ISO9001:2015 Requirements of Quality 
Management Systems – a system standard, not 
a product standard. Its primary purpose is to 
provide organizations with useful internationally 
recognized models for operating a quality 
management system. Specifies requirements 
for a quality management system where 
an organization needs to demonstrate its 
ability to consistently provide products that 
meet customers’ and applicable regulatory 
requirements.
•	 ISO/IEC 17025:2005 Quality Systems for 
Testing and Calibration Laboratories – pro-
vides general requirements for laboratories per-
forming tests and/or calibrations, and sampling. 
ISO/IEC 17025 covers the use of standard meth-
ods, non-standard methods, and laboratory-de-
veloped methods. This standard incorporates 
key requirements of ISO9001:2015. 
•	 ISO /IEC 15189:2007 Medical Laboratories 
– includes requirements for quality and com-
petence, which are particular to medical 
laboratories.
•	 ISO 17034:2016 General Requirements for the 
Competence of Reference Material Producers 
– provides the general requirements that a 
reference material producer must demonstrate 
if they are to be recognized as competent to 
carry out the production of reference materi-
als. References ISO/IEC 17025 as a normative 
document1.
D6.3.  Other Relevant Standards
Additional standards that may be applicable to 
repository operations include those established by 
the Clinical & Laboratory Standards Institute (CLSI), 
American Association of Blood Banks (AABB), and 
European Committee for Standardization (CEN, 
French: Comité Européen de Normalisation) (see 
Appendix A: Internet Resources).
Best Practice: The repository should implement 
multiple (or a combination of) quality standards to 
fit the type of services provided.
D7. INTERNAL AUDITS
Repositories should be subjected to regular audits. Audits 
cover the implementation of all SOPs that govern the 
repository. Audits may be done on a quarterly, semi-an-
nual, or annual basis or in response to a non-compliance 
incident, accident, or a change/deviation in procedure 
required in the light of new information or alterations 
to ethical, regulatory, or health and safety issues. A des-
ignated individual familiar with the specific work being 
reviewed but not directly involved in that work should be 
responsible for each audit. For this function the individual 
should be someone who is not directly supervised by the 
Director (e.g., they should report to a separate department 
or division responsible for quality assurance).
Regular audits for the inventory system should be per-
formed and primarily directed at prevention of non-confor-
mities as well as detection, corrective action, and process 
improvement implementation (see Section I2.1. Specimen 
Location).
Best Practices: The repository should have a procedure 
for periodic verification of the inventory and associated 
data. Random sampling from each storage unit using a 
predefined acceptable quality level can be used for QC 
purposes.
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D8.  ACCREDITATION AND CERTIFICATION
D8.1.  Accreditation
National accreditation bodies can accredit a re-
pository to national or international accreditation 
standards.
D8.1.1. College of American Pathologists  
 Biorepository Accreditation Program ( 
 BAP) 
In 2012, the CAP introduced a BAP to closely 
parallel their accreditation process for clini-
cal laboratories in North America. The CAP 
Biorepository Accreditation Program has a 
particular focus on Quality Management, as 
well as peer-to-peer dialogue aimed at improv-
ing Biorepository practices. Topics covered in 
the program include information technology, 
equipment/instrumentation, specimen han-
dling and QC, quality management, personnel, 
safety, facilities, and regulatory requirements.
D8.2.  Certification
Certification provides an official document attest-
ing to a status or level of achievement. Certification 
to international standards, such as ISO9001:2015, 
or to national standards, such as NF S96-900, can 
be obtained by an independent body, which itself 
is accredited to ISO/CEI 17021 as a “certification 
body”. Certification may also be obtained from 
non-accredited bodies (i.e., Canadian Tissue 
Repository Network [CTRNet], NSW Biobank 
Certification Program) or by performing a self-as-
sessment survey (Biobank Certification Program, 
Biobanking and BioMolecular Resources Research 
Infrastructure [BBMRI] self-assessment survey). 
CITATIONSS
1 Von Versen R, Mönig H-J, Salai M, Bettin D. Quality issues in tissue banking: Quality management systems - A review. Cell Tissue 
Bank 2000;1:181-192.
2 Betsou F, Luzergues A, Carter A, et al, and the Marble Arch Working Group on International Biobanking. Towards norms for 
accreditation of biobanks for human health and medical research: compilation of existing guidelines into an ISO certification/
accreditation norm-compatible format. Qual Assur J 2008;221-294.
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SECTION E: METHOD 
VALIDATION AND QUALITY 
CONTROL CONSIDERATIONS
E1. VALIDATION OF SAMPLE PROCESSING  
  METHODS
Repositories should use validated processing methods for 
their specimens. The repository can use scientific literature, 
feedback from the end users, and/or laboratory quality con-
trol results to evaluate and validate a processing method. 
The repository should list the circumstances requiring new 
validation measures to be taken (e.g., instrument changes, 
specimen type changes). Each processing method should 
be validated for one or more specific intended end uses. 
If no relevant scientific literature is available, the repository 
may have biospecimen research performed to assess 
the potential impact of the most important pre-analytical 
variables, following recommendations on biospecimen 
research. Features of biospecimen quality, including struc-
ture of proteins, function of enzymes, level of metabolites, 
gene expression levels, DNA methylation status, cell via-
bility, and microorganism viability, can be affected by the 
specific procedures followed during sample collection, 
transport, isolation, and storage.
Pre-analytical variations should be noted whenever possible 
and appropriate as an important component to any QMS1,2. 
Examples of in vivo pre-analytical variations include: 
•	 Patient’s clinical condition
•	 Timing of collection
•	 Medication
•	 Organism’s environmental niche/type of habitat, 
host, axenic state, season of collection, and microbial 
phase variation 
Examples of in vitro pre-analytical variation elements include:
•	 Type of collection tube
•	 Pre-centrifugation delay and temperature
•	 Warm and cold ischemia times for solid tissues
•	 Method of sampling
•	 Type and duration of fixation
•	 Time delay before placing into long-term storage
•	 Type of long-term storage
•	 Exact protocol of cryopreservation and of restoration 
for environmental specimens
Implementation of a system to track pre-analytical variables 
will facilitate tracking and communication of the critical 
sample processing steps3,4 in lieu of more sophisticated 
methods found in relational databases and laboratory 
information systems (LIS/LMS) that allow for aggregation 
of pre-analytical data (i.e., time to processing, time to 
storage).
Best Practices: A pre-approved documented method 
evaluation plan should describe the methods used in 
the verification/validation, what is in/out of scope of the 
verification/validation, and the proposed criteria which 
will be used to determine the outcome of the evaluation. A 
summary document should be created after the validation 
exercise to accurately represent the results of the method 
validation.
Best Practice: External Quality Assurance programs 
should be followed, where available, at least once a year.
E2. METHOD EVALUATION  
  CONSIDERATIONS FOR SPECIFIC TYPES  
  OF SPECIMENS 
Many of the QC processes are generic across all types of 
repositories and they concern the four “pillars” of collec-
tion quality: 
•	 Authenticity: correctly assigned identity. 
•	 Purity: freedom from contamination (when applicable).
•	 Stability: capability of a sample material to retain the 
initial value of a measured quantity for a defined pe-
riod of time within specific limits when stored under 
defined conditions5. 
•	 Consent: for human specimens, sample type and 
usage is consistent with the level of consent provided 
by the participant.
Depending upon the molecular analyses that will be 
performed by the end-user, it may be advisable to extract 
and analyze matching molecular entities (e.g., DNA, RNA, 
proteins) as a part of the biospecimen quality control 
testing6,7,8.
QC measures for specific types of biospecimens can also 
be dictated by national/federal or international rules and 
regulations (e.g., health and safety and bioethics)9,10,11,12,13. 
Best Practices: Consider creating a ‘certificate of anal-
yses’ document for critical biomaterials (e.g., cells). This 
document would contain the details needed to ensure 
consistency between lots and analysis methods used.
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E2.1. Quality Control Considerations for 
Specimens
E2.1.1.  Quality Control Considerations for  
 Solid Tissue Specimens
QC examination of tissues collected for re-
search should be appropriate for the research 
protocol. QC of tissue ranges from microscopic 
examination of an aliquot that is representative 
of a specific tissue by a pathologist, cell biol-
ogist, or an equivalently trained individual to 
molecular quality control where nucleic acids 
and proteins are characterized. The highest 
quality control measures (“platinum” level) 
involve enriching the diseased population of 
tissue through macro- or micro-dissection of 
frozen or formalin-fixed, paraffin-embedded 
sections and also potentially performing mo-
lecular analyses. Platinum-based approaches 
are, however, costly and potentially exhaust 
specimen availability. 
Best Practice: For “excess” tissue collected 
by the pathologist from diagnostic surgical re-
section specimens, verification of the diagnosis 
and percentages of tumor and necrosis should 
be performed for each aliquot due to tissue 
heterogeneity. This can occur via pathologist 
top-slide analysis for embedded aliquots or via 
mirror-slide analysis to permit snap-freezing of 
aliquots without embedding medium.  
Best Practice: Tissue quality is fundamentally 
tied to processing conditions (e.g., ischemia 
times, time to processing, fixation type/dura-
tion, time to storage) which may impact down-
stream applications and should be closely 
monitored and recorded as part of the quality 
management program.
E2.1.2.  Quality Control Considerations by  
 Virtual Microscopy/Digital Pathology
E2.1.2.1.  Virtual Microscopy
Virtual microscopy is the method of pro-
ducing a digital image of a tissue section or 
cytological preparation mounted on a glass 
microscope slide that is suitable for visual 
examination, annotation of regions of inter-
est, and interpretation. This method uses 
scanning equipment at a range of magnifica-
tions to produce digital images suitable for 
remote web-based viewing and archiving. 
These digitized images can approximate the 
process of viewing slides microscopically, 
including the capacity to adjust viewing 
magnification and focus on specific regions 
of the image. When optimized, image quali-
ty may be sufficient quality control to confirm 
the histopathological diagnosis and compo-
sition of banked research specimens. 
The use of this technology in certain situa-
tions may provide advantages compared 
with microscopic examination of slides, 
including: elimination of shipping glass 
slides, facilitating rapid review, reducing 
costs of tracking and replacing lost or bro-
ken glass slides, and allowing accessibility 
anytime via the Internet as well as allowing 
concurrent review of the same slide image 
by multiple viewers14. Depending upon the 
availability and type of imaging systems, at 
some locations it may be more cost effective 
to provide a tissue section on a glass slide 
to investigators. Also, high-quality images 
require optimal scanning and significant 
data storage capabilities; thus the storage 
capacity required for a large number of such 
images must be taken into consideration and 
only the most “diagnostically difficult” cases 
may necessitate digital storage.
E2.1.2.2.  Digital Pathology
Digital pathology, built around the examina-
tion of digital virtual microscope images, is 
a workspace environment which integrates 
with other electronic applications such as 
laboratory information systems, electronic 
medical records, medical imaging, molec-
ular testing systems, and specimen tracking 
systems. Digital pathology also allows com-
plex image analysis of both morphology and 
tissue-based assays (i.e., immunohistochem-
istry, immunofluorescence) and can allow 
simultaneous viewing of multiple different 
images concurrently. 
Image analysis of specimens could ultimately 
be used to automate quality control in tissue 
banks by augmenting or replacing the tra-
ditional morphologic review of actual tissue 
sections. It could aid in assessing tissue 
quality by detecting and measuring features 
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such as % tumor, % stroma, % necrosis, % 
cellularity, and other morphologic features. 
Such approaches require validation prior to 
implementation. 
E2.1.3.  Quality Control Considerations for  
 Fluid Specimens
Different collection, processing, and storage 
procedures may adversely affect the structure 
and/or function of molecular components in 
fluid biospecimens (e.g., serum, plasma, urine, 
saliva, cerebrospinal fluid). In some situations, 
fluid biospecimens may require assessment 
as to their integrity in view of the detection or 
measurement of specific analytes. Molecular 
markers to assess specific pre-analytical vari-
ables can be used, such as the hemoglobin 
content to assess hemolysis or the sCD40L con-
tent to assess exposure to room temperature15. 
In many instances, quality control can only be 
performed in reference samples and in a target-
ed manner once the end-use analysis is known. 
E2.1.4.  Quality Control Considerations for  
 Cell Specimens
Contamination control methods for eubac-
teria, fungi, mycoplasma, and viruses can be 
applied to primary cell cultures or cell lines. 
DNA fingerprinting methods can be applied for 
identification of established cell lines. Testing 
for downstream utility can include functional 
assays of the cell specimen (e.g., ELISpot, cell 
proliferation). Cell viability and/or purity of the 
cell suspensions can be assessed after thawing 
of a representative frozen aliquot. 
E2.1.4.1. Assessment of Cell Viability
Estimation of the total number of recovered 
cells and of the number of viable cells in sort-
ed or unsorted cell preparations from blood, 
bone-marrow, or other specimens are 
important for several research applications, 
including stem cell research. Cell number 
may be determined by several methods, in-
cluding dye exclusion (i.e., Trypan Blue) and 
vital staining using tetrazolium salts or fluo-
rescent dyes such as fluorescein diacetate. It 
is essential to standardize viability assays and 
where possible back them up with unequiv-
ocal tests of functionality and clear evidence 
of cell division and growth. Determination of 
total and viable cells recovered post-thawing 
should be assessed both prior to freezing 
and at the time of thawing/warming to esti-
mate loss due to freezing.
The phenomena of delayed onset cell death 
may impact evaluations of viability imme-
diately post-thaw as compared to actual 
long term cell survival and functionality. For 
this reason, post-thaw assessment of cell 
viability may need to be expanded beyond 
a singular assessment via Trypan Blue (or 
similar assays) immediately post-thaw or after 
re-warming in the case of vitrified samples. 
An expanded assessment of post-thaw re-
covery (this may be referred to as True Yield/
Viability) may include multiple methods of 
assessment including Live/Dead assays, cell 
death mechanism assays such as Annexin/
PI, or metabolic assays such as alamarBlue or 
MTT, cell function assays (dependent on cell 
type), and assessment at multiple time points 
post-thaw/re-warming, especially within the 
timeline of delayed onset cell death. These 
expended viability and functionality assays 
may need to be balanced against the re-
search uses of cells that are difficult to obtain 
and have limited supply.
E2.2.  Quality Control Considerations for 
Microorganisms
Phenotypic characterization includes both macro-
scopic and microscopic morphology assessment. 
Genotyping (e.g., DNA sequencing, polymerase 
chain reaction [PCR]-based profiling, microarrays), 
ribotyping, classical biochemical tests, and/or se-
rotyping methods can be applied for taxonomical 
identification purposes. Functional assays include 
viability assays or assays for cytopathic effects.
Quality Control for purity can be performed; how-
ever, certain cultures need to be maintained in a 
non-axenic state (e.g., obligate plant pathogens 
and assemblages of microorganisms, symbiotic 
and beneficial associates found in microalgae and 
cyanobacterial collections). 
The World Federation for Culture Collections 
(WFCC) is a multidisciplinary commission of the 
International Union of Biological Sciences and 
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a Federation within the International Union of 
Microbiological Societies concerned with the 
collection, authentication, maintenance, and distri-
bution of cultures of microorganisms and cultured 
cells. Its aim is to promote and support the estab-
lishment of culture collections and related services 
and develop an international database on culture 
resources worldwide (see Appendix A: Internet 
Resources).
E2.3.  Quality Control Considerations for Plant 
Specimens
The overarching QC process of plant bioreposi-
tories (i.e., gene banks, culture collections, germ-
plasm repositories, seed and field banks) ideally 
involves germplasm characterization before and 
after storage and at the point of dissemination as 
well as plant health (phytosanitary) checks, safety 
duplication, and passport documentation with 
assignment of an accession number. 
In the case of seed materials, the International Seed 
Testing Organization has the mission to develop 
and publish standard procedures in the field of 
seed testing and encourage and establish unifor-
mity in seed testing world-wide.
For clonally propagated plants (and other non-seed 
genetic resources such as pollen and dormant 
buds), quality testing includes assessment of viabil-
ity, phytosanitary status, and disease management 
(comprising quarantine, disease indexing, and 
eradication). 
Phenotype and genotype authentication can be a 
regulatory requirement for some crops and com-
mercial forestry species and can include formal 
confirmation of certification status (trueness-to-
type) by field-testing plants that are evaluated using 
specific phenotypic descriptors and as appropriate 
confirmation using molecular markers. 
The detection, expression, and stability of genet-
ically modified materials may be necessary. The 
risk assessment and management of transgene 
contamination is a requirement for certain types of 
collections. 
Post-storage QC measures include assessments of 
viability, morphogenetic competence, totipotency, 
regeneration, biochemical stability (e.g., for sec-
ondary product producing cell lines), phenotypic 
and genotypic stability (e.g., characterization of 
somaclonal variation), and trueness-to-type assess-
ment under field or glasshouse conditions using 
descriptors. 
E2.4. Quality Control Considerations for Nucleic 
Acid Specimens
DNA and RNA can be assessed for integrity and 
fragmentation (e.g., molecular weight, DNA 
Integrity Number, RNA Integrity Number), quantity/
concentration, and purity. In addition, DNA can be 
assessed for the absence of cross-linking, human 
vs. non-human composition, the absence of PCR 
inhibitors, and the percentage of double-stranded 
DNA. RNA can be assessed for ratio of 5’ to 3’ 
amplicons (ΔCt), amenability to reverse transcrip-
tion, and the maximum length of the quantitative 
real-time PCR (qRT-PCR) products. 
E3.  VALIDATION OF QUALITY CONTROL  
  METHODS
Each QC method should be assessed by the repository 
or by the external laboratory performing the assays, for 
its accuracy, precision, limit of detection, and linearity (if 
applicable). External quality assurance programs using 
Reference Materials should be followed, when available, 
at least once a year16,17. 
Best Practice: Performance of assays should be trended 
to discriminate out of specification (out of trend) results. 
These results should be documented and reconciled 
where appropriate. 
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SECTION F: SAFETY
F1. GENERAL 
Issues related to safe operation of a repository are complex 
and depend on its particular activities. Regulations govern-
ing safety may be covered by national/federal, regional, or 
local regulations. Each repository should determine which 
areas of safety are applicable and develop an appropriate 
safety plan to protect its employees and visitors1,2,3,4. 
Safety plans are used to prevent or to minimize injuries to 
employees and visitors. In order to develop an effective 
safety plan, the likelihood and source of potential injuries 
for each employee should be identified. These will depend 
upon the procedures and activities that the employee 
performs as well as rooms in which they are likely to spend 
time3,4. Each employee and his or her supervisor should 
work together with workplace health and safety experts 
to identify potential sources of injury and reduce the risk 
of injury via changes in procedures or engineering. For 
example, this could include the use of safety equipment or 
the improvement of ventilation within a specific area1,2,3,4. 
Best Practice: Risk assessment should be carried out to 
ensure that all regulations are followed.
F2. NATIONAL/FEDERAL, REGIONAL, AND  
  LOCAL REGULATIONS
Repositories should ensure they have reviewed and com-
ply with national/federal, regional, and local regulations 
regarding the health and safety of employees.
F3. SAFETY INFRASTRUCTURE
The Director or other individual with overall responsibility 
for the organization has primary legal responsibility for the 
safe operation of all components of the organization in-
cluding a repository; however, the day-to-day responsibil-
ity for safety is frequently designated to another individual 
and/or to a Safety Committee. While this person or group 
may be primarily responsible, the responsibility for safe 
operation also lies with each employee.
The organization in which a repository resides usually 
establishes a Safety Committee that is responsible for the 
overall safety plan of the institution, including periodic 
monitoring and updating. The Safety Committee usually 
appoints a Safety Officer to administer the program. 
The Safety Officer establishes a safety training program 
and monitors and maintains compliance with the program, 
evaluates incidents and injuries, and recommends chang-
es to the Safety Committee, as needed. The Safety Officer 
works closely with area supervisors to ensure adherence 
to all safety regulations2,3,4.
F4. TRAINING 
Employees should be advised of the potential hazards as-
sociated with working with specimens and sign an agree-
ment to handle all specimens with the necessary safety 
methods. Individuals should be trained to follow universal 
precautions, i.e. to handle all specimens as though they 
are potentially hazardous, and should take appropriate 
precautionary measures. Additional risks may be present 
when staff come into contact with patients during the 
consenting process (e.g., HIV or tuberculosis) or during 
collection of non-human specimens (e.g., zoonotic patho-
gens that are transmissible from animals to humans). 
Repositories receiving environmental samples should pro-
vide training to minimize exposure to toxic substances See 
Section G: Training for a full discussion of training issues.
F5. PERSONAL PROTECTIVE EQUIPMENT 
All persons, including visitors, should wear appropriate 
clothing (i.e., lab coats, long pants, and covered shoes; 
not shorts, skirts, or open-toed shoes) as well as eye pro-
tection, depending on exposure. Appropriate gloves are 
recommended for handling any specimens, chemicals, or 
hot or cold equipment and supplies. If exposure to haz-
ardous materials occurs, hands and other exposed areas 
of skin should be washed. Laboratory coats may be laun-
dered or disposed; this choice depends upon the type 
and extent of exposure. 
Eyes and other mucous membranes must be protected 
from exposure to biohazardous materials and chemicals. 
Depending on the likelihood of exposure, this protection 
may be accomplished via goggles, safety glasses, or face 
shields. These should be worn any time there is a likelihood 
of exposure. 
Respiratory protection against chemicals is only necessary 
when the exposure to vapors of toxic chemicals exceeds 
the standard specified by regulatory agencies. If respira-
tors are required, they must be individually fitted. 
Appropriate safety equipment for specific tasks must be 
utilized by all staff as designated in the repository’s SOPs.
43ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
F6. SAFETY TOPICS 
F6.1. Biological Risk Assessment and Safety 
All human specimens (and to a lesser extent animal 
specimens) whether fixed, paraffin-embedded, 
fresh frozen or freeze-dried should be considered 
as potential biohazards. As the extent of alteration 
of tissue increases (e.g., fresh to frozen to fixed to 
paraffin-embedded), the risk from various infective 
agents is usually reduced3,4. However, certain 
agents such as prions (e.g., the causative agent for 
Creutzfeldt-Jakob disease [“mad cow disease”], 
scrapie, deer/elk wasting disease, other trans-
missible spongiform encephalopathies) may still 
be infective even when tissues are fixed and pro-
cessed to paraffin blocks or autoclaved. Prions are 
very difficult to inactivate and cannot be destroyed 
by ethyl alcohol, bleach, detergents, or other 
disinfectants. Consequently, all human and animal 
specimens independent of their state should be 
handled at Biosafety Level 2 or higher, i.e., should 
be handled as if infected with agents that may be 
pathogenic to humans. Individuals should receive 
training so that they can recognize symptoms that 
accompany the exposure to certain harmful com-
pounds and diseases to which staff are exposed5 
and reduce their risk as much as possible. 
Disinfectants should be chosen according to repos-
itory or institutional preference. Further information 
on disinfectants may be obtained from the Centers 
for Disease Control and Prevention. Repositories 
should develop a Bloodborne Pathogen Exposure 
Control Plan or similar to eliminate or minimize oc-
cupational exposure to bloodborne pathogens. The 
plan should include a determination of employee ex-
posure, methods to control exposure (e.g., universal 
precautions, personal protective equipment, engi-
neering controls), appropriate vaccinations, post-ex-
posure evaluation and follow-up, communication of 
hazards, and accurate recordkeeping. Applicable 
regulations covering occupational exposure to 
bloodborne pathogens should be determined. 
Staff can consult biosafety manuals on the proper-
ties of human pathogens and recommendations 
for laboratory work involving these agents (see 
Appendix A: Internet Resources). 
Best Practice: Staff at risk of exposure to vac-
cine-preventable infectious diseases should under-
take appropriate immunizations.
F6.1.1. Biological Hygiene Plan
Biological hygiene plans should include the 
following:
•	 Approaches to prevent, contain, and 
clean up biological spills. The plan should 
include a description of how to dispose 
of waste and biologically-contaminated 
materials resulting from the clean-up. 
•	 Approaches to the safe, lawful, and appro-
priate disposal of all repository materials 
that are no longer deemed necessary.
•	 Approaches to ventilation failure, evacu-
ation, medical care, and reporting of bio-
logical exposure incidents.
•	 A description of areas where eating, drink-
ing, storing food and beverages, smoking, 
gum chewing, and application of cosmet-
ics are not permitted. This should include 
areas where specimens are processed, 
stored, and handled.
•	 Requirements for the use of a Biological 
Safety Cabinet to reduce the risk of expo-
sure to potentially infectious disease.
•	 Requirements to minimize the generation 
of and exposure to aerosols.
F6.2. Chemical Safety 
Many countries have developed regulations that 
govern activities relating to chemical safety that 
may affect repositories (see Appendix A: Internet 
Resources). These laws may mandate that an orga-
nization develop a written chemical hygiene plan. 
The chemical hygiene plan should be capable of 
protecting employees from hazardous chemicals 
in the laboratory and of keeping chemical expo-
sures below the action level (or in its absence the 
Permissible Exposure Limit). 
All chemicals used in repositories should be 
labeled, stored, and disposed of appropriately. 
They should also have MSDS or SDS available for 
easy reference for employees who will potentially 
come into contact with the chemicals and auditors 
who will look for these documents. SDS are avail-
able from manufacturers and should be provided 
either in hard-copy or from a provided URL for 
downloading.
44 ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
Best Practice: Replace chemicals that are 
hazardous to staff or the environment with alter-
natives when possible.
F6.2.1. Chemical Hygiene Plan
Chemical hygiene plans should include the 
following2,3,4:
•	 Approaches to prevent, contain, and 
clean up chemical spills. The plan should 
include a description of how waste and 
other chemically contaminated materials 
resulting from the clean-up are to be dis-
posed of. 
•	 Approaches to the safe, lawful, and appro-
priate disposal of all repository materials 
that are no longer deemed necessary.
•	 Approaches to ventilation failure, evacua-
tion, medical care, reporting of chemical ex-
posure incidents, and chemical safety drills. 
•	 A description of areas where eating, drink-
ing, storing food and beverages, smoking, 
gum chewing, and application of cosmetics 
are not permitted. This should include areas 
where specimens are processed, stored, 
handled, or where chemicals are used.
•	 Guidance on allowable pipetting meth-
ods (e.g., mouth pipetting and mouth 
suctioning for starting a siphon should be 
prohibited). 
•	 Guidance on the appropriate use of all 
chemicals used in the fixation or processing 
of tissues.
•	 Requirements for the use of chemical fume 
hoods to minimize exposure to vapors 
from hazardous chemicals (e.g., formalde-
hyde or xylene).
Best Practice: All regulations should be fol-
lowed as to chemical safety.
F6.2.2.  Compressed Gases
Compressed gases such as Argon present 
a risk of asphyxiation by displacing oxygen. 
While eye protection is not required for work-
ing with compressed gases, it is recommend-
ed. Employees should wear oxygen monitors 
while handling compressed gas cylinders or 
working with compressed gases. Cylinders 
should be stored in well-ventilated areas in 
compliance with appropriate regulations. 
Free-standing cylinders should be secured to 
the wall to prevent tipping.
Best Practice: Appropriate protective equip-
ment should be utilized when working with 
compressed gases.
Best Practice: Crush-resistant safety shoes (e.g., 
steel-toed) should be used when moving heavy 
tanks or transporting cylinders with floor trucks.
Best Practice: Compressed gases should be 
stored and transported in well-ventilated areas, 
with detectors and alarms fitted. 
F6.3. Electrical Safety 
Equipment should be tested for grounding when 
first purchased and yearly thereafter, except in 
specific circumstances such as devices that are 
protected by double insulation. All electrical base 
plugs should be in good condition. Electrical 
work should be done with great care ensuring that 
personnel in the affected work area are protected 
during the removal of fuses and while working 
near a water source. There should also be written 
warnings regarding the danger of electrocution 
at the fuse box. Electrical equipment should be 
unplugged prior to service, as appropriate, and 
staff should have visible control of the plug to avoid 
inadvertent energizing of the unit. 
Mechanical storage units are rated to function at a 
specific voltage. Buck boosters will activate to sta-
bilize the voltage should the level drop below that 
specified. If conditions persist, they can result in 
overheating of the wiring or components and pos-
sible failure or fire. Routine checks of facility volt-
ages and/or noting of prolonged use of the buck 
boosters will alert staff to low-voltage conditions. 
Best Practice: All new electrical equipment 
should have an electrical inspection prior to instal-
lation to ensure proper electrical supply and usage.
Best Practice: Surge protectors or voltage 
regulators are recommended for stand-alone 
freezers if this is not part of the building electrical 
infrastructure. 
Best Practice: All electrical equipment and base 
plugs should be tested for grounding. 
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F6.4. Fire Safety 
The local fire department or the organization’s 
Safety Officer can inspect a repository to evaluate 
fire safety prevention plans. Prior to such inspec-
tions and on a regular basis (e.g., annually), fire drills 
should be conducted and fire suppression equip-
ment and safety showers/eye wash units should 
be tested. Emergency pathways should be posted 
at all room exits. Emergency exits should never 
be blocked, obstructed, or locked and hallways 
should not be obstructed or cluttered. Flammable 
agents should be stored appropriately, including 
the storage of large amounts of flammable agents 
in fire cabinets. Refrigerators/freezers that rep-
resent reduced dangers of causing combustion 
can be purchased for use in research laboratories. 
Smoking, if permitted at all, should be limited to 
designated external areas. Furniture, rugs, and 
equipment should be constructed of non-flam-
mable material. Regulations for types of doors to 
serve as fire barriers should be followed as should 
fire requirements for construction of buildings 
that house specific activities (e.g., laboratories). 
Fire safety will be governed by national/federal, 
regional, and local requirements (see Appendix A: 
Internet Resources) For additional information on 
fire prevention systems see Section B7.
Best Practice: Fire safety should be an important 
component of an organization’s safety plan.
F6.5. Physical Safety
The physical safety of employees should be con-
sidered in all repositories. Physical safety ranges 
from preventing falls to ensuring that employees 
are not physically injured by other means. Ensuring 
physical safety involves careful maintenance of the 
physical plant and facilities, such as handling and/
or prevention of tears in rugs and fixing broken 
steps. Care should be taken to ensure that water, 
soap, paraffin, and other substances do not create 
a slippery surface on floors. Power cords should 
be appropriately covered and inappropriate use 
of ladders or use of chairs as ladders should be 
prohibited to prevent falls. Similarly, unsecured 
gas cylinders, unbalanced file cabinets, large bot-
tles containing liquid, and inadequately secured 
shelves can all lead to injuries via falling or moving 
agents or structures.
Also included in causes of physical injuries are 
repetitive-motion injuries (e.g., pipetting) and back 
injuries resulting from movement and inappropriate 
lifting. Repository staff members may be required to 
stand on step-stools and lift heavy racks vertically 
out of the freezer in order to access specimens. Back 
injuries can be avoided by installing an automatic 
pulley mechanism to aid in the removal of the racks 
from the freezers. By analyzing an employee’s work 
environment and improving the placement of ob-
jects and providing the proper tools, the potential 
for injury will be greatly reduced. When ergonomics 
is applied correctly in the work environment, visual 
and musculoskeletal discomfort and fatigue are sig-
nificantly reduced. Where feasible, repositories may 
consider automated specimen input and retrieval 
systems to reduce physical strain on technical staff. 
Ergonomics should be considered when devel-
oping a repository or organizational safety plan. 
Physical injuries that are difficult to avoid include 
minor cuts (e.g., paper), bumps, and strains due to 
inattentive actions. However, such minor injuries 
should not be compounded by exposure to biohaz-
ards or chemical hazards. The overall safety program 
should address other hazards that can be prevented 
or ameliorated by wearing proper protective equip-
ment and clothing such as the use of gloves to avoid 
thermal burns from both heat and cold (e.g., dry ice, 
liquid nitrogen). Check the occupational safety laws 
of your region (see Appendix A: Internet Resources). 
Repositories should maintain a first aid kit for use by 
repository staff and visitors, if required.
For equipment that may be located within a con-
fined space (e.g., large robotic stores for DNA 
samples), procedures should be developed to as-
sure that the equipment is not moved or operated 
during routine cleaning, maintenance, or repair.
Best Practice: Physical safety and ergonomic con-
siderations should be included in an organization’s 
safety plan.
F6.6. Radiological Safety 
While few repositories will store or use radioactive 
material, those that do need a radiological safety 
plan. Specific training is required for personnel who 
use or come into contact with radioactive material 
as well as in the use of specific radiation monitor-
ing equipment. Work with radioactive materials in 
many countries requires a license. Repository staff 
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should refer to the appropriate guidelines for the 
country or region in which the repository is located.
Best Practice: A designated staff member should 
be responsible for ordering, storage, documenta-
tion of distribution/use of the radioactive product, 
and ensuring that isotope limits are adhered to. 
F6.7.  Dry Ice Safety
Those working with dry ice in the laboratory should 
use appropriate protective wear approved for low 
temperatures to avoid skin damage. Dry ice subli-
mates into large quantities of carbon dioxide gas 
which could displace oxygen and pose a danger 
of asphyxiation. 
IATA packing instruction 904 (IATA PI 904) re-
quires that dry ice be labeled specifically with a 
diamond-shaped black-and-white label with the UN 
1845 designation. Arrangements must be in place to 
ensure adequate ventilation so that pressure build-
up does not rupture the packaging (see Appendix 
A: Internet Resources). Further information on dry ice 
is provided in Section J: Packaging and Shipping.
F6.8.  Liquid Nitrogen Safety 
Those working with or around liquid nitrogen (LN2) 
and other cryogenics should use appropriate protec-
tive wear and document their appropriate training. 
A full face shield should be used to protect the eyes 
and face from splashes when working with large 
volumes of LN2. Non-absorbent, insulated gloves 
(cryogenic gloves) should be worn when handling 
anything that is or has been in recent contact with 
LN2. Cryogenic gloves are made to be used only in 
the vapor phase of LN2 and should not be immersed 
in the liquid itself. A long-sleeved, buttoned lab 
coat should be worn at all times when working with 
LN2 to protect the body. Non-absorbent cryogenic 
aprons can also be used and should be used when 
splashes may occur. Clothing with open pockets and 
turn-ups where liquid may collect should be avoided. 
Shoes should cover the entire foot and be sturdy and 
non-absorbent when working with LN2. Nitrogen is 
odorless, colorless, and tasteless. As LN2 evaporates 
it will reduce the oxygen concentration in the air and 
cause a potential risk of asphyxiation, especially in 
confined spaces and may necessitate the use of O2 
monitoring devices (see Section C2.5.1. Oxygen 
Sensors).
Best Practice: All individuals working in areas where 
LN2 is being utilized (including non-repository staff) 
should be made aware of potential hazards and 
trained in appropriate safety policies. Signs should be 
posted indicating the use of proper protective gear 
and need to follow established safety procedures.
Best Practice: Appropriate safety PPE should be 
used when dealing with liquid nitrogen.
Best Practice: O2 monitoring should be installed 
in any areas of the facility where LN2 is utilized. 
F6.9.  Carbon Dioxide Safety
Carbon dioxide (CO2) gas is a colorless, odorless, 
non-flammable gas. In addition to presenting a risk 
of asphyxiation by displacing oxygen, carbon diox-
ide is a toxic gas that can present exposure risks such 
as changes in blood pressure, tinnitus, headache, 
irregular heartbeat, difficulty breathing, etc. While 
eye protection is not required for working with CO2 
gas, it is recommended. Employees should wear 
oxygen monitors while handling CO2 cylinders or 
working with CO2 gas. Cylinders should be stored in 
well-ventilated areas in compliance with appropriate 
regulations. Free-standing cylinders should be se-
cured to the wall to prevent tipping.
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SECTION G: TRAINING
G1. GENERAL
All repository staff should be adequately trained to perform 
the tasks required by their particular position description. 
Proper training is important to ensure quality in specimen 
handling. In some areas of safety, adequate training may 
be mandated by national/federal regulations and severe 
penalties may be imposed on the repository and reposito-
ry personnel if training is not provided as required. 
Support for training is essential for adequate implementa-
tion of certain tasks and in some cases might require addi-
tional resources or time away from regular responsibilities. 
G2. TRAINING INFRASTRUCTURE
G2.1. Training Program
Every individual who enters the repository for the 
purpose of performing work should be trained 
in the particular functions or tasks which they are 
asked to complete. Training should be task and 
location specific and be designed for the particular 
position that is expected to carry out the work. 
Training should involve instruction in the use of 
any equipment used and involve appropriate qual-
ity control and quality assurance practices. See 
Section D: Quality Management for a full discussion 
of quality control and quality management issues. 
Training for some functions may be provided by 
departments outside of the repository (e.g., main-
tenance staff, equipment vendors, infection control, 
professional air transport regulatory trainers); how-
ever, repository staff should ensure that all individu-
als who enter the repository follow required safety 
and other procedures in performing their particular 
tasks. Training must be in a language the employee 
understands and the level of training must be appro-
priate to the employee’s level of comprehension. 
Academic or other institutional training, in the form 
of courses, may be available from some institutions. 
The syllabus of such courses should be reviewed 
for correspondence with particular specific training 
needs and decisions made accordingly. Examples 
of areas covered by such courses may include legal 
aspects, management and financial aspects, cel-
lular and molecular biology, statistical aspects, or 
quality assurance.
Repository staff should be asked to review any writ-
ten procedures for which they are responsible prior 
to the commencement of their “hands-on” training. 
A written record indicating that the employee has 
read the pertinent procedures should be kept 
in the employee’s training file (see Section G2.7. 
Training Records). This record should include the 
title of the procedure, the employee’s initials, and 
the date upon which the procedure was read. It is 
preferable that a short test be administered to per-
sonnel concerning the material that is presented for 
the employee’s review.
At a minimum, it is recommended that repository 
staff be trained in the following areas:
•	 Facility security and procedures, including 
emergency response.
•	 Workplace health and safety.
•	 Technical procedures, including handling of all 
materials in the repository.
•	 Management of records and databases.
•	 The ethical issues surrounding biospecimen 
research, as applicable.
•	 Regulatory requirements.
•	 Participant privacy and confidentiality.
•	 Material release, including samples and 
information.
•	 Good Practices (GLP, GCP, GMP), as applicable.
Best Practice: To ensure quality of repository ac-
tivities, employee performance should be routinely 
monitored to identify needs for additional training 
between regular training intervals. Staff should be 
informed when first hired that routine monitoring 
of employees’ performance is a part of regular 
practices for ensuring quality and is applicable to 
all repository staff.
G2.2. Trainers
The trainer is an employee who regularly per-
forms the procedures in question, has completed 
the training program previously, and is skilled in 
explaining the elements of the task. The trainer 
is responsible for ensuring that the trainee un-
derstands each procedure and task. For special 
areas of training (e.g., human subjects protection, 
privacy, safety), personnel with special expertise 
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may provide the training. Experts via audio-visual 
methods including web-based technologies may 
also provide training. This approach may permit 
employees to complete special areas of training at 
their own pace when time can be scheduled based 
on the employee’s daily activities.
During the training period, the trainer demon-
strates, explains, and reviews the standards to 
be followed in conducting the procedure(s). The 
trainer should provide appropriate feedback, as 
necessary, on the trainee’s performance of the 
procedure. The trainer should supervise the trainee 
in all tasks contained in the procedure(s) until the 
training phase has been completed. The training 
phase should not be completed until the trainer and 
trainee are both comfortable that the trainee is able 
to conduct the procedure without supervision. 
Best Practice: After the training has been com-
pleted, the trainer should be available to answer 
questions when the task is being performed by the 
trainee for the first few times.
G2.3. Training Coordinator 
The Director should ensure all aspects of staff 
training are covered and that SOP changes are 
communicated appropriately. The Director may 
delegate tasks to other repository members, who 
may operate as a Training Coordinator. The Training 
Coordinator may maintain the SOP manual and 
coordinate with the trainer responsible for that 
particular procedure when any revisions are need-
ed either due to the expiration of the SOP or for 
technical reasons. The Training Coordinator closely 
coordinates issues related to training in safety with 
the organization’s Safety Officer and with other 
individuals responsible for specific areas of repos-
itory procedures (e.g., shipping and handling). The 
trainer also needs to have regular training to ensure 
their competency.
The Training Coordinator is responsible for moni-
toring, training, and maintaining appropriate train-
ing documentation of all employees. The Training 
Coordinator maintains records of employees to 
be trained in each required area, tracks the time of 
their periodic updates of training, informs the em-
ployees of potential times of training, and ensures 
the training is completed according to the required 
timeframe.
The Training Coordinator closely coordinates doc-
umentation of training and educational activities 
with personnel who maintain employee records, as 
needed. 
G2.4. Frequency of Training
Training and repeat training should be conducted 
in accordance with applicable regulations and also 
in accordance with the needs of the particular tasks 
and positions held by repository staff. In many coun-
tries, regulations require training before the em-
ployee begins working and yearly thereafter (e.g., 
biohazard and chemical hazard training). Training 
for regular repository tasks should be implemented 
before staff are asked to perform those particular 
tasks. Repeat training should be performed ac-
cording to a defined schedule described by SOPs. 
Supplemental training (sometimes in conjunction 
with “corrective actions” or a protocol change) may 
be required following the evaluation of particular 
incidents in order to prevent their recurrence or to 
enhance staff performance (see Section D4.3.4. 
Corrective and Preventive Actions).
Best Practice: Training should be periodic and 
documented and in accordance with the needs of 
the particular tasks to be performed.
G2.5. Cross-Training
Repositories should cross train personnel in a vari-
ety of procedures to alleviate staff burn-out, reduce 
turn over, and to maintain coverage should staff 
levels change.
G2.6. Training Documentation
Once the training is complete, a written record of 
the completed training should be made that in-
cludes the trainee’s signature as well as the trainer’s 
signature. Electronic signatures should be used 
for documentation of any electronic training that is 
received. 
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G2.7. Training Records
A training file should be maintained for each repos-
itory staff member and should include, but may not 
be limited to, the following:
•	 Position description that includes the job title 
and responsibilities, as well as the educational 
and work experience required to perform the 
specified task.
•	 Curriculum Vitae.
•	 Example of the employee’s signature and initials.
•	 Copies of any certificates documenting that 
the employee has had specialized training. This 
should include training in shipping, safety, and 
applicable regulations such as those required 
in the country in which the repository is located 
(see Appendix A: Internet Resources). 
•	 Documentation that an employee has read and 
understands all SOPs pertinent to the employ-
ee’s responsibilities.
•	 Orientation to the repository. 
•	 Documentation of analytical results to demon-
strate proficiency in specified technical tasks. 
This should include results of reproducibility 
and/or quality control results. 
The training file should be kept in the repository 
and be available for Quality Assurance or client 
review. The training file should be archived accord-
ing to the repository’s SOPs after the employee is 
separated from the organization. If an employee 
moves from the repository to another department 
within the organization, the employee’s training 
file should be transferred to the new department. 
Further information on management of training 
records can be found in Section D5. Records 
Management.
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SECTION H: COST 
MANAGEMENT
H1.  GENERAL
The repository’s activities should be detailed within a 
comprehensive business plan (see Section A3. Repository 
Development) which includes financial support to enable 
proper function. The business plan should be reviewed at 
routine intervals and as necessary to account for changes 
in governance, organizational structure, labor, materials, 
supplies, etc. Repositories should review and document 
costs related to personnel, labor, materials and supplies, 
equipment, equipment support, facilities, and qualifica-
tion. An equipment replacement plan should be imple-
mented and reviewed regularly to determine the actual 
costs of equipment, determine if repair and maintenance 
versus the cost of acquiring new equipment may be less 
expensive, be more efficient, and operate with fewer re-
pairs. It is only when these costs are known that accurate 
budgets can be prepared and funding sources can be 
identified. Failure to accurately document costs may lead 
to unsustainable repository operations.
Requirements for financial support may vary depending 
on the type of institution with which the repository is affili-
ated. Considerations may include the repository’s receipt 
of public or private funding and the amount of funding the 
repository must recover. To ensure continued operations 
without compromising quality, specific plans should be 
developed for five years and beyond to estimate long-
term costs and revenues. 
Best Practice: Repositories should develop a business 
plan based on objectives and strategy as well as known 
and estimated costs while ensuring that all costs are docu-
mented to support sustainability strategies. 
Best Practice: Repositories should have long-term projec-
tions for sustainability in addition to annual budget plans. 
H2.  IDENTIFYING AND DEFINING COSTS
Developing an accurate assessment of costs required to 
support a repository can be complex and dependent 
upon potentially overlapping functions undertaken in the 
repository setting. Understanding operational costs is a 
key component of a repository business plan. Tools exist 
globally to identify the specific cost burden of repository 
operations and opportunities for revenue (see Appendix 
A: Internet Resources). Cost assessment development 
should include financial management representatives of 
the organization(s) with which the repository is involved, 
and, possibly, repository funders. Cost information for 
facilities, equipment, and labor may be available from cur-
rent and historical records. Where possible, information 
should be obtained from within the organization or facility 
to determine current rates for overhead or indirect costs, 
personnel costs, facility costs (e.g., costs for space, HVAC, 
utilities, labor), equipment depreciation, and maintenance 
to permit the development of a cost recovery plan. Terms 
and conditions of shared costs should be detailed in the 
business plan. Some repositories may, for example, have 
part of their operating costs covered by medical facilities 
or universities with which they are associated, or to which 
they provide service.
Critical costs for effectively initiating, developing, and 
maintaining a repository should be considered. The actual 
costs to be considered will depend on the function of the 
repository. For example, costs should be assessed for the 
following:
•	 Physical facilities (e.g., lease, electricity, water, 
overhead).
•	 Staffing and administrative costs (e.g., payroll includ-
ing overtime, benefits, contract support, consultant 
fees, IT services).
•	 Specimen processing and storage equipment (e.g., 
freezers, cabinets, liquid handling machinery, cryo-
stats, nucleic acid extractors), and periodic calibration 
by vendors.
•	 Inventory management software, licenses, and 
maintenance.
•	 Consumables, operating supplies and gases (e.g., 
buffers, reagents, chemicals, disposables, disinfec-
tants, laboratory safety supplies, personal protective 
wear, liquid nitrogen, diesel).
•	 Minor equipment (e.g., monitoring equipment, 
barcode scanners, computers, office equipment, 
telecommunications).
•	 Service contracts for equipment maintenance and 
disaster recovery.
•	 Possible certification and/or accreditation fees or 
other Quality Management fees.
•	 Culling and/or transferring collections.
Evaluation of all costs related to work streams, systems, 
equipment, and supplies should be completed prior to es-
tablishing fee schedules. Under some circumstances, for 
example, costs for collection should be included whereas 
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in others, only the costs for receiving and storing speci-
mens should be considered. Likewise, costs for specimen 
testing may or may not need to be considered depending 
on the mission of the repository. The cost of specimen dis-
tribution should be calculated (e.g., labor for pulling and 
inventorying specimens, shipping supplies, courier fees). 
Once all costs are defined, it is important to review work 
processes and to consider the ability to optimize work-flow 
to improve cost recovery. Equipment and space should be 
multi-purposed whenever possible (i.e., shared facilities). 
A variety of options may be available for reduction of labor 
costs while still performing the work of the repository with 
high precision and quality. Routine repository activities 
should be examined to determine if automation might 
be incorporated to more rapidly process, store, and/or 
retrieve specimens with accuracy and efficiency. While 
automation typically requires an increased initial expen-
diture, the result may be a reduction in labor and facility 
costs over time.
Best Practice: Prior to cost assessment, evaluate all work 
streams, systems, equipment, supplies, and services to 
enable cost recovery and to minimize waste.
Best Practice: The operational life of infrastructure should 
be considered in preparation for timely replacement and 
expansion purchases.
H3. COST RECOVERY
External funding may be obtained through grants, con-
tracts, other private funding mechanisms, and user fees to 
cover the partial or full cost of collecting, maintaining, and 
distributing specimens. Even repositories that have most 
of their costs covered may wish to consider a nominal ser-
vice fee to promote good stewardship and judicious use of 
resources. Regardless of funding sources, repository man-
agers should prepare accurate, annual budgets to support 
orderly repository activities. Services and products should 
be provided according to quote-based, term-limited 
agreements.
Cost recovery policies should be developed with key 
stakeholders of the repository, potential recipients of the 
collected specimens, and, where appropriate, with study 
participant advocates. These policies should be reviewed 
regularly and adjusted as needed. Service fees should be 
kept within a range that accommodates cost recovery and 
permits maximum use of the repository. Additional policies 
should be developed to address the timely collection and 
non-payment of fees, as well as culling or redistribution 
of specimen collections that are no longer supported by 
funding.
Best Practice: Cost recovery policies should be devel-
oped, periodically reviewed, and adjusted as needed to 
meet the needs of the repository and its stakeholders.
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SECTION I: REPOSITORY 
INFORMATION MANAGEMENT 
SYSTEMS 
I1.  GENERAL
Effective tracking systems should be in place to ensure that 
specimens can be tracked accurately from the site at which 
they are collected through their entire lifecycle at the re-
pository. Critical components of these systems include the 
use of unique specimen identifiers, appropriate specimen 
labels, electronic data inventory systems for specimen 
tracking, consent form and/or permit tracking, and other 
features that are described in detail below. 
I2.  INVENTORY SYSTEMS
A computer-based inventory system should be in place to 
track the location and pertinent annotation of every speci-
men in the repository. The system should also track significant 
events such as specimen thaws, receipt, processing delays, 
destruction, movement of the specimen within the reposi-
tory, and specimen distribution and return (if applicable). Full 
query capability for all data stored should be provided.
Procedures for validation and documentation of the IT 
system including backup routines should be developed 
and included as part of a Quality Management System. 
Audit trails, software bug tracking, troubleshooting/
help desk functions and resolution procedures, and IT 
security and access policies and procedures should be 
documented and maintained (see Sections D4.2. Types of 
Documents of the Quality Management System and D5.1. 
Recordkeeping). 
The system should have the capacity to assign a unique 
ID to each specimen entered in the database and track its 
lineage (parent specimen to child to grandchild, etc.). If an 
ID exists but a new specimen ID reflective of the inventory 
system into which the specimen is being entered needs to 
be added, the inventory system should be able to track the 
original specimen ID as well as the newly assigned one. 
Selection of an inventory system depends on a number 
of factors that are unique to each repository. Among 
these the most critical are cost of ownership, fitness for 
purpose, time to implementation, and ongoing support. 
Repositories can choose from a range of commercial off-
the-shelf software programs or purchase a customized sys-
tem. ISBER has developed a checklist to assist in selecting 
the best fit (see Appendix A: Internet Resources).
Best Practice: Specimens received in the repository 
should be given a printed label including both a barcode 
and specimen ID, if one is not already on the specimen 
container. 
Best Practice: Inventory systems should allow for differ-
ent reports of data elements to facilitate research ques-
tions and collections management. Systems should have 
the capability of linking specimens with associated data 
(i.e., clinical, demographic, pre-analytical). 
I2.1. Specimen Location
Each freezer, refrigerator, room temperature stor-
age cabinet, or other unit appropriate to the collec-
tions should have a unique identifier. A convention 
should be established for numbering shelves, 
racks, boxes, as well as each location within the 
storage container. Certain storage systems (e.g., 
straws) are stored in containers such as goblets 
and the database should be able to capture such 
containers that do not follow the normal box/row/
column configuration. 
Each location combination (e.g., building, room, 
freezer, rack, box, row, column) should uniquely 
identify a location in the repository. Fixed compart-
ments in liquid nitrogen tanks and upright freezers 
need to be uniquely identified as well as the boxes 
placed in these compartments. For example, straw 
sample locations in boxes are linked to racks or 
compartments in the freezer. The inventory system 
should support different storage environments for 
the same repository and should also record the 
container type (e.g., vial, straw, slide). The inventory 
system should be able to report on available stor-
age space and able to assign and reserve space for 
incoming specimens. 
Changing the location of a specimen should be 
tracked in the Audit Trail (see Section I2.5. Audit 
Trail). The system should allow for mass movement 
of specimens with a single option to quickly and 
efficiently document required movement of large 
numbers of specimens (e.g., when a freezer fails).
Best Practice: The properties of the freezer or oth-
er storage unit should be maintained in the system 
(e.g., type, location, temperature). 
Best Practice: To audit (i.e., Quality Control) spec-
imen location, a randomly generated specimen 
list should be checked on a subset of the stored 
53ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
specimens on a regularly scheduled basis to ensure 
that the correct specimens are in the location speci-
fied by the inventory system. 
I2.2. Specimen Descriptors 
The inventory system should track specimen type; 
vial or container type; specimen amount; date and 
time of specimen collection, timestamps for receipt 
and/or processing; processing method; storage 
temperature; preservatives; and any other char-
acteristics needed for the collection. Information 
should be included on the history of specimen 
processing and movement, including the location 
of shipments to and from external sites. Finally, any 
information about the specimen being compro-
mised in any way should be recorded and available 
to the user. 
The inventory system should also be able to store 
data that are important to the study or protocol 
to which the specimens belong. Having this 
study-specific data stored with the specimens will 
enable users to utilize the data for specimen selec-
tion, reporting, and other activities at the reposito-
ry. Also, conditions listed in permits for the original 
collection of the specimens may require provision 
of information to the provider country. 
I2.3.  Information for Human Repositories
When dealing with human specimens, information 
relating to the following data may be maintained for 
a repository depending upon the nature, purpose, 
and type of the resource (if relevant, available, or 
not stored in another interoperable information 
management system): 
•	 Donor information: age of donor at the time of 
collection, sex, race, ethnicity, occupation, visit 
number, etc.
•	 Diagnosis: anatomic site (e.g., breast), tissue 
type (e.g., normal), diagnosis (e.g., fibrocystic 
disease), and modifiers to provide additional 
detail regarding the diagnosis. It may be import-
ant to document the gross diagnosis (what the 
specimen was thought to be when collected, 
e.g., breast-normal), the pathological diagnosis 
(diagnoses rendered by pathology for the actual 
resection, e.g., breast-malignant-adenocarci-
noma-ductal), quality control diagnosis of the 
specific specimen obtained for research (e.g., 
breast-normal-fibrocystic changes), and the 
pathologic stage at time of surgery. In some situ-
ations, it may also be appropriate to provide the 
diagnosis code (ICD10) and the text of clinical 
diagnosis. 
•	 Diagnostic procedure: type of procedure (e.g., 
surgery), date of procedure, procedure details 
(e.g., mastectomy), procedure identification 
number (e.g., surgical pathology number).
•	 Type of specimen collected: tissue, blood (indi-
cate type of vacutainer tube), saliva, cerebrospi-
nal fluid, genital fluids, etc.
•	 Availability of other specimens (e.g., normal vs. 
diseased tissue, other tissues, blood, buffy coat, 
serum, plasma, paraffin embedded tissue, H&E 
slide, formalin fixed tissue, DNA, RNA, urine, 
feces, saliva, ascites fluid and synovial fluid) from 
the same donor.
An inventory system may also be designed so that 
digitally scanned documents are included such as 
pathology reports, H&E slides of tissues collect-
ed, clinical lab reports, donor consent forms, and 
material transfer agreements (MTAs, see Section 
M2.5. Material and Data Transfer Agreements). 
The information stored will vary according to 
the purpose, nature, and intended uses for the 
specimen collection. Since a repository may track 
specimens of many different studies, consideration 
should be given to what the inventory system can 
contain and what should be stored in an external 
database and linked to the inventory.
I2.4. Information for Biodiversity, Environmental, 
and Veterinary Specimens 
Many items listed in I2.3. can also be applied to the 
information tracked for biodiversity, environmental, 
and veterinary samples, specifically animal sam-
ples, as well as additional information not included 
above. The Global Genome Biodiversity Network 
(GGBN) has developed the GGBN Data Standard 
for standardized data exchange which lists some 
of the information that is important when collecting 
for animal/fungal/plant/microorganismal biobanks 
or ESBs. The VeNom (Veterinary Nomenclature) 
Codes developed by the VeNom Coding Group 
is a list of terms that are used in veterinary practice 
and have been standardized across institutes to 
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facilitate academic discussion, research and clinical 
auditing. See Appendix A: Internet Resources for 
more information. 
Natural history collections use globally unique spec-
imen identifiers for their specimens and samples, 
usually accomplished through the so-called ‘Darwin 
core triplet’ (institution:collection:specimenID). The 
Global Registry of Biodiversity Repositories offers a 
curated list of such institution and collection codes 
(see Appendix A: Internet Resources).
I2.5.  Audit Trail
The inventory system should include a full audit trail 
of changes made to the database. This includes 
recording changes to both specimen data and 
system metadata. The audit trail should include but 
not be limited to: the original data; the changed 
data; who made the changes; and how the change 
was made, date and time of change, and if possi-
ble, why the changes were made. This audit trail 
should be automatically recorded and available 
for read-only access. The audit trail data should be 
able to be reported electronically.
Record changes should not obscure previously 
recorded information in the audit trail. Such audit 
trail documentation should be retained for a period 
at least as long as that required for the electronic re-
cords and should be available for audit (see Section 
D7. Internal Audits).
If Personal Health Information (PHI) or PII is stored in 
the system, an additional audit trail may be required 
by the relevant legislative authority. In these cases, 
every instance of viewing or reporting the data 
should be documented in the audit trail with the 
date, time, and name of the person viewing or re-
porting the data. If an individual requests a list of all 
persons viewing their PHI or PII, the system should 
be able to provide that data.
I2.6.  Risk Assessment and Security
Access to the computerized inventory system 
should be tightly controlled. Security roles with 
defined privilege levels should be assigned to indi-
vidual users of the system. Some individuals may be 
able to view specimen availability whereas others 
can enter or modify specimen descriptions and 
make requests to have specimens shipped from 
the repository. All PHI or IACUC should be secured 
within the inventory system through access con-
trols and/or encryption. All remote communication 
should be able to be conducted on an encrypted 
socket. 
Best Practice: The system should provide a mech-
anism to log off users after a specified period of 
time of inactivity.
Best Practice: The inventory system should 
provide for single sign-on utilizing the operating 
system’s user name and password if possible.
Best Practice: Repositories should use a com-
puterized inventory system that includes a layered 
approach to security in which the system, applica-
tion, transmission, and network are secured. The 
repository system should be isolated from other 
systems that might be compromised.
Best Practice: Passwords should conform to the 
minimum institutional standards.
I2.7.  Interoperability
Within modern repository informatics systems, in-
tegration and interoperability are highly desirable. 
Systems should be able to integrate with other local 
applications such as electronic medical records, 
cancer registries, pathology systems, and freezer 
temperature monitors. This allows other systems to 
be the Single Source of Truth (SSoT) for appropriate 
data.
Integration and interoperability have many benefits 
including, but are not limited to the following:
•	 Reduced re-entry of data. Every time data are 
manually reentered from one system to another 
there is a risk of error. Re-entering of data can be 
costly.
•	 Data errors found and corrected in the SSoT 
system need not be replicated to other systems.
Data should be electronically convertible into for-
mats that can easily be shared among collaborating 
institutions, where possible and appropriate. The 
inventory management system should enforce all 
data integrity, security, and audit trail requirements 
for external access. To achieve interoperability, 
inventory management systems should include the 
following:
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•	 Public documented Application Programming 
Interface (API) to enable other systems to inte-
grate with it.
•	 Common public vocabularies for relevant data 
points (e.g., SNOMED, ICD9-CM, ICD10, ICDO).
•	 A framework that allows it to connect to other 
systems and to communicate with external APIs 
on an event driven or periodic basis.
•	 A security policy to ensure proper sharing of data.
I2.7.1. Data Exchange Standards
In recent years, a sector of human biobanks 
related to the medical/clinical community has 
developed two main data standards. The first 
standard is BRISQ (Specimen Reporting for 
Improved Study Quality1, a 3-tier standard to 
better understand, interpret, compare, and 
reproduce experimental results, which involve 
human specimens. The second standard is 
SPREC2,3, a standard to share pre-analytical 
data related to collection, processing, and stor-
age through assigned codes. 
Other data exchange standards that have been 
developed are:
•	 Minimum Information About BIobank data 
Sharing4 provides information about the 
sample collection and study of human 
specimens.
•	 GGBN Data Standard5 enables standard-
ized exchange of DNA and tissue sample 
data and fulfills the requirements of the 
Nagoya Protocol. 
Natural History Data Standards:
•	 Darwin Core (DwC)6 
•	 Access to Biological Collection Data7
I2.8.  Cloud Computing
Cloud computing and storage solutions are 
Internet-based services that offer on-demand, 
online access to shared computing resources with 
varying levels of functionality depending on the us-
ers’ requirements, ranging from mere data storage 
to complete software solutions (e.g., a Repository 
Inventory Management system), platforms to sim-
plify the ability of application developers to create 
new products, and entire computing infrastructure 
for software programmers to deploy and test pro-
grams. Cloud services providers (CSPs) are gen-
erally an entity separate from the repositories and 
provide various capabilities to store and process 
data in either privately owned or third-party data 
centers that may be located far from the user. A 
repository that engages a CSP should understand 
the cloud computing environment and conduct 
risk analysis and establish risk management pol-
icies as well as enter into an appropriate business 
associate contract or agreement and a service level 
agreement.
Repositories seeking information about types of 
cloud computing services, cloud data manage-
ment data interface, and technical arrangement 
options may consult a resource offered by the 
National Institute of Standards and Technology 
(NIST, 2014) or the International Organization 
for Standardization (ISO/IEC 17826-2016) (see 
Appendix A: Internet Resources).
Best Practice: Repositories should ensure that any 
cloud service providers utilized are compliant with 
regulations that maintain the privacy and security of 
ePHI and PII.
I2.9.  Reporting
The information management system should have 
the ability to produce reports to support the repos-
itory workflow, document adherence to standards 
and practices, and provide any business metrics 
required by the repository. 
The system should provide the user with an inter-
face for specifying display content and search crite-
ria for the report. The exact nature of this interface 
can vary from full “what you see is what you get” 
(WYSIWYG) report designers to simple field selec-
tion for tabular reports. The query editor can also 
be presented utilizing several approaches, includ-
ing simple data query forms, Query By Example 
screens, customized query builders, and text areas 
for native query specification.
The information management system should have 
the ability to save report specifications for future 
execution. The system should also have the ability 
to edit these saved specifications as well as share 
the specifications with other users.
The inventory system should have the ability to 
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generate report output and electronic data files 
(e.g., in ASCII, XML, CSV, or XLS). The system 
should provide full access to the database for re-
porting, provided that the system’s security rules 
are enforced. This access will allow users to gener-
ate reports on inventory status, freezer status, user 
access, audit trail entries, and other data tracked by 
the database to meet their needs.
If the database contains PHI records, the security 
model should restrict reporting on confidential 
data to only authorized users. Additionally, the 
repository should maintain SOPs about the gener-
ation, use, and destruction of reports that contain 
PHI and PII to ensure that donor confidentiality is 
maintained. 
I2.10.  Validation 
Whether the inventory system is a commercial 
off-the-shelf software or a customized bespoke sys-
tem, the repository should employ procedures and 
controls designed to ensure the authenticity, integ-
rity, and, when appropriate, the confidentiality of 
electronic records. Such procedures and controls 
should include the following:
•	 Validation of systems to ensure accuracy, reliabil-
ity, consistent intended performance, and the 
ability to discern invalid or altered records.
•	 Protection of records to enable their accurate 
and ready retrieval throughout the records re-
tention period.
•	 Use of operational system checks to enforce 
permitted sequencing of steps and events, as 
appropriate.
•	 Use of authority checks to ensure that only 
authorized individuals can use the system, elec-
tronically sign a record, access an operation or 
computer system input or output device, alter a 
record, or perform a specific operation.
•	 Use of checks to determine, as appropriate, the 
validity of the source of data input or operational 
instruction.
•	 Determination that persons who develop, 
maintain, or use electronic record/electronic 
signature systems have the education, training, 
and experience to perform the assigned tasks.
•	 The establishment of, and adherence to, written 
policies that hold individuals accountable and 
responsible for actions initiated under their elec-
tronic signatures to deter record and signature 
falsification.
•	 Use of appropriate controls over systems docu-
mentation including:
•	 Adequate controls over the distribution of, 
access to, and use of documentation for 
system operation and maintenance.
•	 Revision and change control procedures 
to maintain an audit trail that documents 
time-sequenced development and modi-
fication of systems documentation.
In addition to validation at the initiation of the 
system, ongoing validation should be performed 
when the system is updated in a maintenance re-
lease or new features are added. The amount and 
depth of validation necessary is dependent on 
the scope of the update. Modified portions of the 
system should be re-tested in order to ensure that 
no regression errors have been introduced. New 
features should be validated if they are going to be 
utilized.
Best Practice: All validation performed should be 
documented to ensure traceability and ongoing 
accuracy of the system.
I2.11. Quality Assurance
In order to provide high-quality information to serve 
the tracking system, standards, policies, and proce-
dures should be used to ensure and maximize the 
accuracy and completeness of the data. Periodic 
reviews of data quality issues and adjustments to 
programs and processes will ensure continuous 
quality improvement. The electronic inventory 
system should comply with industry-applicable 
GP guidelines (see Section D6.1. Good Practices). 
An established Quality Assurance program for the 
inventory system should be primarily directed at 
prevention of non-conformances as well as detec-
tion, corrective action, and process improvement 
implementation.
Regular Quality Assurance audits and reviews 
should completely assess:
•	 User requirements, as well as industry-specific 
certification requirements.
•	 Details of the review and approval process for 
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software developed in-house or obtained from 
a third party.
•	 Procedures followed to test the software func-
tionality compared with user requirements.
•	 Corrective actions or processes used to handle 
program errors and modifications.
•	 Training provided to personnel associated with 
the use (and development, if applicable) of the 
inventory system.
•	 A quality manual on the quality assurance of a 
repository’s database.
Best Practice: A periodic audit of the database 
should be performed to ensure accuracy of data.
I2.12. Backup
The database should be backed up on a regular 
basis, depending on the institutional policies and 
frequency of data modification. The more frequent 
the data is changed, the more frequently the back-
ups should be made.
The procedures to preserve the integrity of repos-
itory data should include (but are not limited to) 
steps to limit the extent of the destructive event, 
protocols for periodic backing up and storing of 
information, procedures for off-site storage of back-
up data, and protocols/procedures for restoring 
information from backed up media. 
The backup procedures should specifically address 
the recoverability of information. Backups should 
be tested on a regular basis to ensure the data can 
be accurately recovered.
Best Practice: Repository databases should be 
backed up frequently (i.e.: daily, weekly) based on 
institutional protocols or frequency of database 
modifications.
I2.13. Labels
Each specimen should receive a label that tightly 
adheres under all planned storage and processing 
conditions. Information printed on labels should be 
resistant to all common laboratory solvents. Labels 
should contain an ID linking to a database contain-
ing details about the specimen collection and pro-
cessing information (see Section I2.2. Specimen 
Descriptors). Flexibility should be allowed in the 
location and size of the label to allow for label legi-
bility on a wide variety of containers. 
Material used in composition of containers for 
some specimens may pose special problems for 
label adherence and therefore, in some cases, the 
label should be able to adhere to itself. 
The adherence of labels to containers as well as the 
use of particular types of ink should be tested un-
der conditions more extreme than the anticipated 
storage and processing conditions before they are 
put into regular use. 
I2.13.1. Labels for Specimens
Specimens should be labeled in such a way 
that protects privacy and confidentiality and is 
in compliance with applicable laws and institu-
tional policies. Specimens should be labeled 
with a unique code or ID not derived from 
personal information of the donor. No other 
study or personal health information should 
be encoded in the specimen ID. Depending 
on the type of repository, essential information 
such as genus and species or other details may 
be part of the label. 
Best Practice: For all specimens, the reposito-
ry’s unique identifier for each specimen should 
be printed on the label in both barcode format 
and/or human readable form. The ID should 
not be reflective of its storage location in the 
repository, as locations may change over time. 
I2.13.2. Barcoding
Whenever possible, labels should be printed 
with a barcode that uniquely identifies the spec-
imen and links to the database with the relevant 
metadata about the specimen. 
I2.13.3. RFID
Radio-Frequency Identification (RFID) tags may 
be used instead of barcoded labels. The identi-
fier stored in the RFID tag must be linked in the 
database with the relevant metadata about the 
specimen, in the same way a barcode is. 
I2.14. Shipping Log
For more details on shipping, consult Section J: 
Packaging and Shipping. Each repository should 
maintain a shipment log to record the receipt and 
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dissemination of shipments sent from the reposito-
ry. This log should be integrated into the functional-
ity of the inventory management system described 
above. Each shipment entry should be given a 
unique shipment ID. The electronic log should be 
able to track the following elements:
•	 Shipment/Invoice ID
•	 Source
•	 Destination
•	 Date shipped and date received
•	 Courier name
•	 Package Tracking ID, if applicable
•	 Unique specimen identifier
•	 Specimen type(s)
•	 Genus and species or family (if required)
•	 Material Transfer Agreement 
•	 Quantity sent and received
•	 Study name and/or number if available
•	 Shipping conditions (e.g., dry ice, room 
temperature)
•	 Name/Signature of individual receiving the 
shipment
•	 Any discrepancies between the shipping mani-
fest and the actual shipment
•	 Any indication that a specimen has been com-
promised (e.g., record deviations in specimen 
quality upon receipt)
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SECTION J: PACKAGING AND 
SHIPPING
J1.  GENERAL
Packaging and shipping should conform to applicable 
regulations. For example, air shipments should conform 
to International Air Transport Association (IATA) standards 
and ground shipments should conform to applicable na-
tional/federal standards. All personnel involved in ship-
ping biological materials should be appropriately trained 
(IATA/Department of Transportation, Alternative Dispute 
Resolution, and other standards relevant to shipping and 
transport). 
J2.  TRANSPORT SPECIFICATIONS
The first step in the preparation of a shipment for transport 
is the determination of the specifications for the specimens 
to be shipped. 
J2.1. Regulatory Requirements
The shipper should first determine how to classify the 
specimens that are to be transported. Specimens 
such as infectious substances, diagnostic speci-
mens, biological products, genetically modified 
organisms and microorganisms, or toxic substances 
may be considered dangerous goods. Also, the 
preservatives and excipients that have been ap-
plied to the specimens may be considered as toxic, 
flammable liquid, non-flammable gas, or corrosive, 
all of which are dangerous goods. National or fed-
eral transport regulations as well as those from their 
International Civil Aviation Organization (ICAO) and 
IATA should be consulted in order to properly classi-
fy the specimens to be included in a shipment.
Non-human specimens must be checked for CITES 
(Convention on International Trade in Endangered 
Species of Wild Fauna and Flora) regulations. 
Depending on shipping origin and shipping des-
tination, CITES documentation must accompany 
the specimens and be clearly marked with CITES 
labels. Only registered organizations are allowed 
to send out or retrieve CITES material with a notable 
exception of when shipping CITES material within 
the European Union.
Many countries require that personnel involved in 
the transport of dangerous goods receive training 
in this area before they begin their shipping respon-
sibilities. As regulations change, training may need 
to be updated.
J2.2. Temperature Requirements
To preserve specimen quality, shipment tempera-
ture should be tracked (when possible) and docu-
mented and any fluctuations in temperature should 
be minimized. The staff preparing shipments 
should be trained and understand the conditions 
required for shipping different types of specimens.
The following are typical temperature conditions 
required for transport of specimens and the 
insulation/refrigerant helpful to maintain that 
temperature:
•	 Ambient (20 to 30°C) - insulated packaging 
to protect from extreme heat or cold ambient 
conditions. 
•	 Refrigerated (2 to 8°C) - wet ice or gel packs 
(conditioned at –15°C, designed for refrigerated 
temperatures, or phase change material rated 
for refrigerated transport).
•	 Frozen (-20°C) - gel packs designed for frozen 
temperatures; conditioned at or below -20°C.
•	 Frozen (-70°C) - dry ice pellets, blocks, or 
sheets. Note that dry ice (solid CO2) employed 
for frozen shipments is considered a hazardous 
material and appropriate labeling should be 
included. 
•	 Frozen (at or below –150°C) - liquid nitrogen dry 
shipper, also referred to as a vapor shipper. Dry 
nitrogen shippers are insulated containers that 
contain refrigerated liquid nitrogen that is fully 
absorbed in a porous material, and is therefore 
considered a non-dangerous product and is not 
subject to IATA regulations as a dangerous good 
(special provisions A-800) if properly filled (i.e., 
no free residual liquid nitrogen remains). 
Best Practice: Shipments of cold or frozen material 
should be shipped with sufficient and appropriate 
refrigerant to maintain temperature throughout the 
shipping cycle with allowance for at least a 24-hour 
delay in arrival time. 
Best Practice: Shipments of specimens with high 
value or those with critical temperature require-
ments should include a temperature-recording 
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device (e.g., datalogger, temp card) that can ver-
ify the temperature of the material being shipped 
throughout the transport cycle.
J2.3. Humidity Requirements
Specimens sensitive to humid conditions may need 
to be shipped in sealed bags with desiccant to pre-
vent exposure to moisture during transit.
J2.4. Arrival Time Requirements
Time sensitive specimens such as fresh whole 
blood should be consigned to couriers with a 
proven reputation of successful on-time delivery 
(see also Section J5. Cold Chain). Time required 
for shipment processing should be considered as 
well. Shipments should be initiated when there 
are at least two working days left in the week after 
the estimated delivery date, in case they do not 
arrive on the day scheduled for delivery. Shipments 
should also be scheduled so that they do not arrive 
at the recipient location on a holiday or weekend. 
Attention should be paid to weather forecast when 
planning a shipment to ensure the shipment is not 
delayed due to bad weather conditions. 
J2.5.  Packaging Shipments 
The quantity of specimens to be transported will af-
fect the type of packaging and amount of refriger-
ant required to maintain appropriate temperatures 
for all specimens in the shipment. The container 
should be appropriate (i.e., validated) and of the 
right size for the number of specimens and amount 
of refrigerant that will be included in the container. 
Shipments involving a large number of specimens 
may be divided into multiple, smaller shipments to 
minimize risk or accommodate available containers.
J2.6. Other Packaging Considerations
•	 Specimens should be positioned between the 
refrigerants used rather than being placed on 
top of or underneath the refrigerant. 
•	 After the specimens and the refrigerant have 
been placed into the container, empty space 
should be filled with Styrofoam or wadded 
paper to prevent movement of the specimens 
during shipment.
•	 Any labels remaining on the exterior of the ship-
ping container from a previous shipment should 
be removed or marked through.
•	 Air-bills should not be reused.
J3.  VERIFICATION OF SHIPPING  
  CONDITIONS
J3.1. Review of Packaging Test Report
The shipper is responsible for choosing appropri-
ate packaging for the shipped material. The ship-
per should review all test reports for the packaging 
to ensure that the packaging regulations are met. 
Packaging that has undergone stringency (i.e., 
validation) testing should be used in the same con-
figuration under which it was tested. Tests may in-
clude measuring all parameters that could influence 
specimen integrity (i.e., temperature, humidity, light 
sensitivity, structural quality, spill containment).
J3.2. Test Shipments
In some situations, especially relating to extremely 
valuable samples, repositories may choose to first 
send a test shipment that approximates the char-
acteristics of the actual shipment. This may inform 
the shipper as to the adequacy of packing coolants 
and also serve to identify any potential obstacles 
for the successful shipment. 
Best Practice: A temperature-recording device 
or an irreversible temperature indicator should be 
used during shipping tests to ensure that tempera-
ture requirements have not been exceeded.
J3.3. International Shipments
Special permits or other requirements may be unique 
to certain nations and regions, including regulations 
related to ethical issues that prohibit the import/
export of certain types of human specimens or have 
specific requirements concerning the import/export 
of such specimens. Special permits such as the CITES 
permit and additional paperwork may be required for 
field collection of organisms that are endangered or 
protected. 
Most international shipments also require a customs 
clearance note to be clearly displayed on the out-
side of the package. Identification of all national/
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federal requirements for shipping should be per-
formed prior to the initiation of the shipment. Use 
of a customs broker can be helpful or even critical. 
Certain couriers can provide this service, which can 
be essential for transport to/from a foreign country. 
Best Practice: Due to possible delays in complet-
ing customs requirements, temperature-sensitive 
material should be consigned with a courier capa-
ble of replenishing refrigerant in the event of a de-
lay. As a precaution, three additional days’ worth of 
refrigerant is recommended for shipments in cases 
where customs clearance may be difficult.
Best Practice: International shipments should 
include a letter on institutional letterhead (as ap-
propriate) documenting the contents and handling 
requirements. Copies of all import permits and san-
itary certificates should be included, as needed.
J4.  TRACKING SHIPMENTS DURING  
  TRANSPORT
Both the shipper and recipient should track all packages 
while in transit.
J4.1. Notification of Shipment
The shipper should notify the recipient that a 
shipment is scheduled to arrive on a specific date. 
The recipient should confirm that they are able to 
receive the package and that they have the proper 
facilities for storage before the shipper releases the 
shipment. The shipper should provide a 24-hour 
emergency contact for all packages transporting 
dangerous goods.
J4.2. Shipping Manifest and Tracking Number
The shipper should send a shipping manifest 
(preferably electronic) to the recipient prior to the 
release of the shipment. A paper copy should also 
be included with the shipment itself. The tracking 
number should be provided to the recipient as 
soon as this is available.
J4.3. Sample Receiving and Verification 
Confirmation of receipt and the condition upon 
arrival should be documented using a Verification 
Report Form for every delivery or shipment of 
specimens. This form could originate from the 
shipper or recipient. If originating from the shipper, 
it should be sent with the shipment/delivery. The 
Verification Report should be sent to the shipper 
and any discrepancy between specimens sent and 
received should be immediately resolved.
J5.  COLD CHAIN 
J5.1.  General 
The cold chain is the temperature-controlled 
supply chain (below ambient), which must remain 
unbroken over a series of collection, storage, and 
distribution events (from field, to repository, to 
other research institutions). The purpose of the 
cold chain is to safeguard perishable specimens 
and preserve specimen quality and integrity. Cold 
chain temperatures range from +4°C to -196°C, 
depending on the specimen type shipped and the 
intended use. 
The cold chain distribution process is an extension 
of the Good Manufacturing Practice (GMP) which 
all drugs and biological products are required to 
adhere to by various health regulatory bodies. The 
same principles apply for animal and plant speci-
mens. As a result, all distribution and storage pro-
cesses should be validated to ensure that there is 
no negative impact on the quality of the specimens. 
Best Practice: The management of cold chain 
should include all measurements, qualifications, 
validation, and corresponding documentation. All 
components and operations should be demon-
strated to perform reliably. 
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J5.2.  Cold Chain Validation 
Cold chains need to be validated in advance and 
controlled. Test runs are recommended, when 
feasible:
•	 Logistics Providers: specialist couriers, carriers, 
and logistics providers should have the techni-
cal ability to link with airlines for real time status, 
generate web-based export documentation, 
and provide electronic tracking. Providers 
should also offer on-the-ground troubleshoot-
ing, where possible.
•	 Transport and Shipping Containers: a wide 
variety of refrigerated vehicles, warehouses, in-
sulated shipping containers, and other special-
ized packaging are available. These containers/
packages should be tested and evaluated to 
be fit-for-purpose and/or compliant with ap-
propriate shipping regulations for packaging 
class and dangerous goods transportation (e.g., 
flammable preservatives, dry ice, ICAO, IATA, 
road [ADR], rail [RID], maritime regulations) (see 
Appendix A: Internet Resources). 
•	 Tracking: temperature data loggers, and/or 
other devices (e.g., thermocouple probes, RFID 
tags, color-coded vaccine labels) should be 
used when collecting samples and specimens 
in the field destined for shipment. The purpose 
is to monitor and record temperature and han-
dling history from field to repository.
•	 Documentation: each step of the custody 
chain should follow established protocols and 
maintain proper records. To avoid customs 
delays due to inaccurate or incomplete customs 
paperwork, guidelines for creating all necessary 
commercial invoices, etc., should be strictly 
followed.
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SECTION K: SPECIMEN 
COLLECTION, PROCESSING, 
RECEIVING, AND RETRIEVAL 
K1. GENERAL
Specimen collection and retrieval practices have many 
elements in common, while specimen processing will 
vary according to the specific research or clinical activities 
associated with the repository. Specimen availability and 
potential analytical objectives for their utility should be 
considered prior to initiating specimen collection and 
methods should be used to ensure that all specimens col-
lected are fit for purpose (see also Section E1. Validation of 
Sample Processing Methods). 
It is important to ascertain the sensitivities of different types 
of specimens and associated analytes to collection, pro-
cessing, storage, and retrieval procedures. These may vary, 
particularly between viable and non-viable specimens; 
therefore, when appropriate, collection protocols should 
be consistent and incorporate any special requirements 
necessary for the preservation of viability, functionality, 
structural integrity and stability of cells, tissues, organs, 
cell-free fractions, macromolecules, and/or analytes. In 
addition to specimen type, other considerations prior to 
initiating a collection include: regulatory, safety, and legal/
ethical issues. 
Specific personnel responsibilities, training, risk manage-
ment, and skills may be required for specimen collection. 
Planning of collection logistics should take into account 
distance from the collection point to the processing lab, 
interim transport containment, and security of the storage 
facility (if this is a different location). Standard protocols for 
specimen collection and sample handling should be es-
tablished and followed. Protocols for stabilization and/or 
preservation of samples during transit may be necessary. 
Due to the potential impact of pre-analytic processes on 
specimen quality, it is important to apply strategies that 
maintain the stability and functionality of biospecimens 
and macromolecules of interest (see Section E1. Validation 
of Sample Processing Methods). Stringent procedures are 
similarly required for specimen labeling and tracking from 
the point of collection to processing and storage in the 
repository, shipment to and receipt at the site of analysis, 
and final specimen disposition. 
Based on availability, many different specimens may be 
collected, processed, and/or stored from the same source 
(e.g., solid tissue, blood, saliva, urine) even longitudinally 
over time. Furthermore, specimens may be processed 
into a variety of formats (e.g., formalin-fixed paraffin em-
bedded [FFPE], optimal cutting temperature [OCT] blocks, 
snap-frozen, viable cell fractions, lyophilized fractions). 
Redundancy of specimen types can maximize the op-
portunity for future usage; however, limitations imposed 
by processing time requirements and the repository’s 
storage capacity must be considered when collecting 
multiple specimen types and processing them in a variety 
of formats.
Best Practice: Multiple fit for purpose specimens should 
be collected. When possible, multiple aliquots should be 
made and stored separately to minimize the risk of com-
promised sample integrity or freeze/thaw events.
Best Practice: The time, temperature, and the person 
handling the sample should be documented every time 
the specimen is manipulated.
K2. PILOT STUDIES AND PROOF OF  
  PERFORMANCE STUDIES
When possible, small-scale pilot studies should be em-
ployed to assess feasibility and to optimize and validate 
new protocols, equipment, and laboratory processing 
methods. Pilot or feasibility studies can identify problems 
or critical points and instigate preventative actions at an 
early stage of collection, handling, and processing before 
a larger study is undertaken. Pilot studies can also help 
optimize new processes and identify training required 
before implementing a new protocol. These studies are a 
requirement in some countries.
Best Practice: Repositories should formalize and doc-
ument test plans used for evaluating the performance of 
equipment or validating a processing method.
K3. SPECIMEN INTEGRITY
The relative importance of the period of time between 
receipt, processing, and storage of a specimen depends 
on its intended use and application. Biological specimens 
can lose functionality and molecules can degrade at 
different rates dependent upon type and status of donor 
and collection circumstances1,2. It is important to identify 
critical factors which predispose different specimens to 
deterioration and contamination. For example, for spec-
imens from vertebrate animals, cellular integrity and mo-
lecular degradation may begin when the vascular supply 
to an organ is interrupted during surgery (warm ischemia) 
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or when tissue is removed and placed in a cold container 
(cold ischemia). The speed at which the degradation oc-
curs will depend upon many complex factors including, 
but not limited to: donor, organism, and/or organ health 
status, type of organ and tissue, collection procedures, 
the temperature and hydration at which the specimen is 
maintained, as well as the stability of the molecules of in-
terest3. Tissue specimens should be maintained at optimal 
temperatures, as specified by the collection protocol. In 
general, specimens should be processed as rapidly as 
possible with minimal manipulation.
Best Practice: All pre-analytical procedures including 
collection, processing, storage, and shipping should be 
documented since pre-analytical variables may affect an-
alytical results.
Best Practice: End-users should be provided with the 
recorded pre-analytical variables so that informed, evi-
dence-based assumptions and conclusions about the ex-
perimental data can be made.
K3.1. SPECIMEN STABILITY
Specimen stability may be affected by parameters 
such as the use of anticoagulants and stabilizing 
agents like ethylene diamine tetraacetic acid (EDTA) 
in blood and ascorbate in urine4,5. It is important to 
know in advance the specimen collection require-
ments by manufacturers of specific assay kits. For 
some applications, rapid dehydration is an effective 
method to stabilize molecules. Dehydration meth-
ods may be more practical in field settings where 
access to refrigerants or chemical fixatives is dan-
gerous, cumbersome, or unavailable. 
Specimen stability is also detrimentally affected 
by exposure to the environment. Excessive ultra-
violet rays can alter DNA or RNA structure; excess 
humidity can lead to mold; untreated atmospheric 
air may oxidize protein and other metabolites; 
and a large sample volume to container dead-air 
volume may alter pH, as well as create an inefficient 
storage solution. An important variability factor in 
pre-analytical procedures is time: collection time, 
processing time, or long-term storage time. The 
impact of this time can be assessed by short- or 
long-term stability studies. A standardized tool has 
been developed to facilitate these studies (e.g., 
body fluids) (see Appendix A: Internet Resources).
Best Practice: Selected methods for collecting 
and preserving specimens should be followed 
to ensure that any preservatives, dehydration, or 
other protective treatments used do not have a 
deleterious effect on future analyses.
K3.2. TEMPERATURE
Because cold preservation is a critical stabilizing 
factor for many specimen types, the temperatures 
at which specimens are collected, processed, and 
stored should be carefully considered and docu-
mented6,7. These range from chilling/hypothermic 
(2 – 8°C) to low subzero (-4°C to 0°C), freezing 
(-20°C to -150°C) in mechanical/electrical freezers 
and storage at the ultra-low temperatures of liquid 
and vapor-phase liquid nitrogen (to a minimum 
of -196°C). Choice of collection and storage tem-
perature depends upon impact to specimens from 
chilling, freezing, and cold-induced dehydration; 
duration of exposure and tolerance to cryoprotec-
tive treatments; and intended analyses. The gen-
eral rule is that a warm storage environment, even 
for a short period of time, can lead to physiological 
stress and macromolecular degradation. For this 
reason, it is necessary to maintain appropriate 
temperature(s) from the point of collection through 
processing and storage. Hypothermic tempera-
tures (2 – 8°C) have generally been considered 
as the default condition for specimen transport/
storage when not frozen; however, for some pro-
cessing/applications the ambient temperature 
is recommended. Consideration of downstream 
assays is critical, as biological specimens may react 
to hypothermic conditions by changing their meta-
bolic and molecular profiles. 
The type and duration of low-temperature expo-
sures are also dictated by the intended use of the 
specimen. For example, blood samples collected 
to yield serum will need to be maintained at room 
temperature to allow clotting. The collection and 
processing time should be documented and re-
ported to the end-user. This information is critical 
for quality control measures (e.g., will help explain 
the presence of fibrin, a common occurrence when 
insufficient time is allowed for clotting to occur). 
Specimens can also be collected, shipped, 
and stored at ambient temperatures using new 
technologies that have been developed specifi-
cally for such purposes (see Section C7. Ambient 
Temperature Storage). Ambient preservation is 
available for purified analytes (RNA and DNA)8 as 
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well as for more complex specimen types (e.g., 
saliva, feces, blood, cells, tissue). Preservation du-
ration can range from a few days to, in some cases, 
greater than 25 years9. Technology for preserving 
dried blood spots on cellulose-based cards/filter 
papers at ambient temperature for longer than 15 
years has been well described in literature10.
Best Practice: Continuity of the cold chain should 
be maintained and documented from the point of 
collection to deposition in the repository and to 
eventual use.
K3.3.  Biopreservation/Cryopreservation
Biopreservation is a general term used to describe 
the preservation of biological materials of all types 
(e.g., living cells, tissues, fluids, organs, organisms) 
using a variety of fixation/preparation techniques 
and a range of low temperatures or ambient stor-
age methods. Cryopreservation is a more specific 
form of preservation that involves the storage of 
specimens (e.g., living cells, tissues, fluids, organs, 
organisms) at their optimum ultra-low tempera-
tures. Cryopreservation of tissues and fluids in-
volves storage at temperatures low enough to stop 
most enzymatic or chemical activity (e.g., storage 
below -136°C, the glass transition point of polyol’s 
water solution). 
K3.3.1.  Biopreservation
Common methods of biopreservation (exclud-
ing cryopreservation and storage at ultra-low 
temperatures, discussed in more detail below) 
include chemical fixation (e.g., in 10% formalin, 
in alcohol) or desiccation within a preservation 
matrix at ambient temperatures. From mummi-
fication to modern techniques, tissue fixation is 
the oldest way to preserve tissues and organs. 
A common tissue specimen preservation tech-
nique involves fixation in a formalin solution 
with subsequent embedding of the fixed tis-
sues into paraffin, creating an FFPE tissue block. 
This technique has been used for the past 100+ 
years for morphological assessment of tissue 
structure and, more recently, for the preserva-
tion of molecular analytes (e.g., proteins, DNA, 
RNA). Frozen samples may be processed to 
FFPE blocks. This conversion should always be 
documented, as it may affect its fitness-for-pur-
pose. Another common clinical technique is 
preservation of dry blood spots on paper or 
other matrix. Once dried, the sample’s nucleic 
acids, metabolites, and proteins could be sta-
ble for months to years at ambient temperature 
or under refrigeration. Other methods include 
biofluids concentration and preservation on a 
dry matrix (e.g., dry concentrate of urine or its 
components on a membrane), vacuum drying, 
and freeze drying.
K3.3.2. Cryopreservation
Cryopreservation of viable cells and tissues 
involves the process of cooling cells or whole 
tissues to ultralow temperatures at which any 
biological activity, including the biochemical 
reactions that would lead to cell death, is effec-
tively stopped (e.g., storage below -136°C, the 
glass transition point of polyol’s water solution). 
There are two distinct methods of cryopreser-
vation: (1) preservation in the frozen state which 
can involve either immediate freezing (also 
known as snap-freezing or ultra-rapid freezing) 
or controlled-rate (slow programmable) cooling 
and (2) vitrification, which is preservation in the 
glassy, non-crystalline state. Both methods may 
require the addition of cryoprotectants which 
have different protective properties (colligative 
or osmotic), although generally they will lower 
the freezing temperature. Cryoprotectants are 
applied in different regimens, combinations, 
and concentrations dependent upon the mode 
of cryopreservation (frozen or vitrified). 
In contrast to snap-freezing, controlled-rate 
cooling of cells/tissues/organs minimizes the 
potential for lethal, intracellular ice to form 
during the freezing process controlling extra-
cellular ice nucleation (also termed ‘seeding’) 
and applying optimally slow cooling rates that 
allow sufficient water to leave the cell during the 
progressive freezing of the extracellular fluid. 
Controlled-rate cooling requires the careful 
control of cooling rate (e.g., around 1°C/minute 
is appropriate for many mammalian cells), ice 
nucleation temperature and terminal freezing 
temperature and hold time (i.e., before spec-
imens are transferred to LN2), the optimization 
of which will vary between cells of differing 
size and water permeability. To circumvent 
cryoinjury caused by toxic cell volume changes 
and the excessive concentration of solutes, 
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the application of colligative cryoprotectants, 
such as dimethyl sulfoxide (DMSO), is required 
during controlled-rate cooling. 
A 1°C/minute cooling rate may be achieved 
for some cells using devices such as a rate-
controlled freezer or a bench-top portable 
freezing container. For other cells, a device 
in addition to a cryoprotectant is preferable. 
Alcohol-based or alcohol-free portable devices 
are commercially available and may also be cus-
tomized as a ‘do-it-yourself’ device11,12.
Vitrification is a process that avoids the poten-
tial damage to cells caused by intracellular and 
extracellular ice formation by the addition of 
cryoprotectants at higher concentrations which 
increases the viscosity of the sample and pre-
vents ice crystals from forming. 
Common cryoprotectants, such as DMSO, 
ethylene glycol, or propanediol13 are often 
toxic in high concentrations and care must be 
taken to limit the damage produced by the 
cryoprotectant itself. When possible, research-
ers should test available preservation solutions 
to determine which is optimal for their specific 
research activities and, as required, pilot test 
the cryoprotectant strategy for their preserved 
samples. Using an appropriate cryopreserva-
tion medium and cryoprotectant(s) will reduce 
the rate of degradation at hypothermic tem-
peratures and offset the risks of inadvertent 
devitrification at ultra-low temperatures. 
The temperature at which frozen and vitrified 
preparations are stored can affect the length 
of time cells can be stored before they lose 
viability (generally, the lower the storage tem-
perature, the longer the viable storage period). 
As temperature is reduced, metabolic and 
degradation processes in cells are slowed; 
however, they are not effectively slowed to 
allow for long-term storage (years to decades) 
until the temperature falls below the glass tran-
sition (Tg) temperature of pure water (effectively 
< -132°C for most mixtures of cells and aqueous 
cryopreservation media). The Tg of some vitri-
fication solutions can be higher and it may be 
prudent to determine the actual critical Tg using 
thermal analyses. 
K3.4. Freeze/Thaw and Cooling/Re-warming Cycles 
Freeze/thaw cycles for specimens cryopreserved 
in the frozen state and cooling/re-warming cycles 
for specimens in the vitrified state can be damag-
ing to the macromolecules and cells intended for 
analysis. Damage can also occur via osmotic and 
dehydration injury during exposure and removal 
of cryoprotective additives and vitrification treat-
ments. Therefore, it is important to select aliquot 
sizes that are appropriate for the intended uses for 
the specimens in order to minimize the number 
of times a sample is thawed and frozen or vitrified 
before it is used. Number of freeze/thaw cycles be-
fore processing should be minimized. Cell and tis-
sue specimens are generally maintained at liquid/
vapor nitrogen temperatures in order to achieve 
biopreservation of the sample below the Tg (be-
low which the cell biochemical activity is virtually 
stopped). Thermal cycling intervals of freezers re-
sulting in sample temperature increases above the 
Tg may lead to repeated freeze/thaw cycles even 
within the sub-zero frozen state. 
In addition to storage temperature, handling during 
removal from storage will affect the viability of cells 
and may result in degradation of cellular compo-
nents. Every time a specimen is warmed above the 
Tg, it experiences a micro-thaw event. Repeated 
thermal cycling episodes lead to increased cell 
death via apoptosis and necrosis. The temporal 
nature of delayed onset cell death resulting from 
preservation stress may affect the quality of data 
obtained from these specimens depending on the 
timing of experiments post-preservation and the 
ability of the cells to recover from cryoinjury in the 
long-term. 
Moving specimens from a lower frozen state to a 
higher temperature during retrieval of other speci-
mens will change the composition of the specimens 
in the storage container that are not retrieved but 
just kept at warmer temperatures for a short while. 
For these reasons it is essential to limit the potential 
of cooling/re-warming, freeze/thaw, and vitrifica-
tion/devitrification cycles occurring when these or 
other specimens are introduced or removed from 
storage and during transport or shipping6. 
Best Practice: The number of freeze/thaw cycles 
of a sample before and after processing should be 
minimized and documented.
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K4. COLLECTION AND STORAGE  
  CONTAINERS
Collection and storage containers vary according to speci-
men types being collected, the temperature of the intend-
ed storage, and the analytical goals of the study. During 
selection of container type, consideration should be given 
to the long-term use, standardization and applicability to 
new platforms, and automation. Also, the same contain-
ers used for specimen collection may not be suitable for 
specimen storage. In some cases, contaminants associat-
ed with the container (e.g., persistent organic pollutants, 
heavy and trace metals) may interfere with subsequent 
analysis. This issue is especially true for specimens stored 
for environmental analysis. Container labels or other iden-
tifying elements such as embedded barcodes should be 
permanent and able to endure excursions in and out of 
cold conditions and exposure to high humidity and ambi-
ent temperatures, especially when samples are taken from 
extreme environments (e.g., cryogenic temperatures, heat 
shock) (see Section I2.13. Labels). Light-sensitive material 
should be stored in containers that do not allow penetra-
tion of light such as amber vials or amber-coated bags. 
K4.1.  Sterility and Cleanliness
Risk assessments and mitigation exercises should 
be undertaken in the context of a specimen’s 
requirements for asepsis. While complete sterile 
conditions may not be required for many specimen 
collections and processing, adequate consider-
ation should be given to the cleanliness of instru-
ments, surfaces, and equipment used in specimen 
processing and handling. RNA is particularly 
sensitive to RNAses which may be present on tools 
and surfaces that have not been properly cleaned/
sterilized. Contamination of microbial DNA may 
interfere with downstream applications and, sim-
ilarly, endotoxin contamination may affect down-
stream functional immunological assays. Where 
disposable instruments are used, every specimen 
should be handled with fresh instruments and 
when non-disposable instruments are used, they 
should be appropriately cleaned after each speci-
men processing. Sterility of preservatives, cryopro-
tectants, and liquid nitrogen supplies should also 
be considered.
K5. COLLECTION PROCEDURES
A variety of protocols exist for the collection of different 
specimen types. The protocol chosen should be suited 
to the particular needs of the study, specimen types col-
lected, collection locations (e.g., geographic and clinical 
setting), and intended downstream assays. Sources of 
specimens may be determined by study goals, cost to im-
plement the collection, and ease of collection. For exam-
ple, tissues may be collected post-surgery or post mortem; 
bodily fluids may be collected from study participants; and 
environmental samples may be site specific. Special con-
siderations for clinical specimen collection procedures 
are presented below. Protocols for the field collection of 
non-human specimens are often highly taxon-specific and 
recent guidelines for major eukaryotic taxonomic groups 
may be found in Gemeinholzer et al14. 
Best Practice: Institutional collection of human and ani-
mal specimens for research should under no circumstance 
interfere with appropriate patient diagnosis or care.
Best Practice: Institutional specimen collection should 
be reviewed by a Human Subjects Review Board/Ethics 
Review Committee or other appropriate ethics board 
(see Section L2.1. Human Subjects Review Board/Ethics 
Review Committee). 
Best Practice: Staff should wear personal protective 
clothing/equipment, as appropriate, when working 
with specimens (see Section F5. Personal Protective 
Equipment). 
Best Practice: Field collecting (biodiversity) should not 
threaten a species’ or population’s existence.
K5.1. Solid Tissues
The appropriate handling of tissues procured for 
research purposes can be facilitated by having a 
practicing pathologist supervise the actual pro-
curement of the tissue; this is especially important 
to prevent the compromise of diagnostic spec-
imens. Information from the pathologist on the 
characteristics of the biopsy or surgical material 
(e.g., percentage normal, percentage tumor, per-
centage necrosis, and/or percentage fibrosis) as 
determined by microscopic evaluation should be 
obtained on a per-specimen basis and recorded. It 
is well known that tissue specimens are heteroge-
neous with respect to the percent tumor, normal, 
necrosis, and fibrosis. Where possible, multiple 
sections or samples (aliquots) should be created 
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to allow for greater use of the specimens. A proce-
dure should be in place to evaluate the character-
istics of each aliquot by reviewing a representative 
cryostat section. Alternatively, one representative 
section from a determined number of sections may 
be reviewed. 
The use of standard FFPE protocols (including 
properly validated fixative and timing of fixation) 
is important for producing optimal quality spec-
imens. Multiple pre-analytical factors may affect 
FFPE specimen quality and suitability for further 
analyses15.
K5.1.1. Surgical Samples
Remnant clinical specimens may be collected 
from diagnostic surgical procedures. With 
proper ethics committee approval and ap-
propriate informed consent, specimens may 
be resected specifically for research. Policies 
documenting the subset of surgical specimens 
exempt from pathologic review are in place at 
most hospitals16,17. If the specimen in question 
is not exempt, it must arrive at the pathology lab 
intact for examination before research samples 
can be procured. Any exceptions should be ap-
proved by the pathologist in advance of tissue 
collection.
If not processed immediately, specimens should 
be placed in a clean or sterile container on wet 
ice (2 – 8°C) for transport from surgery to pa-
thology or to the repository. It is also important 
to prevent cross-contamination, dehydration, 
and desiccation of tissues during transporta-
tion. Vacuum sealing, cooling of fresh tissues, 
or covering with sterile gauze moistened in 
biopreservation media is recommended if 
immediate fixation/stabilization cannot occur. 
The optimal procedure would be to handle all 
specimens in a sterile manner; however, that is 
not always practical, as few surgical pathology 
gross rooms have a biosafety hood or similar 
designated area. Many research protocols do 
not require that tissue specimens be procured 
or processed following sterile procedures. A 
“clean” area should be set up for aseptic speci-
men procurement/processing. 
During specimen procurement, contact be-
tween different specimens should be avoided 
(specimen contamination) and equipment used 
for procurement should be replaced between 
different specimens. Fresh blades and instru-
ments should be used with each new specimen 
as well as in different areas of the same speci-
men. Gloves and clean instruments should be 
used for resection and processing. To avoid 
desiccation and compromise of subsequent 
analyses, specimens should not be resected on 
a dry towel or other absorbent material. 
Unless previously specified, tissue provided 
to the repository may be placed directly in 
appropriately labeled clean containers of cold 
biopreservation media (2 – 8°C) for transport 
to the repository for processing. If the tissue is 
to be frozen immediately, it is not necessary to 
place it in preservation media. Such media may 
cause ice crystals to form on the outside of the 
specimen when freezing. It is important to ed-
ucate/train all personnel who will be handling 
the specimen on the specific handling require-
ments unique to each protocol.
Specimens requiring snap-freezing or flash 
freezing (cooling at sufficiently high rates to limit 
damage to cell structure from intracellular ice 
formation or prevent compositional changes 
in labile molecules) can be frozen in a Dewar 
of liquid nitrogen or on dry ice at the time of 
collection. Where specimen morphology but 
not viability of cells needs to be conserved, 
snap-freezing may be done in isopentane 
or isobutane pre-cooled with dry ice or with 
liquid nitrogen. Data should be maintained 
and tracked on the time that elapses between 
relevant time points (collection, processing, 
preservation, storage). A date and time stamp 
can be utilized for maintaining these records 
efficiently. 
Referencing the associated diagnostic pa-
thology report is not sufficient QC for surgical 
remnant clinical tissue aliquots collected by the 
biorepository. Because of tissue heterogeneity, 
QC for tissue specimens should be aliquot-spe-
cific with percentages of tumor, normal, necro-
sis, and/or fibrosis recorded using a patholo-
gist’s microscopic examination. This may be 
accomplished through hematoxylin and eosin 
(H&E) top-slide creation from FFPE and OCT-
embedded tissues. Less resource-intensive 
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alternatives taking advantage of mirror-faces 
of tissue samples have been described18. Such 
alternatives offer both lower cost and the ability 
to know the composition of mirrored aliquots 
that are obtained without embedding, such as 
those snap frozen without additional media. 
All specimens should be labeled appropriately 
(Section I2.13. Labels) and all relevant accom-
panying data should be documented (Section 
I2. Inventory Systems). Specimen collection 
containers should be pre-labeled with bar-
code/donor ID for high-volume collections to 
improve workflow and ensure accurate labeling 
and specimen tracking.
Best Practice: All personnel who will be 
handling the specimen (e.g., surgeons, nurses, 
pathologists, repository personnel) should be 
trained on the specific handling requirements 
of each protocol.
Best Practice: QC for surgical tissue samples 
should be aliquot-specific and performed prior 
to distribution.
K5.1.2. Post Mortem Collection (Autopsy/ 
 Necropsy) 
Remnant samples may be collected from au-
topsy/necropsy procedures consistent with 
relevant regulations. Requests for biospeci-
mens should specify a maximum time interval 
post-mortem prior to processing. Autopsy/
necropsy procedures may yield “normal” 
tissues or large quantities of a specimen that 
would not otherwise be available from surgical 
procedures (e.g., heart, brain). Specimens that 
are not removed as part of the routine autopsy 
procedure (i.e., leg, arm, hand, foot, face tissue) 
are not usually available as their procurement 
may result in disfigurement of the body. There 
may be exceptions allowing procurement of 
such specimens if a specific consent has been 
obtained from a donor and/or the next of kin as 
appropriate under specific laws of the country 
or region of the acquisition.
Tissue specimens collected post-mortem 
should be appropriately labeled as to the organ 
site, tissue type, and time of resection, and then 
placed immediately into a container of cold bio-
preservation media (2 – 8°C) on wet ice. These 
organs can be dissected into smaller sections 
for processing and storage. Detailed informa-
tion about the decedent should be recorded 
such as disease condition, age, sex, race, cause 
of death, time and date of death, and time of 
organ procurement. Information about the 
procured organ should include the condition 
(normal or diseased). Processing and storage 
of collected post-mortem specimens should be 
completed in a timely manner. 
 K5.1.3. Transplant
Occasionally, organs that are inappropriate for 
transplant may be offered or made available 
to a repository for research purposes. It is not 
unusual for the organ to have been out of the 
body for many hours beyond the normal time 
frame identified for procurement of samples. 
However, because transplant tissue is usually 
placed in a biopreservation medium at 2 – 8°C 
to maintain viability for transplant, most re-
searchers will still accept transplant tissue as it is 
likely to be of superior quality to either surgical 
or autopsy specimens. Transplant organs may 
also be dissected into smaller sections during 
processing and storage. Information about the 
donor from whom the organ was procured 
should be obtained from the transplant center 
and recorded. All organs/tissues intended for 
research should be maintained in appropriate 
biopreservation media at 2 – 8°C until pro-
cessed. Isotonic saline or culture media may 
not be considered optimal for hypothermic 
biopreservation of viable cells/tissues/organs. 
Specific perfusion techniques can be applied 
to organs, such as the liver, to enable isolation 
of specific cell types, such as hepatocytes.
In general, it is important to remove as much 
blood and other native fluids from the resect-
ed tissue/organ as soon as possible prior to 
processing. For larger or highly vascularized 
tissues in preservation solution, clot formation 
within the vasculature obstructs the penetration 
of the preservation solution into the tissue. This 
situation results in tissue specimens that are not 
homogeneously preserved and there could be 
localized tissue damage due to ischemia. Also, 
tissue damage could occur because ischemia 
and the clotting cascade impact the molecular 
profile of the tissue. These activities can pro-
duce changes in the molecular profiles of the 
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tissue, resulting in the tissue section being less 
representative of its original resected state. 
K5.2. Blood 
One of the primary decisions in storing blood sam-
ples is whether to collect anticoagulated (i.e., plas-
ma, buffy coat, RBC) whole blood or coagulated 
(i.e., serum, clot) blood. When serum is collected 
without anticoagulant, the blood clot obtained 
after processing can be used as a source of DNA 
for genotyping and other DNA-related studies19. In 
similar fashion, blood collected with anticoagulant 
can yield a packed cell volume (containing both the 
buffy coat and RBC) to be used as a source of RNA, 
DNA, or viable cells.
When multiple blood collection devices/contain-
ers are involved there is a prescribed priority order 
of draw (see Appendix A: Internet Resources). The 
order of draw for clinical testing may be different 
from an investigator’s requested order of draw. The 
phlebotomist should follow the specified protocol 
and document the order of the draw. It is also 
important to determine which anticoagulants are 
acceptable for a particular downstream procedure 
(see Section K3.1 Specimen Stability).
Collection of blood samples may be done for many 
purposes. The collections should be done within 
a fit for purpose protocol with consideration of 
constraints of the collection (e.g., geographic dis-
tance(s) between collection and processing site, 
low resource setting). 
Blood collection and processing should take into 
consideration the required downstream experi-
mental usage with special consideration of cellu-
lar, metabolic, and/or genomic analyses. These 
may require unique collection tubes, processing 
protocols, and storage conditions which need to 
be determined prior to blood collection.
Consideration should be given to the fact that cell 
viability and functionality of blood samples may be 
compromised during extended ambient storage/
transport20. For DNA molecular analyses, new 
technologies have been developed to significantly 
extend ambient storage/transport of blood sam-
ples for up to 1 year21. Hypothermic temperatures 
(2 – 8°C) may allow for extended stability of certain 
blood-derived cell products (red blood cells). 
Best Practice: Blood samples should be pro-
cessed and stored within one to 24 hours of draw, 
depending on the analytical endpoints22. 
Best Practice: The protocol for a blood collection 
should be fit for purpose and considerations should 
be made for collection and transport constraints.
K5.2.1. Cord Blood 
Arterial and venous cord blood can be obtained 
from delivered placentas after delivery and used 
for measuring blood gases or frozen and stored 
as a source of undifferentiated stem cells. 
K5.3. Urine Specimens
Urine specimens should be maintained on wet ice 
or refrigerated after collection. Collection con-
tainers should be sterile and dry, have a 50-mL to 
3-L capacity, a wide mouth, and a leak-proof cap. 
Depending upon the analyte to be measured, a 
preservative may be needed. The type of preser-
vative may differ according to test methodologies, 
time delay, and transport conditions. EDTA, acidi-
fication, and sodium metabisulfite are examples of 
preservatives commonly used in urine collections. 
Urine containers used for environmental toxicol-
ogy assays should be consistent with protocol 
requirements (i.e., use of collection containers pre-
screened for phthalate metabolites). 
Because urine may contain cellular and other el-
ements, a urine sample is typically centrifuged to 
remove cells and debris. The acellular urine and 
separate cell pellet can then be analyzed and/
or frozen as aliquots. A condensed urine on filter 
may be an alternative, cost-effective way of storing 
large-volume specimens. There are various meth-
ods of urine collection depending on the type of 
analysis intended. The collection method should 
be documented in the sample record.
K5.3.1 Urine Collection Time Parameters
K5.3.1.1.
First morning specimens are best for detect-
ing substances in a more concentrated solu-
tion (e.g., white and red blood cells, urinary 
hormones). The donor voids a urine speci-
men before going to sleep and collects the 
“first morning” urine immediately on rising.
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K5.3.1.2.
Random collections are suitable for routine 
screening and cytology studies.
K5.3.1.3.
Fractional collections are used to compare 
the concentration of an analyte in urine with 
its concentration in blood. First morning 
urine, which contains solutes and metabo-
lites from the evening meal, is discarded and 
a second urine sample following a period of 
fasting is collected.
K5.3.1.3.
Timed collections allow for comparisons 
of patterns of excretion of certain biomol-
ecules. Typical collection times are 12 and 
24-hour. For the 24-hour collection on day 
one, the donor empties his/her bladder and 
for the next 24 hours all subsequent urine is 
collected. 
K5.3.2. Urine Flow Parameters
A midstream (clean-catch) can be conducted at 
any time of day or night. There is a reduced in-
cidence of cellular and microbial contamination 
compared to the random sample because the 
donor is asked to clean his/her skin prior to col-
lection and the urine is collected ‘midstream’, 
meaning the donor starts urinating and then 
positions the collection container in the stream 
of urine.
K5.4.  Nail and Hair 
Nail and hair clippings can be used for trace metal 
analysis to provide a longer-term measure of expo-
sure. These samples are simple to collect, store, 
and ship. They can also be used as a source of 
DNA. Hair follicles may be collected and used for 
molecular analytes. 
K5.5.  Oral Specimens
Oral specimens can be used in a variety of assays. 
Collection devices for these specimens include 
swabs, washes, a non-covered cotton roll, a poly-
propylene-covered polyether roll, and can be com-
bined with stimulation (e.g., paraffin wax chewing 
stimulation). 
K5.5.1.  
Saliva may be collected for drug testing, HIV 
detection, monitoring of hormone levels, isola-
tion of the microbiome, and as a source of DNA 
(buccal cells). It may be collected directly into 
a container with an opening large enough to 
facilitate this collection or mixed with mouth-
wash as the vehicle for collection. Saliva can 
be stored either as non-centrifuged aliquots 
or centrifuged, which results in supernatant 
and pellet aliquots which can then be analyzed 
and/or stored separately. 
K5.5.2 
Buccal cells may be useful as a source of 
DNA. A variety of collection techniques and 
containers have been developed specifi-
cally for these collections (see Appendix A: 
Internet Resources).
K5.5.3
Throat swabs and washes are collected pri-
marily for research of Group A Streptococcus 
and M. tuberculosis.
K5.5.4
Nasopharyngeal swabs and washes are col-
lected primarily for research of B. pertussis 
and respiratory viruses.
K5.6. Breast Milk Samples
Breast milk collection can be initiated when 
breast-feeding starts. Breast milk can be collected 
by manual expression or vacuum pump and should 
be collected in sterile or specially-cleaned bottles 
and is typically stored frozen. If certain analytes 
such as phthalates are of interest, the sample can 
be collected in a glass bottle and stored in the par-
ticipant’s household freezer. 
K5.7. Stool Samples
Samples are self-collected by participant into a con-
tainer that can be lined with plastic wrap or placed 
inside another container and then frozen. Some 
procedures will allow for lyophilizing the sample for 
long-term storage which provides a more inert (less 
odoriferous), smaller sample for analysis. 
72 ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
Collection of stool samples in a stabilizer is the 
collection method of choice to avoid microbiome 
alterations taking place at room temperature and to 
minimize variability.
K5.8. Genital Specimens
Genital tract specimens are generally collected for 
the detection of sexually transmitted diseases such 
as N. gonorrhoeae, Chlamydia trachomatis, herpes 
simplex virus (HSV), human papillomavirus (HPV), 
agents of BV (bacterial vaginosis), Trichomonas, 
group B streptococci, and Candida species. 
Seminal fluid may be collected for semen analysis 
as part of fertility studies or post-vasectomy review.
K5.8.1. Female
Cervical screenings are routinely performed 
using liquid-based cytology in which the speci-
men is collected, normally by a small brush in a 
similar way as for a conventional smear test, but 
is deposited into a small bottle of preservative 
liquid rather than being transferred directly to 
a microscope slide. Cervical vaginal lavages 
(CVL) can be obtained and used for HPV and 
HSV studies23,24. CVL should be collected in 
one container and transported to the labora-
tory on wet ice within one hour of collection, 
vortexed gently, and aliquoted in a biosafety 
cabinet. 
K5.8.2.  Male
Collection of male genital specimens for bac-
terial or viral infections may be performed by 
urogenital swabbing, swabbing of lesions, 
or testing first morning urine specimens (see 
Section K5.3.1.1). Seminal fluid is collected in 
a warm (20 – 40ºC), clean, dry, wide-mouth 
container and should be delivered within an 
hour of collection if the collection takes place 
at a patient’s home, but is preferably collected 
during a clinic visit in a private room.
K5.9 Miscellaneous Fluids
Other body fluids are collected for microbiological 
or clinical laboratory testing as part of diagnosis and 
management for a variety of diseases. Most (e.g., 
pleural, peritoneal, pericardial) are collected by 
ultrasound-guided aspiration, while others, (e.g., 
synovial fluid, amniotic fluid) collection employs 
visually-guided needle aspiration. Commonly col-
lected body fluids include:
•	 Cerebrospinal fluid samples
•	 Synovial fluid 
•	 Follicular fluid 
•	 Serous fluids (e.g., pleural, peritoneal, pericardial)
K6.  SPECIMEN PROCESSING 
Several online resources are available (see Appendix A: 
Internet Resources). Repositories should establish and 
follow their own Standard Operating Procedures (SOPs) 
or follow previously validated SOPs. 
Some general considerations for specimen processing 
include:
•	 Safety precautions (see Section F6. Safety Topics)
•	 Inspection for accuracy of label, specimen deficiencies, 
etc.
•	 Maintaining specimen integrity (i.e., stability, sterility, 
temperature)
For some downstream analyses, the presence or degree 
of non-conformities may be important and therefore 
should be recorded at the time of processing (e.g., a 
minor non-conformity may be a volume under a specific 
amount and a major non-conformity may be the presence 
of hemolysis, lipemic (milky), or icteric/jaundiced (dark 
yellow) material). If any non-conformity or combination of 
non-conformities will result in specimen rejection, the re-
jection criteria should also be defined (e.g., blood sample 
arrives with no label and identity cannot be determined) 
and the subsequent actions described (e.g., specimen that 
meets the rejection criteria will be discarded) (see Section 
D4.3.3. Non-Conformities).
Best Practice: Non-conformities observed and subse-
quent actions taken during processing should be identi-
fied and documented.
Best Practice: When possible, two or more samples 
per specimen should be processed and stored for 
redundancy. 
K7.  RECEIVING SPECIMENS
SOPs should be in place for receiving specimens into 
the repository. All specimens provided to the repository 
from outside sources should be confirmed/verified and 
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a Verification Report maintained by the repository (see 
Section D5.3. Record Retention) and a copy provided to 
the site of origin. The report should document the follow-
ing: receipt date and time, the shipment tracking number, 
package and container condition after visible inspection 
for signs of damage, confirmation of the condition of 
the coolant used during shipment, confirmation that 
specimens received match those listed on the Shipment 
Manifest sent with the shipment, and if number of contain-
ers match (if multiple are in the shipment) (see Section J4.2. 
Shipping Manifest and Tracking Number). If data loggers 
are enclosed in the shipper, they should be checked to 
determine if adverse temperature spikes have occurred. 
All discrepancies should be documented and reported 
immediately to the originating site. Both sites should at-
tempt to resolve these discrepancies as soon as possible 
and the resolution documented in the Verification Report 
(see Section J4.3. Sample Receiving and Verification). 
These forms should identify the person recording the en-
tries (name/signature/date). 
Best Practice: Any problems encountered with a ship-
ment should be communicated to the sender to aid in the 
prevention of similar problems in the future. Particular note 
should be made of the stability of the cold chain for speci-
mens shipped in the chilled, vitrified, or frozen state.
K8. RETRIEVAL OF SPECIMENS FROM  
  STORAGE
Retrieval of specimens for shipment or analysis requires 
strict adherence to protocols for proper specimen inven-
tory and tracking, as well as adherence to established 
safety standards in working with freezers and other stor-
age equipment. 
K8.1.  Locating Specimens in Storage
The location of specimens to be retrieved should 
first be verified in the appropriate specimen in-
ventory system (Section I2. Inventory Systems). A 
requisition should be generated before specimens 
are retrieved from storage and retrieval should be 
performed following the repository’s specimen 
requesting, tracking, and inventory protocols. 
Best Practice: All requisitions should be checked 
against the inventory for accuracy before retriev-
al according to established SOPs and Quality 
Standards.
K8.2. Specimen Retrieval
Specimens should be located and pulled from 
storage as documented on specimen requisition 
forms. If specimens are frozen or vitrified, speed/
efficiency is necessary during the retrieval process. 
Such speed may require that at least two individ-
uals carry out the retrieval process. If possible, 
specimens being retrieved should be maintained 
at the storage temperature throughout the process 
(e.g., specimens stored at -80°C should be kept 
on dry ice during the retrieval process). There are 
many commercial products available to maintain 
cold chain temperatures during retrieval. Forceps 
may be used when withdrawing specimens stored 
at liquid nitrogen temperatures to prevent warming 
of the specimens from body contact.
Once retrieved, staff should confirm that all requisi-
tioned specimens have been included in the pull. 
Quality control checks should be performed to 
confirm that all specimens listed on the requisition 
were retrieved as well as the accuracy and integrity 
of their labels. 
If specimens appear to be missing, the repository 
should have protocols to locate and/or document 
the missing specimens. Inventory systems should 
be updated to indicate missing and/or improp-
erly located specimens and corrections made to 
specimen locations. To ensure collections are not 
depleted without careful consideration, mecha-
nisms should be established to alert the repository 
when specimens being placed in a requisition 
to be pulled/used reach a defined, critical level. 
Depletion of remaining specimen(s) may require 
scientific and/or administrative approval (see 
Section M2.4. Review of Specimen Use Requests).
Best Practice: A second, independent quality 
control check should be performed to ensure that 
the correct specimens have been retrieved.
Best Practice: A policy should be in place re-
garding notification and actions to be taken when 
retrieval of specimens results in the remaining stock 
reaching a defined, critical level. 
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K8.3. Thawing, Re-warming, and Aliquoting 
Specimens
K8.3.1. Liquid and Solid Tissue
If thawing of a frozen tissue specimen is re-
quired, this should be done using stipulated 
protocols relevant for the downstream uses 
of the specimen. If a water bath is used, care 
should be taken that surface moisture from wa-
ter baths does not enter the sample containers. 
In the case of vitrified samples, optimization of 
re-warming is critical and it may be necessary 
to apply a two-phase and/or rapid re-warming 
process to ensure that the samples do not form 
ice crystals as they pass through the Tg.
Large-volume liquid samples (e.g., sera, plasma, 
urine) may need to be processed into smaller 
aliquots for distribution to multiple end-users. 
Thawing before aliquoting may occur on wet 
ice or room temperature. The recommended 
protocol should be followed to maintain spec-
imen integrity. The proper pipette and tip to 
use is determined by the required volumes and 
eventual analysis. If analyzing for persistent or-
ganic pollutants, using a plastic pipette and tip 
may contaminate the sample further. A different 
pipette tip should be used for each specimen. 
An alternative to thawing a specimen for 
aliquoting is a drilling system that includes a 
motor that produces a sonic, linear oscillatory 
motion that removes a frozen biological sample 
from a stored frozen specimen without thawing 
the remainder of the specimen. However, the 
process can “burn” the edges of the specimen 
and, for liquid specimens, care should be taken 
that several aliquots are taken and combined 
since liquid samples may not be homogenous 
in their frozen state.
Best Practice: Specimen thawing method 
should be determined by the protocols of the 
end-user and downstream application.
Best Practice: Specimen containers should 
be opened and the specimens aliquoted in a 
biological safety hood, when sterility is critical. 
Sterile/clean vials and pipettes should be used 
to avoid contaminating samples.
K8.3.2. Viable Cells
The rate and method of freezing/thawing 
and cooling/rewarming specimens can have 
serious effects on the viability of cells. Specific 
freezing/thawing, vitrification, and cooling/
re-warming protocols should be developed 
and validated, including the validation of appro-
priate biopreservation media (cryopreservation 
solution), devices, and cooling rate to ensure 
that the method used supports the known or 
anticipated use for the specimens (see Section 
K3.3. Biopreservation/Cryopreservation).
Although slow cooling is generally best to 
ensure cell viability in frozen specimens, the 
opposite process is required when thawing 
from the frozen state. Samples should be rap-
idly thawed for just enough time to thaw visible 
crystalline ice and so that sample temperature 
is still hypothermic (2 – 8°C). Cells should be 
quickly diluted in appropriate media to mini-
mize toxicity from the cryoprotectant. Dilution 
protocols (which may include several washing 
steps in order to gradually dilute and wash out 
the cryoprotectant) should be optimized to 
circumvent damaging osmotic effects. In the 
case of vitrified specimens, optimizing cooling 
and re-warming regimens is critical for ensur-
ing the formation and maintenance of a stable 
glassy state and preventing de-vitrification and 
ice nucleation during re-warming. Therefore, 
in contrast to controlled-rate freezing proto-
cols, vitrification can involve rapid cooling and 
re-warming regimens.
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SECTION L: LEGAL AND ETHICAL 
ISSUES FOR BIOSPECIMENS
L1.  GENERAL
The collection, storage, distribution, and use of biological 
materials in research raises many legal and ethical issues 
with repositories often serving as the intermediary be-
tween study participants and the scientific research com-
munity. On an international level, the collection and use 
of these materials is currently regulated by an amalgam of 
differing, and occasionally conflicting, laws and policies. 
Thus, repositories should proceed carefully, not only in 
their daily work, but also with respect to international ex-
change of specimens and associated data. Regulations in 
some countries address the ethical issues related to collec-
tions and use of specimens and to import and/or export of 
specimens as well as shipping regulations (see Section J: 
Packaging and Shipping). References and links to applica-
ble regulations and guidelines are included in Appendix 
A: Internet Resources.
L2. COLLECTION OF HUMAN SPECIMENS
Key discussions of ethics in human subject research are 
found in a number of documents including the Declaration 
of Helsinki adopted by the World Medical Association in 
1964 and revised several times subsequently, most recent-
ly in 2013. These issues are also discussed in the Belmont 
Report published by the U.S. Department of Health and 
Human Services in April 1979 (see Appendix A: Internet 
Resources). These documents include several fundamen-
tal key concepts: 
•	 Freely-given informed consent is necessary before 
procurement of specimens and research on speci-
mens may be conducted. 
•	 Research should be well designed, be conducted 
by persons with appropriate expertise, and lead to 
meaningful conclusions. 
•	 Every effort should be taken to reduce the risks to 
subjects and ensure that the risks do not exceed the 
benefit of the expected findings. 
•	 Studies in animals should provide reason to believe 
that the study of humans is needed and is the only way 
to get the necessary information. 
It is important to understand key terminology related to the 
legal and ethical issues for human specimens. Terms that 
describe whether and how specimens are linked to donor 
identity are often used in different ways and with different 
meanings in different contexts. Definitions of key terms 
have been included in the Glossary found in Appendix B.
The collection, storage, and use of human specimens 
and associated data should be conducted in a way that 
respects the subject and maintains privacy and confiden-
tiality. In addition, repositories should adhere to and keep 
up-to-date on relevant national/federal human subject 
regulations, privacy regulations, and other relevant nation-
al/federal, regional, and local laws. Respecting individual 
privacy and confidentiality with respect to tissues and data 
must be considered in a context that includes risks and 
benefits to family members, community, and identified 
populations. This means that group risks and benefits can-
not be ignored. For example, some regions prohibit the 
use of fetal tissues, embryos, or embryonic stem cells in 
biomedical research. Regulations that govern the collec-
tion and import and/or export of human specimens, in-
cluding those mandated by the Convention on Biological 
Diversity, should also be observed. 
L2.1. Human Subjects Review Board/Ethics 
Review Committee
A human subjects review board (institutional review 
board or ethics review committee) is any board, 
committee, or other group formally designated by 
an institution to review biomedical research involv-
ing humans, to approve the initiation of the research 
or of collections, and conduct periodic review of 
such research or collections. As a component of a 
human subjects/ethics review, the processes and 
procedures for collection, storage, distribution, 
and use of human specimens for research should 
be evaluated to ensure that these procedures are 
appropriate to protect human subjects. This re-
view may include review of operating procedures 
and policies for obtaining informed consent and 
protecting the participant’s privacy and confiden-
tiality. The review may also include a review of 
repository governance and oversight systems and 
mechanisms for ensuring that use of specimens 
are for research that is scientifically and ethically 
sound (see Section A.2. Repository Governance). 
Data-sharing mandates should also be reviewed. 
In some countries, a National Ethics Body or a 
Central Ethical Committee may have the authority 
to approve the establishment and functioning of 
institutional repositories of human samples with the 
purpose of supporting health research.
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L2.2. Informed Consent
Informed consent for the collection, retention, and 
use of specimens is a process that offers donors 
information sufficient to allow them to make an in-
formed choice about whether to donate specimens 
and data to the repository and agree, where appli-
cable, to future research use. Consent should only 
be obtained under circumstances that provide the 
prospective donor or the donor’s representative 
sufficient opportunity to consider whether or not 
to donate and minimizes the possibility of coercion 
or undue influence. The information that is given to 
the donor or the representative should be under-
standable to the subject or their representative. 
Types of consent include: 
•	 Specific consent – obtained for a specific re-
search project such that the details of the pro-
posed use of the specimen(s) can be specifically 
outlined. Allows the use of biological specimens 
and related data only in immediate research and 
forbids any future study that is not foreseen at 
the time of the original consent. 
•	 Broad consent – obtained for future research in 
which case general information regarding, or 
examples of, the possible future research uses 
are provided.
•	 Partially restricted consent – allows for the use 
of biological specimens and related data in spe-
cific immediate research and in future investiga-
tions directly or indirectly associated with them.
•	 Multi-layered consent (also termed tiered con-
sent) – requires several options to be explained 
to the research subject in a detailed form. 
Known restrictions on specimen use, including 
use in future studies, should be documented and 
associated with the specimen(s)/collection within 
the repository. A separate consent for research pur-
poses other than those originally outlined may be 
required. In all conditions, the type of consent must 
be in accordance with applicable national/federal, 
regional, or local regulations and laws, as different 
jurisdictions may not permit the use of certain types 
of consents. The repository should have mecha-
nisms in place to ensure that future research uses of 
specimens are consistent with the original consent 
(e.g., through review by a human subjects/ethics 
review committee or other mechanisms consistent 
with applicable regulations, laws, and repository 
guidelines) (see Sections A3.1. Organizational 
Planning Considerations and Section M: Specimen 
Access, Utilization, and Disposition).
In some jurisdictions, regulations and laws may per-
mit a human subjects or ethics review committee to 
waive informed consent for the use of human spec-
imens for minimal risk research, provided certain 
conditions are met. Researchers should check with 
their human subjects or ethics review committee or 
other institutional officials to determine the permis-
sibility and requirements of such a waiver.
Some regulations and laws may permit the use of 
an ‘opting out’ principle for human tissue leftovers 
from diagnostic sampling. After an obligatory infor-
mation of potential donors, the consent for includ-
ing the leftover material in a repository is presumed 
to be given, unless it is actively withdrawn by the 
donor.
Regulations regarding return of individual research 
results in some countries guarantee research partic-
ipants access to information obtained through the 
use of their specimens. Other jurisdictions require 
that repositories have policies in place that de-
scribe how the discovery of serious and significant 
findings (defined as information that is uncovered 
either directly within the scope of the research or 
incidental to the research that has serious and sig-
nificant health implications for the participant and/
or their genetic relatives) should be handled. Thus, 
it is essential to perform a meaningful discussion 
regarding these issues with the human subjects/
ethics review committee during the design of a 
repository protocol and informed consent, before 
attempting to return any research results to sub-
jects, their families, or physicians.
Best Practice: An information sheet or brochure, 
describing the research, which may mention return 
of research results, should be distributed to partici-
pants when consent is sought.
L2.2.1. Withdrawal of Informed Consent
Participants should have the right to withdraw 
consent and to have their unused specimens 
and data removed from the repository unless 
the specimens and associated phenotypic or 
demographic data are anonymous and cannot 
be linked by the repository to donor identities. 
The conditions under which a donor may make 
this request as well as the logistics for how a 
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donor initiates this request should be specifical-
ly outlined in the informed consent document. 
Any limitations on the withdrawal should also 
be described. For example, it may not be pos-
sible to retrieve specimens once they are ano-
nymized or distributed and used for research. 
Different types of withdrawal of consent 
include:
•	 No further contact with the donor of the 
specimen - continued retention and use 
of previously obtained specimens and 
information is permitted, as is access to 
information from health records. 
•	 No further access - continued retention 
and use of specimens and information is 
permitted but no further access to informa-
tion from health records is allowed.
•	 No further use of the specimen - no fur-
ther contact with the donor is allowed, 
specimens and information are no longer 
available to researchers, no access to infor-
mation from health records, and remaining 
specimens are to be destroyed.
Best Practice: Donor consent must be ob-
tained unless waived by an authorized human 
subject/ethics committee constituted in accor-
dance with applicable laws or regulations.
Best Practice: Repositories should have an 
ethically approved policy and/or procedure in 
place regarding the return of research results. 
The policy should define what (if any) results will 
be returned and to whom (e.g., participant and/
or genetic relatives), how participants would be 
contacted (if applicable), the process to be fol-
lowed if re-contact is not possible, and whether 
or not support (e.g., from a genetic counselor) 
would be provided.
Best Practice: The participant information 
sheet and consent form should address wheth-
er or not research results are expected to be 
returned. If research results may be returned, 
the consent form should explain the potential 
impacts the return of such findings may have 
on various issues such as income protection, 
insurance, employment, psychosocial coping, 
and family dynamics for the participant. 
L2.3. Protection from Research Risks
Care should be taken to minimize the risks to 
subjects and ensure that risks do not outweigh 
the benefits of the expected findings from studies 
using the specimens. This includes minimizing 
physical risks and psychosocial risks associated 
with the collection and use of specimens and/or 
data. It is particularly important that the collection 
of specimens and data does not affect patient care.
The repository should follow well-documented 
procedures to protect the privacy and confiden-
tiality of the donors from whom the specimens 
and/or data are obtained. Two examples of such 
approaches are anonymization and de-linking (or 
de-identifying).
Best Practice: The collection of specimens and/
or data for research must never adversely affect 
patient care.
Best Practice: Every effort should be made to 
protect the privacy and confidentiality of data asso-
ciated with the specimens.
Best Practice: Use of specimens should remain 
within the scope of permissible consent obtained.
L2.4.  Specimens Obtained from Vulnerable 
Subjects
Extra care and attention should be given to the 
consent process when subjects are incapable of 
signing the consent form themselves. 
L2.4.1. General
Vulnerable subjects may include those under 
heavy sedation, patients with dementia, or 
patients with syndromes of impaired conscious-
ness such as coma, brain death, locked-in syn-
drome, and persistent vegetative state. Ethical 
guidelines for the management of patients in 
these conditions have been published by the 
British Medical Association (1996)1 and the 
American Neurological Association Council 
on Ethical and Judicial Affairs (1999)2. In cases 
of demented or mentally incompetent donors, 
a relative or legally authorized representative 
could sign the consent form on the donor’s 
behalf. In some countries, the donor must be 
informed regardless of their age, medical, or 
mental condition. 
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Best Practice: Special measures need be tak-
en to obtain consent for use of specimens from 
subjects incapable of consenting themselves. 
Legally authorized representative’s consent 
may be an option. Repositories should be well-
versed with ELSI regulations when working on 
specimens from these subjects. 
L2.4.2. Ethnic and Social Groups
At times ethnic and social groups or communi-
ties may be at risk due to the release of aggre-
gate research findings even when no individu-
ally identifiable information has been revealed. 
In addition, some populations or groups have 
specific beliefs about the disposal and use of 
their specimens, which should be respected. 
Best Practice: When research focuses on a 
particular community, it is best to seek input 
from representatives of the group on relevant 
aspects of the design of the study, the consent 
process, appropriate uses of specimens, and 
dissemination of collective research findings.
L2.4.3. Pediatric Subjects
The collection, storage, and distribution of spec-
imens from pediatric subjects creates additional 
ethical considerations, particularly in the areas 
associated with the gathering of informed con-
sent from subjects3. All elements associated with 
the use of samples from adult subjects should 
also be adhered to when working with pediatric 
subjects, including securing human subjects/eth-
ics review board approval for all processes and 
procedures, the minimization of risk associated 
with subject participation including the risks asso-
ciated with the loss of privacy and confidentiality, 
and the termination of specimen resources. The 
age of pediatric participants may be critical and 
require more detailed documentation (e.g., days, 
months, years). Policies and legal requirements 
may differ by country and region. 
L2.4.3.1. Parental Permission and  
 Pediatric Assent
Subjects below a certain age (which may 
differ by region or country) are not able to 
provide informed consent. Instead, parental 
permission and pediatric subject assent (in 
cases where assent may be given) is obtained 
in lieu of informed consent. Assent should 
include helping the patient understand the 
nature of their condition, informing them of 
what they can expect with tests and treat-
ment(s), and obtaining an expression of the 
patient’s willingness to accept the proposed 
care4 (see Appendix A: Internet Resources).
The documentation associated with obtaining 
parental permission is similar in nature and con-
tent to a document used to obtain informed 
consent from an adult with the exception that 
the documentation contains references to the 
minor child as the donor. The components 
of the parental permission documentation 
must include a complete and understandable 
description of the procedures associated with 
the collection, storage, and distribution of the 
specimens; risks and benefits (if any); options 
other than participating; and opportunities to 
withdraw permission. The process of securing 
parental permission should include the op-
portunity for the parent or guardian to discuss 
and question the pediatric donor’s potential 
involvement in the research until a level of full 
understanding is reached.
Once parental permission is obtained, the 
process of securing pediatric assent may be 
undertaken if the donor in question is at an 
age and developmental level where assent 
may be given. The assent process should 
be conducted through the discussion of the 
research, procedures, and processes with the 
child in age-appropriate language, including 
the opportunity for the child to ask questions. 
As with the securing of parental permission, 
key topics must be covered with the child, 
including the facts that they do not have to 
participate and that they may withdraw their 
assent to participate at any time in the future. 
For children who are either not yet old enough 
to read or not able to read, this assent process 
may be conducted orally, assuming that the 
appropriate human subject/ethics committee 
has approved the enrollment of children of that 
age. For children of reading age and ability, a 
pediatric assent document should be utilized. 
Assent documentation should be drafted in 
language that is age appropriate, easily under-
stood, and likely to encourage questions and 
discussion. As with the process to obtain in-
formed consent and parental permission, the 
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process associated with obtaining pediatric 
assent should be an interactive process where 
information is freely shared and decisions are 
made in an informed fashion.
L2.4.3.2.  Age Considerations
Until the subject in question is of legal age, 
parental or guardian permission is required 
for the pediatric subject to participate in 
research. The question of when to progress 
from using a pediatric assent document to 
using an informed consent document is less 
clear and tends to be institution and/or hu-
man subject/ethics committee dependent. 
The process and documentation must be de-
signed with the emotional, developmental, 
and cognitive abilities of the pediatric pop-
ulation in question. If the pediatric subjects 
are adolescents, it may be possible to use 
the same documentation as is used to secure 
informed consent from adult participants, 
with the caveat that parental permission is 
still required as a necessary first step. A new 
consent may be required from the participant 
once he/she reaches the age of majority. 
L2.4.3.3. Withdrawal of Assent and/or  
  Permission
Pediatric subjects and their parents or legal 
guardians must be informed that they are 
able to withdraw their assent or permission, 
respectively, at any point and decline to fur-
ther participate in the process. 
Best Practice: Appropriate parental permission 
and age-related assent, based on local regulations, 
should be obtained from pediatric subjects. 
Best Practice: Repositories should consult with 
human subjects/ethics committee for guidance on 
whether subjects that have reached the age of ma-
jority should be re-consented or whether a waiver 
of informed consent by the human subjects/ethics 
committee is appropriate.
L2.5. Specimens Obtained from Autopsies
Specimens may also be obtained during autopsy 
from pathologists at hospitals, institutions, or the 
coroner’s office. Full consent or authorization 
should be obtained from the deceased individual 
(e.g., a signed agreement to donate their body 
for scientific research), the next of kin, or a legally 
authorized representative. 
Repositories should follow relevant regulations 
pertaining to their particular jurisdiction. 
L2.6.  Specimens to be Used for Genetic Analyses
Complex ethical issues arise when genetic testing 
is performed on specimens. These issues include 
concerns about the potential identification of do-
nors and risks to family members, particularly from 
whole genome-sequencing technologies. In addi-
tion, genetic analyses may raise complex questions 
such as whether to inform donors of their individual 
research results, whether to inform participants’ 
families when heritable genetic factors about dis-
ease risks are identified in tissues, whether to ask 
relatives to collaborate on heritable genetic test-
ing, and whether to advise relatives to seek genetic 
counseling. 
Local requirements regarding use of specimens 
for genetic testing vary. In some jurisdictions, par-
ticipants may consent only to some aspects of the 
research. In others, a separate consent form may 
be required when specimens are to be used for 
genetic testing or for germ line mutation analysis. 
Repositories should follow local regulations and 
laws regarding specific requirements for generat-
ing, using, and sharing genetic data.
Maintaining privacy of the participants and the 
confidentiality of their data is particularly important 
when genetic data are generated (see Section I: 
Repository Information Management Systems).
Best Practice: The repository procedures for 
collection, storage, distribution, use, and disposal 
of specimens should respect the perspectives and 
traditions of donors from whom the specimens 
were obtained and minimize the risks to communi-
ties, populations, and groups.
L2.7.  Sharing and Distribution of Specimens and 
Data
Repositories should provide responsible custodi-
anship of the specimens and data that they collect, 
maintain, and share. Mechanisms should be in 
place to maintain the quality of specimens and 
data, protect donor privacy, and confidentiality, 
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and to ensure that specimens are shared in a man-
ner that is consistent with any consent obtained for 
them (see Section M2. Access and Utilization). 
Specimens and/or data should only be made 
available for ethical and scientifically appropriate 
research that is expected to contribute to scientific 
discovery. Copyright and intellectual property in 
relation to sample metadata provided directly to re-
searchers or presented on public websites should 
be accompanied by a policy that outlines the terms 
and conditions of its use. 
L2.8.  Ethical and Legal Disposal of Human 
Specimens
For some populations, disposal of specimens may 
have ethical considerations. Depending upon the 
nature of the study population and the repository, 
repositories and recipient researchers may be 
required to dispose of unused specimens accord-
ing to local, legal, ethical, and safety rules for the 
disposal of human remains. Alternatively, recipient 
researchers may be requested to return unused 
specimens to the repository. 
L3.  COLLECTION OF NON-HUMAN  
  BIOSPECIMENS 
L3.1.  Non-Human Organisms: Compliance 
with National Laws/Regulations and 
International Agreements
Collecting and carrying out certain types of re-
search on wild organisms is controlled by interna-
tional directives and national laws. Failure to heed 
these laws can be damaging for biodiversity, can 
circumvent fair access and benefit sharing among 
countries, and can create serious legal and op-
erational problems for research organizations. 
International treaties set out requirements and 
advice on the rights and responsibilities of pro-
vider countries (the origin of a genetic resource/
biological specimen) and users of that resource (in-
cluding researchers and repositories). The relevant 
international agreements include the Convention 
on Biological Diversity (CBD) texts on Access and 
Benefit-Sharing (particularly the Bonn Guidelines 
and the Nagoya Protocol), the International 
Treaty on Plant Genetic Resources for Food and 
Agriculture, and the Cartagena Protocol on 
Biosafety. CITES permits are necessary for species 
covered under that convention. The special status 
of access and benefit sharing for genetic resources 
in food and agriculture has been discussed by the 
Food and Agriculture Organization of the United 
Nations. Each country, if it is party to any of these 
agreements, will have its own implementing leg-
islation. For any sample collected there may be 
relevant legislation in the provider country, the 
collection’s or researcher’s own country, and any 
country through which the samples are carried.
In addition to permits relating to international 
agreements, other documents may be needed 
such as for collecting in protected areas, export 
and import permits, and phytosanitary/veterinary 
certificates. Some of these permits can take many 
months to obtain. Permits are often highly specific 
and attention should be paid to include the target 
sample derivative(s) (e.g., whole specimen, viable 
cells, fixed tissue, DNA). For veterinary hospital 
patients, all processes and procedures for collec-
tion, storage, distribution, and use of specimens 
for research should receive prior approval from 
an IACUC board (U.S.) and collections should fol-
low the same informed consent regulations listed 
above for human specimens, making sure the infor-
mation is clear to the patient representative (own-
er). Broad consent and specific informed consent 
(for immediate research use) are most often used in 
veterinary hospital collections.
Best Practice: Legal and regulatory requirements 
of all relevant countries should be checked and 
necessary permits obtained during the collection 
planning process where possible.
L3.1.1.  Access and Benefit Sharing
Many countries have national legislation and 
regulations, particularly with regard to access 
and benefit sharing. These may require that 
users or collectors of biological material: 
•	 Obtain Prior Informed Consent (PIC) re-
garding their proposed utilization of the 
genetic resources within the material from 
the appropriate national and/or interna-
tional bodies (e.g., indigenous and local 
communities). This sets out an agreement 
regarding what will happen to the material 
after collection.
•	 Decide upon Mutually Agreed Terms (MAT) 
regarding sharing the monetary and/or 
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non-monetary benefits arising from that 
utilization. Such agreements may be part 
of a Permit or Material Transfer Agreement 
or covered by a Memorandum of 
Understanding (MoU, also Memorandum 
of Cooperation). Several agreements may 
cover a single sample. Often little or no 
distinction is drawn between the genetic 
resources (i.e., functional units of heredity) 
and the biological resources (i.e., speci-
mens) containing them.
The terms and conditions agreed to with PIC 
and MAT may persist and should be associated 
with the organisms when they enter collections 
or become subject to research.
Advice regarding requirements under access 
and benefit sharing legislation may be sought 
from the National Access and Benefit Sharing 
(ABS) focal point; contact details can be found 
on the ABS Clearing House. However, there 
may be additional regulations from different 
government departments of which the ABS 
Focal Point is unaware.
The benefits agreed to when the provider 
country gives approval to collect may be mon-
etary (particularly if the utilization of the material 
has a commercial goal) or non-monetary, such 
as training and capacity building. Examples of 
both monetary and non-monetary benefits are 
listed in Appendix II of the Bonn Guidelines of 
the Secretariat of the Convention on Biological 
Diversity and the Annex of the Nagoya Protocol 
on Access and Benefit Sharing.
Good practice for academic institutions, in-
cluding repositories, in the context of access 
and benefit sharing is set out in Biber-Klemm 
& Martinez (2016)5. Some consortia have also 
developed best practices and tools to assist 
in their implementation (e.g., Consortium 
of European Taxonomic Facilities GGBN, 
Botanical Garden Conservation International). 
Code of Conduct documents sets out the basic 
principles to which the consortium adheres, 
and the Best Practices provide advice on how 
these principles might be implemented, and 
the policies and processes required. See 
Appendix A: Internet Resources for examples.
Increasingly, groups of organizations are 
combining to adopt common policies and 
standardized access and benefit sharing prin-
ciples and agreements. For example, the Swiss 
National Academy of Sciences has produced a 
document that includes a sample access and 
benefit sharing agreement, as well as case stud-
ies and a Step-by-Step guide to compliance6.
L3.1.1.1.  Additional Information for  
 Microorganisms
The Belgian Science Policy Office has 
produced the MOSAICC code of conduct 
(Micro-Organisms Sustainable use and 
Access regulation International Code of 
Conduct), the MOSAICS recommendations 
(a system for appropriate management of 
access to and transfer of microbiological 
resources), and TRUST (TRansparent User-
friendly System of Transfer). TRUST is devel-
oped in cooperation with the World Data 
Centre for Microorganisms of the WFCC via 
the Global Catalogue of Microorganisms; 
it aims at managing the influence of CBD-
compliant agreements on the scientific, 
technical, and administrative activities of 
culture collections and, more generally, 
incorporating the Nagoya Protocol into the 
daily life of microbiologists (see Appendix A: 
Internet Resources).
In addition to the above-mentioned documents, 
the Best Practice Manual on Access and Benefit 
Sharing issued by the Microbial Resource 
Research Infrastructure provides guidance for 
microbial biological resource centers on im-
plementation of institutional ABS policies with 
regard to genetic resources and associated 
traditional knowledge. It suggests operating 
procedures for acquisition/accession and 
transfer of material as well as for other services. 
The document also aims at generally increasing 
transparency on how microbial resource centers 
conduct research on their holdings and utilize 
genetic resources and associated traditional 
knowledge. Access and Benefit Sharing is fur-
ther discussed in Section M2.2. Benefit Sharing.
Best Practice: Repositories should follow 
national/federal, regional, local, and interna-
tional guidelines related to Access and Benefit 
Sharing when planning to start collections.
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L3.1.2.  Responsibilities
Repositories should establish documented pro-
cedures and policies to ensure:
•	 The repository understands its rights and 
responsibilities under the appropriate trea-
ties and relationships with providers.
•	 Its staff and associates abide by appropriate 
national laws /regulations and international 
agreements (e.g., Nagoya Protocol).
•	 Material entering the repository is obtained 
with appropriate legal certainty and ani-
mals were collected in a manner consistent 
with pertinent guidelines (e.g., IACUC).
•	 Material deposited in the repository can 
legally be retained and used as required.
•	 Terms and conditions (PIC, MAT, MTAs, 
permit(s), and MoUs) governing samples 
are managed effectively and complied 
with by the repository, including internal 
and external users of the repository.
•	 Terms and conditions (PIC, MAT, MTAs, 
permit(s), and MoUs) governing samples 
can be accessed effectively to manage 
use of those samples, including third-party 
transfer and disposal. This will include in-
corporation within a records management 
system and data management system.
•	 Third-party use of samples is carried out 
according to terms and conditions (PIC, 
MAT, MTAs, permit(s) and MoUs) govern-
ing those samples. 
•	 Any proposed use outside the original 
terms and conditions (PIC, MAT, MTAs, 
permit(s), and MoUs) is renegotiated with 
the provider.
L3.2. Ethical Collection of Animal Specimens for 
Research 
Scientific researchers who work with animal 
models generally agree that experiments that 
follow the best animal welfare procedures 
result in the best science. Three Rs (reduction, 
refinement, and replacement) in animal proce-
dures should be an integral part of any research 
project to help minimize animal use and suffer-
ing and to facilitate good scientific practice. 
The refinement of scientific procedures carried 
out on animals to minimize adverse effects and 
to maximize the scientific benefit gained is a le-
gal and ethical requirement under the laws and 
regulations of numerous countries worldwide, 
including the U.S. Animal Welfare Act (United 
States Code, Title 7, Chapter 54, Sections 2131-
2159), the U.K. Animals (Scientific Procedures) 
Act 1986, the U.K. Animal Welfare Act 2006, 
the Animal Health and Welfare Strategy for 
Great Britain, Australian Animal Welfare Strategy, 
Canadian Council on Animal Care in Science, 
among others. Nevertheless, refinements are not 
always implemented for a variety of reasons7,8.
The ‘five freedoms’ concept first presented by 
the British Farm Animal Welfare Council (FAWC, 
1979)9 can be used as general indicators of 
laboratory animal welfare. These five freedoms 
are: (1) freedom from injury and disease; (2) 
freedom from discomfort, hunger, and thirst; 
(3) freedom from pain; (4) freedom to express 
normal behaviors; and (5) freedom from fear 
and distress. In any animal resources facility, re-
searchers must implement actions to minimize 
the impact of the procedures they perform on 
these five freedoms. 
Currently, animals are sacrificed in laboratories 
or breeding establishments for a variety of rea-
sons including: 
•	 When animals have passed the age of be-
ing suitable for breeding. 
•	 To provide blood and other tissues sam-
ples for a scientific analysis. 
•	 At the completion of an experiment or due 
to continuing adverse effects.
•	 To end an experiment because the levels 
of pain, distress, and suffering are likely to 
exceed a certain level. 
•	 In situations where the health or welfare of 
the animals are a matter of concern. 
•	 To eliminate animals with improper charac-
teristics, such as type or sex. 
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In terms of animal welfare, the primary criteria 
for euthanasia should follow these rules: the 
method should be painless; achieve rapid 
unconsciousness and death; require minimum 
restraint; avoid excitement; should be suitable 
for the age, species, and health of the animal; 
must minimize fear and psychological stress in 
the animal; should be reliable, reproducible, 
irreversible, and simple to administer (in small 
doses if possible); and safe for the operator. 
In the U.S., the IACUCs ensure that all projects 
involving the use of live vertebrate animals com-
ply with federal regulations and guidelines and 
they review the appropriateness of euthanasia. 
IACUC uses The American Veterinarian Medical 
Association Guidelines for Euthanasia as cri-
teria when reviewing euthanasia protocols, 
specifying appropriate methods and agents 
based upon published empirical evidence 
that demonstrates the minimization of pain and 
distress. Animal repositories in other countries 
should refer to their local regulations on animal 
euthanasia.
Through the harmonization of procedures 
among animal resource centers, it is expected 
that minimization/elimination of pre-analytical 
confounding variables and the resulting com-
patibility of studies will result in a reduced num-
ber of animals used for experimental research. 
Such harmonization will result in improved ani-
mal welfare standards in a way that both animals 
and science benefit from harmonization. 
Best Practice: To ensure the ethical collection 
of animal specimens for research, repositories 
should refer to their local and national animal 
care and usage policy. Measures to minimize 
animal use, as well as pain and distress to 
them, in research should be undertaken where 
possible.
L3.3. Sharing and Distribution of Non-Human 
Specimens and Data
Repositories should provide responsible custodi-
anship of the specimens and data that they collect, 
maintain, and share. Mechanisms should be in 
place to maintain the quality of specimens and 
data, protect the provider country rights, and en-
sure that specimens are shared in a manner that is 
consistent with legal and regulatory requirements 
(see Section L3.1. Non-Human Organisms: 
Compliance with National Laws/Regulations and 
International Agreements and Section M2. Access 
and Utilization). Some ABS agreements state that 
specimens may not be transferred to any third 
parties or may require written permission from the 
provider country for this to take place.
Specimens and/or data should only be made 
available for ethical and scientifically appropriate 
research that is expected to contribute to scientific 
discovery. Agreements with provider countries and 
others as a condition for access should be adhered 
to when considering third-party transfer and usage. 
A large number of Botanic Gardens have jointly 
created the International Plant Exchange Network, 
an organization that is legally one “person”, which 
enables free movement of samples among its 
members while respecting ABS. Copyright and in-
tellectual property in relation to samples metadata 
provided directly to researchers or presented on 
public websites should be accompanied by policy 
that outlines the terms and conditions of its use.
L3.4.  Ethical and Legal Disposal of Non-Human 
Specimens
Disposal of non-human specimens may be gov-
erned by repository policy and also by agreements 
entered into with the provider country. These may 
be included in the original agreements governing 
collection and research.
L4. TERMINATION OF REPOSITORIES 
Repositories should develop plans at the time of their es-
tablishment for the disposition of specimens and/or data 
should the repository be terminated for any reason. The 
disposition, including any transfer of specimens and/or 
data to third parties, should be consistent with the condi-
tions and agreements under which specimens and/or data 
were obtained (see Section M3. Specimen or Collection 
Disposition). 
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SECTION M: SPECIMEN ACCESS, 
UTILIZATION, AND DISPOSITION
M1. GENERAL 
Repositories should establish written policies and pro-
cedures addressing how specimens and associated data 
will be accessed, what will constitute appropriate uses of 
the specimens preserved in the repository, and how de-
cisions will be made to approve requests for specimens. 
Access and use of the collections should be included in the 
planning process and reflected in the governance of the 
repository. 
Access to repository collections and associated data may 
be governed by legislation and regulations, which should 
be considered prior to release to the requestor especially 
if monetary benefits arise from their use (see also Section 
A2. Repository Governance)
Repositories should make their access and use policies 
available to sponsors and funding providers, donors, and, 
when appropriate, to the general public (see Section A2. 
Repository Governance) in order to create trust in the 
repository. 
Best Practice: Repositories should establish written poli-
cies governing access and use of specimens and associat-
ed data and policies for culling and transfer of collections.
M2.  ACCESS AND UTILIZATION
M2.1. Access and Use Policies 
Repositories should develop policies governing 
sharing and distribution of specimens including 
guidance for determining what constitutes appro-
priate research use of the repository’s specimens 
and associated data. The written policies that guide 
access and distribution should consider:
•	 Who can access the specimens and which 
specimens and associated data are available for 
sharing.
•	 Mechanism for submitting requests.
•	 Review process: who will review the requests 
and how decisions will be made.
•	 Criteria for determining whether a specimen 
request can be filled.
•	 Designated person or group providing oversight.
•	 Process for appealing requests that are rejected.
•	 Acknowledgement of repositories in publica-
tions and reporting requirements. 
Restrictions on retention time of specimens in a 
repository and any restrictions on use of specimens 
(such as genetic research) specified in the Informed 
Consent documents for human subjects should be 
tracked and taken into consideration when distrib-
uting specimens.
Donor privacy and confidentiality should be 
protected at all times and specimens required 
for clinical care should not be made available for 
researcher use unless approved by an appropriate 
research ethics committee.
Those managing repositories storing genetic re-
sources obtained from plants, animals, or microbes 
should be aware of any agreements made with 
providing countries that outline the utilization of 
samples for both non-commercial purposes (e.g., 
taxonomy, conservation) and for commercial de-
velopment (e.g., pharmaceutical development, 
industrial biotechnology, commercial horticulture). 
Any proposed use outside the original terms and 
conditions must be renegotiated with the provider. 
Best Practice: Access policies should be in com-
pliance with existing rules, regulations, policies, 
and applicable laws. 
Best Practice: Human specimens and associat-
ed data should be distributed without personal 
identifiable information unless this information is 
necessary and the human subjects or ethics com-
mittee review has granted permission for inclusion 
of identifying information. 
Best Practice: Terms and conditions governing 
access and use of genetic resources obtained from 
plants, animals, or microbes should be tracked by 
the repository and taken into consideration when 
establishing access and use policies.
M2.2. Benefit Sharing 
Sharing benefits from specimen research is im-
portant to ensure that providers of resources, es-
pecially those in developing countries, are treated 
in a fair and equitable way. The Nagoya Protocol, 
a supplementary agreement to the Convention 
on Biological Diversity (CBD), requires the fair 
and equitable sharing of benefits arising from the 
utilization of genetic resources and/or traditional 
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knowledge1. Users or collectors of biological 
material may be required to obtain Prior Informed 
Consent (PIC) and decide upon Mutually Agreed 
Terms (MAT) regarding sharing the monetary 
(e.g., capacity-building, education, research part-
nerships, training) and/or non-monetary benefits 
(e.g., access fees, commercial products, royalties, 
salaries). Depending on the Providing Country and 
domestic legislation, additional agreements with 
indigenous and local communities that hold rights 
on genetic resources need to be considered or 
may be required.
Benefits to participants in studies that collect 
human specimens, especially in developing coun-
tries, may include building local capabilities and 
infrastructure for biorepositories and research, 
creating research collaborations, and potentially 
improving the health of participating communities. 
The repository policies should address ownership 
and benefiting from specimens, including intellec-
tual property rights. Repositories supported with 
public funds should make their resources available 
to the wider community of researchers with due 
consideration to ethical and legal obligations. 
Best Practice: Repositories that import specimens 
and data from other countries should ensure that 
fair and equitable benefits are made available to 
the providing country. 
M2.3. Sharing Specimen/Sample Associated Data 
Specimens/samples are most useful for scientific 
research when accompanied by specific data that 
characterize their key attributes and source to aid 
with the interpretation and analysis of experimental 
results. Data governance plans and policies should 
take into account:
•	 Type of data needed to accompany speci-
mens from different human and/or non-human 
sources.
•	 Legal requirements related to data, protocols, 
consents, and other documents governing the 
repository.
•	 Material and data transfer agreements (Section 
M2.5.).
For human specimens, it is important to protect 
subject/donor identity and privacy, as described 
in detail in Section L. Whenever possible, human 
subject data should have all identifying information 
removed. 
Quality control measures should be in place to 
ensure that the specimens are linked to the correct 
data. 
Best Practice: Repositories should develop data 
sharing policies describing what type of specimen 
(or sample) associated data can be accessed and 
provided.
Best Practice: Repositories should develop poli-
cies for sharing specimen associated data consis-
tent with applicable laws and regulations, including 
those related to transfer of intellectual property, 
informed consent, ethical and privacy standards, 
and formal agreements covering specific data shar-
ing arrangements.
M2.3.1.  Transfer of Specimen Associated Data 
Specimens are most useful for scientific re-
search when accompanied by specific data 
that characterize their key attributes and source 
to aid with the interpretation and analysis of 
the scientific user’s experimental results. It is 
therefore important to ensure that specimens 
are linked to the correct corresponding data. 
The specimens associated data should be used 
in accordance with appropriate legal require-
ments including protocol, consent, and other 
documents governing the repository. For hu-
man specimens, it is important to protect sub-
ject/donor identity and privacy, as described in 
detail in Section L. Whenever possible, human 
subject data should have all identifying informa-
tion removed. 
Best Practice: Repositories should develop 
policies consistent with applicable laws and 
regulations, including those related to transfer 
of intellectual property, informed consent, 
ethical and privacy standards, and formal 
agreements covering specific data sharing 
arrangements.
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M.2.4. Review of Specimen Use Requests 
Requests for specimen use should undergo some 
level of scientific and/or administrative review to 
ensure proper utilization. 
Considerations may include: 
•	 Scientific merit and potential impact of the pro-
posed research.
•	 Whether the research use is appropriate to the 
nature and purpose of the repository. 
•	 Availability of specimens of the specific type 
requested.
•	 Adequacy of the research design and benefits 
and risks of the proposed research.
•	 Legal and ethical considerations.
•	 Qualifications of the research team and research 
environment and funding to carry out the pro-
posed research. 
The level of review and administrative actions re-
quired may depend on the type of requests, such 
as requests for rare specimens and potential com-
petition for their use, requests for large amounts of 
data, and those that require additional processing, 
pre-analysis, or special handling by the repository 
staff. Some repositories may have a cost recovery 
system for services associated with specimen dis-
tribution, as defined in the business plans of the 
repository (see Section H: Cost Management).
When investigators are required to obtain human 
subjects or ethics committee review and approval 
for the research use of specimens and/or data re-
quested, documentation of such approval needs to 
be obtained prior to specimen or data distribution. 
Repositories should establish transparent and effi-
cient procedures and processes for review and dis-
tribution of specimen and data requests. Requests 
should be reviewed in a timely manner by qualified 
individuals. 
Best Practice: A repository’s policies and proce-
dures for utilization of specimens and associated 
data should be consistent with all applicable 
institutional and national/federal legal and ethical 
requirements.
Best Practice: Repositories should train their staff 
on policies related to specimen access and use.
Best Practice: Repositories should have well-doc-
umented and clearly defined criteria for evaluating 
requests for access consistent with the repository’s 
policies for specimen and data sharing.
M.2.5.  Material and Data Transfer Agreements 
M2.5.1.  Material Transfer Agreement
A Material Transfer Agreement (MTA) is a contract 
that governs the transfer of tangible research 
materials between two organizations (a provider 
and a recipient) when the recipient intends to use 
it for his or her own (research) purposes. The MTA 
defines the rights of the provider and the recipient 
with respect to the materials and any derivatives. 
Biological materials such as specimens (including 
whole animals, plants, microorganisms), reagents, 
cell lines, plasmids, and vectors are the most 
frequently transferred materials, but MTAs may 
also be used for other types of materials, such as 
chemical compounds or software.
Other types of agreements without the title of 
MTA may be used but generally would serve 
the same purpose and have the same compo-
nents as an MTA.
 M2.5.2.  MTA for Specimens
An MTA (or other document) for transfer of 
specimens to a recipient should address at a 
minimum:
•	 Purpose of the transfer.
•	 Restrictions on the use of the specimens 
(e.g., specimens may not be banked, sold, 
used in other projects, redistributed to 
third parties).
•	 Requirements for maintaining privacy and 
confidentiality.
•	 Restrictions on re-identification (where 
de-identified specimens are provided).
•	 Requirements for appropriate biosafety 
knowledge for handling.
•	 Intellectual property rights.
•	 Publication/authorship rights and required 
acknowledgement of the repository pro-
viding specimens.
•	 Providing reports to the repository about 
specimen use and/results.
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•	 Other factors that may govern the transfer 
(e.g., indemnification, insurance, contrac-
tual requirements).
Best Practice: An MTA or similar agreement 
should be executed to document the obliga-
tions and responsibilities of parties involved in 
the transfer of materials from a repository prior 
to shipment. The agreement should be in place 
before the transfer occurs. 
Best Practice: Repositories that receive or 
send material should have an MTA and main-
tain documentation for such transactions. 
Repositories should have templates of this doc-
ument that can be used or modified as needed. 
 M2.5.3.  MTDA or DTA for Specimen Data 
Repositories should execute an agreement with 
recipients prior to data transfer. This agreement 
may constitute a stand-alone Data Transfer 
Agreement (DTA) or the necessary terms may 
be included in an MTDA (Material and Data 
Transfer Agreement). Content of such agree-
ments may include: 
•	 Description of the data to be distributed.
•	 Purpose for which the data will be used.
•	 Whether redistribution or forwarding of 
the data to others is permitted and under 
what circumstances.
•	 Protection of data against unauthorized 
access.
•	 Protection of donor privacy and confidenti-
ality and re-identification (where de-identi-
fied specimens are provided). 
•	 Custodianship, access, and control of 
transferred data.
•	 Disposition of data (destruction) upon 
research completion or agreement 
termination.
•	 Terms of agreement, indemnification, 
payment of fees, and rights and title to the 
research performed.
•	 Other factors that may govern the trans-
fer (i.e., contractual requirements, local 
considerations).
Best Practice: Repositories should execute an 
MTA that incorporates terms for data transfer or 
similar agreement with recipients who receive 
specimen-associated data from the repository.
M2.5.4. Requirements for Transfer of a  
 Collection
A repository may have a need to transfer an 
entire collection to another repository or cus-
todian. An MTA will need to be established to 
document allowable uses for the collection. 
The transfer agreements should include sign-off 
by recipients to handle all specimens with the 
necessary safety methods and a statement that 
the providing repository is not liable for any 
health risk or damage that may result from the 
recipient’s unsafe handling of the specimens. 
For more detailed information, see Section 
M3.3. Transfer of a Collection.
M2.6. Acknowledging Repositories and Reporting 
Utilization 
In publications that result from the use of speci-
mens, the repository should be acknowledged 
as the source of the specimens, preferably in the 
Material and Methods section (or in the acknowl-
edgements) of a manuscript. Recommended 
format for repository citation can be found in Bravo 
et.al 20162.
Repositories may require users to provide reports 
on utilization of specimens provided and include 
the requirement in the MTA or MTDA (Section 
M2.5. Repositories may ask researchers to provide 
the repository with data derived from individual 
specimen or samples or aggregate research results.
Repositories may specify a date by which specimen 
recipients should provide data, taking into consid-
eration any special requirements that some recipi-
ents may have to delay dissemination of results as 
specified in study protocols or to secure intellectual 
property rights.
Best Practice: Repositories supporting research 
should establish policies and procedures for ac-
knowledgement in publications and for reporting 
requirements about the use of the specimens and 
the data provided by the repository. These require-
ments should be specified in the Material Transfer 
Agreements.
90 ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
M3. SPECIMEN OR COLLECTION  
  DISPOSITION
Policies should be established for transfer or disposition 
of collections, specifying criteria and conditions and how 
decisions will be made and approved. Collections or 
specimens may be transferred out of the repository when 
specimen resources have fulfilled their original purpose, 
are no longer suitable for their intended purpose, or if par-
ticipants no longer request the withdrawal of their speci-
mens. Information about MTAs for transfer of collections is 
provided in Section M2.5.3. MTDA or DTA for Specimen 
Data.
M3.1.  Culling
Culling of specimens or collections is the process 
of reviewing and eliminating selected specimens or 
entire collections from the repository either by de-
struction or transfer to a new custodian. Repositories 
should review their collections periodically and 
determine the need for their continued storage. 
This action may be needed periodically due to stor-
age space constraints and/or the need to control 
costs. Other reasons may include consent issues, 
regulatory changes, and protocol modifications 
and/or compromised specimen integrity. Costs for 
retrieval, destruction, and/or transfer of specimens 
or collections should be considered and included in 
the repository budget plans.
Best Practice: Repositories should establish 
criteria for continued retention or disposition of 
specimens and collections that are included in 
repository policies. 
Best Practice: Repositories should have docu-
mented procedures in place for regularly sched-
uled reviews of the inventory to ensure that speci-
mens meet criteria for continued retention. 
Best Practice: Repositories should document 
disposition of specimens or collections through de-
struction or transfer to a new custodian and retain the 
documents in the archival records of the repository.
M3.2. Specimen Destruction 
There are a number of circumstances that may 
influence decisions to destroy an entire collection 
or specific specimens. Some of the reasons for de-
stroying samples may include, for example:
•	 Specimen-associated information has been lost, 
the identity of the specimen(s) is not known, 
and potential risks and biohazards cannot be 
assessed.
•	 Specimen quality has been compromised by 
equipment failure or repeated freeze/thaw cy-
cles that limit fit for research uses.
•	 When required by consent, study design, or 
regulation; when specimens in excess of the 
approved protocol were collected; when the 
status of a participant changes from “eligible to 
ineligible” or their case/control status changes; 
or when consent is withdrawn.
•	 Specimens have not been accessed or used or 
custodianship cannot be verified. 
Repositories should include documentation about 
specimen destruction due to compromised qual-
ity in their quality management procedures. This 
information can be important indicators for areas 
needing improvement either in specimen handling 
or repository operations and risk management.
Safety precautions appropriate for the type of spec-
imens and risk level need to be observed when 
specimens are destroyed. The repository should 
consider specific protocols (SOPs) to include meth-
ods to be used for destruction of all the specimen 
types stored in the repository.
Best Practice: Repositories should develop poli-
cies for destruction of specimens and collections, 
including the criteria and approvals needed. 
Best Practice: A repository should document 
the destruction of any specimens, and monitoring 
specimen destruction due to compromised quality 
as part of quality management for the repository. 
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M3.3. Transfer of a Collection
When a repository needs to transfer an entire col-
lection to another repository or custodian, an MTA 
will need to be established as described in Section 
M2.5.4. Requirements for Transfer of a Collection. 
Provisions should be made for transferring docu-
mentation associated with the collection to allow for 
an assessment of the risk level and biosafety require-
ments for handling the specimens, and to enable 
future uses of the specimens. The recipients must 
be advised of any known potential risks associated 
with the collections and of any consent and custodi-
anship issues that may limit future use. 
For human specimens, a research ethics review may 
be required by the institution accepting the new 
collection and for new uses for the specimens. For 
animal, environmental, and microbial specimens, 
any agreements or permits outlining access or ben-
efit sharing must be transferred with the specimens. 
Transfer and future use of specimens must be in 
agreement with the details specified in these doc-
uments. The cost for retrieving and transporting the 
collection to the new custodian should also be taken 
into account (see Section H: Cost Management). 
92 ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
REFERENCES
American Academy of Pediatrics Committee on Bioethics. Informed 
consent, parental permission, and assent in pediatric practice. Pediatrics 
1995;95:314-317.
American Neurological Association Council on Ethical and Judicial 
Affairs. Medical futility in end-of-life care: Report of the Council on 
Ethical and Judicial Affairs. JAMA 1999;281:937–941.
Aumakhan B, Gange SJ, Beyer C, et al. Quantitative and qualitative 
coorelates of cervocovaginal herpes simplex virus type 2 among HIV-
infected women in the women’s interagency HIV study. Intl J STD AIDS 
2011;22:273-277.
Aumakhan B, Hardick A, Quinn TC, et al. Genital herpes evaluation by 
quantitative TaqMan PCR: correlating single detection and quantity 
of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and 
longitudinal clinical data. Viro J 2010;7:328.
Bass BP, Engel KB, Greytak SR, Moore HM. A review of preanalytical 
factors affecting molecular, protein, and morphological analysis of 
formalin-fixed, paraffin-embedded (FFPE) tissue: How well do you know 
your FFPE specimen? Arch Pathol Lab Med 2014;138:1520-1530.
Belgrader P, DelRio SA, Turner KA, et al. Automated DNA purification 
and amplification from bloodstain cards using a robotic workstation 
BioTechniques 1995;19:426-432.
Benson EE. Cryopreservation of phytodiversity: A critical appraisal of 
theory & practice. Crit.Rev Plant Sci 2008;27:141-219.
Betsou F, Luzergues A, Carter A, et al, and the Marble Arch Working 
Group on International Biobanking. Towards norms for accreditation of 
biobanks for human health and medical research: Compilation of exist-
ing guidelines into an ISO certification/accreditation norm-compatible 
format. Qual Assur J 2008;11:221-294.
Betsou F, Lehmann S, Ashton G, et al, and the ISBER Working Group on 
Biospecimen Science. Standard preanalytical coding for biospecimens: 
defining the sample PREanalytical code (SPREC). Cancer Epidemiol 
Biomarkers Prev 2010;19:1004-1011.
Betsou F, Bulla A, Cho SY, et al. Assays for qualification and quality 
stratification of clinical biospecimens used in research: A technical re-
port from the ISBER Biospecimen Science Working Group. Biopreserv 
Biobank, 2016;14:398-409.
Biber-Klemm S, Martinez S. Utilization of genetic resources and asso-
ciated traditional knowledge in academic research. A good practice 
guide for access and benefit-sharing 3rd ed. Bern, Switzerland, Swiss 
Academy of Sciences (SCNAT), Swiss Biodiversity Forum, House 
of Academies, 2016. Available at: http://www.naturalsciences.ch/
organisations/biodiversity/abs/goodpractice
Biber-Klemm S, Martinez SI, Jacob A, Jetvic A. Agreement on access 
and benefit-sharing for academic research. A toolbox for drafting mu-
tually agreed terms for access to genetic resources and to associated 
traditional knowledge and benefit-sharing. Bern, Switzerland, Swiss 
Academy of Sciences (SCNAT), Swiss Biodiversity Forum, House 
of Academies 2016. Available at: http://www.naturalsciences.ch/
organisations/biodiversity/abs/toolbox
Bravo E, Calzolari A, De Castro P, et al. Developing a guideline to stan-
dardize the citation of bioresources in journal articles (CoBRA). BMC 
Med 2015;13:33.
British Medical Association (1996). BMA Guidelines on Treatment 
Decisions for Patients in Persistent Vegetative States. London, British 
Medical Association, 1996.
Buck M, Hamilton C. The Nagoya protocol on access to genetic re-
sources and the fair and equitable sharing of benefits arising from their 
utilization to the convention on biological diversity. Reciel 2011;20: 
47–61.
Budapest Treaty Regulations. Budapest Treaty on the International 
Recognition of the Deposit of Microorganisms for the Purposes of 
Patent Procedure. Geneva, Switzerland, World Intellectual Property 
Organization 1977. 
Compressed Gas Association, Inc. Handbook of Compressed Gases. 
Norwell, MA, Kluwer Academic Publishers 2012.
Damjanov I, Vranic S, Skenderi F. Does everything a surgeon takes out 
have to be seen by a pathologist? A review of the current pathology prac-
tice. Virchows Arch 2016;468:69-74. doi: 10.1007/s00428-015-1801-0. 
Day JG, Lorenz M, Wilding TA, et al. The use of physical and virtual 
infrastructure for the validation of algal cryopreservation methods in 
international culture collections. Cryoletters 2007;28:359-376.
Day JG, Stacey G, eds. Cryopreservation and Freeze Drying Protocols, 
2nd ed. Totowa, NJ, Humana Press, 2007.
Dey-Hazra E, Hertel B, Kirsch T, et al. Detection of circulating micropar-
ticles by flow cytometry: Influence of centrifugation, filtration of buffer, 
and freezing. Vasc Health Risk Manag 2010;6:1125-1133.
Doedt T, Kist R, Heckle D, et al. QIAsafe DNA tubes for room-tem-
perature archiving of purified DNA samples. International Society 
for Biological and Environmental Repositories (ISBER) Conference, 
Portland, OR, 2009. 
Droege G, Barker K, Seberg O, et al. The Global Genome Biodiversity 
Network (GGBN) data standard specification. Database 2016 baw125; 
doi:10.1093/database/baw125.
Engel KB, Moore HM. Effects of preanalytical variables on the detection 
of proteins by immunohistochemistry in formalin-fixed, paraffin-embed-
ded tissue. Arch Pathol Lab Med 2011;135:537-543.
FAO. Global Plan of Action, for the Conservation and Sustainable 
Utilization of Plant Genetic Resources for Food and Agriculture. Rome, 
Italy, FAO of the UN, 1996.
Farm Animal Welfare Committee. The Five Freedoms. Published 
December 5, 1979.
Fleming DO, Hunt DL. Biological Safety, Principles and Practices. 4th 
ed. Washington, DC, American Society for Microbiology, 2006.
Fuller BJ, Diijk S. Low temperature organ preservation, blood vessels, 
and the human tissue act 2007: Impact and Implications. CryoLetters 
2008;29:175-179.
Gemeinholzer B, Rey I, Weising K, et al. (2010): Organizing specimen 
and tissue preservation in the field for subsequent molecular analy-
ses. In: Eymann J, Degreef J, Häuser C, et al, eds., Volume 8 - Manual 
on Field Recording Techniques and Protocols for All Taxa Biodiversity 
Inventories. Belgium, Abc Taxa, 2010:129-157.
Grizzle WE, Polt SS. Guidelines to avoid personnel contamination by 
infective agents in research laboratories that use human tissues. J Tissue 
Culture Method 1988;86:217-221.
93ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
Grizzle WE, Fredenburgh J. Avoiding biohazards in medical, veterinary 
and research laboratories. Biotech Histochem 2001;76:183-206.
Grizzle WE, Bell W, Fredenburgh J. Safety in biomedical and other labo-
ratories. In: Patrinos G, Ansorg W, eds. Molecular Diagnostics. London, 
UK, Academic Press, 2005:421-428.
Grizzle WE, Sexton KC, Bell WC. Quality assurance in tissue resources 
supporting biomedical research. Cell Preserv Technol 2008;6:113-118.
Grizzle WE, Bell WC, Fredenburgh J. General considerations concern-
ing safety in biomedical research laboratories. In: Patrinos G, Ansorg 
W, eds. Molecular Diagnostics, 2nd ed. London, UK, Academic Press, 
2009:563-72.
Hamot G, Ammerlaan W, Mathay C, et al. Method validation for 
automated isolation of viable peripheral blood mononuclear cells. 
Biopreserv Biobank 2015;13:152-163.
Hartley P, Lloyd M, Burton N. Obstacles to the refinement of scientific 
procedures using living animals. Poster presentation. In: Kirkwood JK, 
Roberts EA, Vickery S, eds. Proceedings of the UFAW International 
Symposium ‘Science in the Service of Animal Welfare’, Edinburgh 2003. 
Animal Welfare 2004;13(Suppl):S57-69. 
Holetschek J, Dröge G, Güntsch A, et al. The ABCD of rich data access 
to Natural History Collections. Plant Biosyst 2012;146:771–779.
Hubel A, Spindler R, Skubitz AP. Storage of human biospecimens: 
Selection of the optimal storage temperature. Biopreserv Biobank 
2014;12:165-175.
Huppertz B, Kivity V, Sammar M, et al. Cryogenic and low temperature 
preservation of human placental villous explants – a new way to explore 
drugs in pregnancy disorders. Placenta 2011;32 Suppl:S65-76. doi: 
10.1016/j.placenta.2010.11.020.
Isa K, Yamauch MS, Nago TT, Yamane N. Quantitative estimation of 
preanalytical variables which may influence the determinations of pro-
thrombin time (PT) and activated partial thromboplastin (APTT). Rinsho 
Byori 2010;58:979-985.
Jansen B. Bio-banking and genetic testing: A comparison between 
European countries and India. J Int Bioethique 2009;20:57-68, 147-148.
Jewell SC, Srinivasan M, McCart LM, et al. Analysis of the molecular 
quality of human tissues: An experience from the Cooperative Human 
Tissue Network. Am J Clin Pathol 2002;118:733-741.
Karas A. Barriers to assessment and treatment of pain in laboratory 
animals. Laboratory Animals Europe 6, 30–9 FAWC (1979) The Five 
Freedoms. London, Farm Animal Welfare Council, 2006.  
Kaufman D, Geller G, LeRoy L, et al. Ethical implications of including 
children in a large biobank for genetic-epidemiologic research: A quali-
tative study of public opinion. Am J Med Genet Part C Semin Med Genet 
2008;148C:31–39.
Lehmann S, Guadagni F, Moore H, et al. Standard preanalytical 
coding for biospecimens: review and implementation of the Sample 
PREanalytical Code (SPREC). Biopreserv Biobank 2012;10:366-374.
Merino-Martinez R, Norlin L, van Enckevort D, et al. Toward Global 
Biobank Integration by Implementation of the Minimum Information 
About Biobank Data Sharing (MIABIS 2.0 Core). Biopreserv Biobank 
2016;14:298-306.
Moore HM, Kelly AB, Jewell SD, et al. Biospecimen reporting for im-
proved study quality (BRISQ). Cancer Cytopathol 2011;119:92–101.
Muller R, Betsou F, Barnes MG, et al. International Society for Biological 
and Environmental Repositories (ISBER) Biospecimen Science Working 
Group. Preservation of biospecimens at ambient temperature: Special 
Focus On Nucleic Acids And Opportunities For The Biobanking 
Community. Biopreserv Biobank 2016;14:89-98.
Ozudogru EA, Capuana M, Kaya E, et al. Cryopreservation of Fraxinus 
excelsior L. embryogenic callus by one-step freezing and slow cooling 
techniques. CryoLetters 2010;31:63-75.
Ramirez NC, Barr TJ, Billiter DM. Utilizing virtual microscopy for quality 
control review. Dis Markers 2007;23:459-466.
Schmehl MK, Bank HL, Cobb L. Evaluation and validation of statistical 
methods for viability assays. Monte Carlo simulation and power analysis 
of limiting dilution assay data. Cryobiology 1989;26:239-247. 
Somiari SB, Somiari RI, Hooke J, et al. TIBETS 2004;1:131-143.
Stacey GN, Day JG. Long-term ex situ conservation of biological resourc-
es and the role of biological resource centres. Methods in Molecular 
Biology 2007;38:1-14.
Stacey GN. Control of contamination in cell and tissue banks. 
CryoLetters 1999;20:141-146. 
Stacey GN. Fundamental issues for cell-line banks in biotechnology and 
regulatory affairs. In: Fuller BJ, Lane N, Benson EE, eds. Life in the Frozen 
State. Abigdon, UK, Taylor & Francis, 2004:437-452. 
Stacey GN, Doyle A. The biodiversity convention: The key role of culture 
collections. CryoLetters Supplement 1998;1:31-38.
Tomlinson M. Risk management in cryopreservation associated with 
reproduction. CryoLetters 2008;29:165-174.
Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for se-
rum and plasma collection: Early detection research network consensus 
statement standard operating procedure integration working group. J 
Proteome Res. 2009;8:113-117. 
Von Versen R, Mönig H-J, Salai M, Bettin D. Quality issues in tissue 
banking: Quality management systems - A review. Cell Tissue Banking 
2000;1:181-192.
Wan E, Akana M, Pons J, et al. Green technologies for room temperature 
nucleic acid storage. Curr Issues Mol Biol 2010;12:135-142.
Wendland AE, Camargo JL, Polanczyk CA. Effect of preanalytical vari-
ables on myeloperoxidase levels. Clin Chim Acta 2010; 411:1650-1655.
Wieczorek J1, Bloom D, Guralnick R, et al. Darwin core: An evolv-
ing community-developed biodiversity data standard. PLoS One 
2012;7:e29715.
Wilkinson SP, Stassinopoulos S, Whitney S, et al. Gene expression and 
genomic DNA stabilization in whole blood stored at room temperature. 
CHI Tri-Molecular Medicine Conference 2011, San Francisco, CA. 
Xie R1, Chung JY, Ylaya K, et al. Factors influencing the degradation of 
archival formalin-fixed paraffin-embedded tissue sections. J Histochem 
Cytochem. 2011;59:356-365.
Yin P, Peter A, Franken H, et al. Preanalytical aspects and sample qual-
ity assessment in metabolomics studies of human blood. Clin Chem, 
2013;59:833-845.
Zarbo RJ, Nakhleh RE. Surgical pathology specimens for gross ex-
amination only and exempt from submission: A College of American 
Pathologists Q-Probes study of current policies in 413 institutions. Arch 
Pathol Lab Med 1999;123:133-139.
94 ISBER HEAD OFFICE  750 West Pender Street – Suite 301, Vancouver BC V6C 2T7, Canada 
T: +1.604.484.5693 • F: +1.604.874.4378 • E: bestpractices@isber.org • www.isber.org
ISBER BEST PRACTICES
APPENDIX A: INTERNET RESOURCES
These internet references are made available for information only. ISBER does not warrant any of the information contained therein.
SUBJECT WEBSITE ORGANIZATION/SOURCE TOPICS
Access and Benefit 
Sharing
(Genetic Resources)
http://abs.scnat.ch
Swiss National Academy of 
Sciences 
The joint regulation of access to genetic 
resources and the sharing of benefits 
arising from their use by the researchers 
or companies from user countries and the 
representatives of the states, in which the 
genetic resources have been accessed
Access and Benefit 
Sharing
(Genetic Resources)
https://www.cbd.int/
Convention on Biological 
Diversity
Bonn Guidelines and the Nagoya Protocol 
that address sharing the benefits from the 
utilization of genetic resources in a fair and 
equitable way
Access and Benefit 
Sharing
(Plant Genetics)
http://www.fao.org/plant-treaty/en/
Food and Agriculture 
Organization of the United 
Nations
International Treaty on Plant Genetic 
Resources for Food and Agriculture 
addresses conservation and sustainable use 
of plant genetic resources 
Access and Benefit 
Sharing
(Biodiversity)
https://absch.cbd.int/
The Access and Benefit-
sharing Clearing-house 
(ABSCH) 
A platform for exchanging information on 
access benefit sharing and a key tool for 
facilitating the implementation of the Nagoya 
Protocol
Access and Benefit 
Sharing
(Plants)
https://www.bgci.org/policy/policytools
Botanical Garden 
Conservation International 
(BGCI)
Policy development and implementation 
relating to plant conservation
Access and Benefit 
Sharing
(Microorganisms)
http://bccm.belspo.be/projects/mosaicc Belgian Science Policy Office
Micro-Organisms Sustainable use and Access 
regulation International (MOSAIC) Code of 
Conduct and recommendations 
Access and Benefit 
Sharing
(Microorganisms)
http://bccm.belspo.be/projects/trust
Belgian Coordinated 
Collections of Micro-
organisms (BCCM)
TRUST (TRansparent User-friendly System of 
Transfer) of microbial material
Animal Welfare
http://homeoffice.gov.uk/
science-research/animal-research/
Animal Health and Welfare 
Strategy for Great Britain, 
Home Office
The regulated use of animals for research 
in the development of drugs and medical 
technologies that help to reduce suffering 
among humans and animals
Best Practices 
(Biological Materials of 
Human Origin)
http://www.coe.int/t/dg3/
healthbioethic/texts_and_documents/
Rec_2006_4.pdf
Council of Europe 
Recommendation Rec 
(2006) 4 of the Committee of 
Ministers to member states 
on research on biological 
materials of human origin
Recommendations on the management of 
patient safety and prevention of adverse 
events in health care
Best Practices 
(Biological Resource 
Centers)
http://www.oecd.org/
dataoecd/7/13/38777417.pdf
Organisation for Economic 
Co-Operation and 
Development
Consensus Best Practices for Biological 
Resource Centers in OECD Countries
Best Practices 
(Biological Resource 
Centers)
https://biospecimens.cancer.gov/
bestpractices/2016-NCIBestPractices.pdf
National Cancer Institute; 
National Institutes of Health; 
U.S. Department of Health 
and Human Services
Best Practices for biospecimen handling, 
processing, storage and retrieval for 
specimens collected through NCI-sponsored 
research
Best Practices
(Laboratory Medicine)
https://wwwn.cdc.gov/LabBestPractices/
The Centers for Disease 
Control and Prevention’s 
(CDC) Division of Laboratory 
Systems (DLS)
Laboratory Medicine Best Practices provides 
recommendations on effective laboratory 
medicine practices
Best Practices (Access 
and Benefit Sharing 
of Biodiversity 
Collections)
https://www.cetaf.org/taxonomy/
publications
Consortium of European 
Taxonomic Facilities (CETAF)
CETAF Code of Conduct & Best Practices for 
Access and Benefit-Sharing 
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SUBJECT WEBSITE ORGANIZATION/SOURCE TOPICS
Best Practices (Access 
and Benefit Sharing of 
Microorganisms)
http://www.mirri.org/fileadmin/mirri/
media/Dokumente/generalDocs/
MIRRI_ABS_Manual_web.pdf
Microbial Resource Research 
Infrastructure (MIRRI)
Best Practice Manual on Access and Benefit 
Sharing issued by the Microbial Resource 
Research Infrastructure (MIRRI)
Biodiversity 
Repository Registry
http://grbio.org/
Global Registry of 
Biodiversity Repositories
Clearinghouse of information about 
biological collections in natural history 
museums, herbaria, and other biorepositories
Bioethics
https://www.aap.org/en-us/about-the-
aap/Committees-Councils-Sections/
Section-on-Bioethics/Pages/Bioethics.
aspx
American Academy of 
Pediatrics Committee on 
Bioethics
Policies on bioethics in pediatric clinical care
Bioethics 
http://bioethics-international.org/iab-2.0/
index.php?show=objectives
International Organisation of 
Bioethics
The IAB facilitates the exchange of 
information between those working in 
bioethics in different parts of the world 
Bioethics Advisory 
Committee
http://www.bioethics-singapore.org/
Bioethics Advisory 
Committee, Singapore
Resources for the ethical, legal, and social 
issues arising from biomedical sciences 
research in Singapore
Biorepository 
Protocols
http://www.abrn.net/protocols.htm
Australasian Biospecimen 
Network
Protocols and best practices for collecting 
and processing human biospecimens
Biosafety
http://governance.iarc.fr/ENG/Docs/
safetymanual.pdf
The Division of Biosafety 
and Biotechnology (SBB), 
Scientific Institute of Public 
Health in Belgium
Biosafety risk assessment tools and Biosafety 
manuals, laws and regulations, guidelines 
on containment facilities, equipment and 
practices, shipping and transport
Biosafety http://www.ebsaweb.eu/Resources.html
European Biosafety 
Association
Conferences and other resources on 
European biosafety issues
Biosafety
http://www.ebsaweb.eu/ebsa_media/
Downloads/Biosafety7-view_image-1-
called_by-ebsa.pdf
World Health Organisation
Laboratory biosafety manual covering 
equipment and facility design and techniques
Biosafety
https://www.canada.ca/en/public-
health/services/laboratory-biosafety-
biosecurity/pathogen-safety-data-sheets-
risk-assessment.html
Public Health Agency of 
Canada (PHAC)
Pathogen Safety Data Sheets (PSDSs) that 
describe hazardous properties of a human 
pathogen and provide recommendations for 
work involving these agents in a laboratory 
setting
Biosafety http://www.cjd.ed.ac.uk
UK Surveillance Unit for 
Creutzfeldt-Jakob Disease
Surveillance data on Creutzfeldt-Jakob 
Disease; technical information; links
Biosafety http://bch.cbd.int/protocol
Convention on Biological 
Diversity
Cartagena Protocol on Biosafety is an 
international agreement on the safe 
handling, transport, and use of living 
modified organisms resulting from modern 
biotechnology that may have adverse effects 
on biological diversity
Biospecimen Stability 
Calculator Tool
http://www.isber.org/?page=STABCALC
Biospecimen Stability Testing 
Calculator Tool (STABCALC)
Standardized tool to perform stability studies 
and examine biomarker stability 
Blood Collection 
Protocols
http://www.csmc.edu/5455.html Cedars-Sinai Medical Center Blood collection guidelines
Convention on 
Biological Diversity
http://www.cbd.int
United Nations 
Environmental Programme
Sustainable development and Intellectual 
Property Rights 
Convention on 
International Trade in 
Endangered Species 
of Wild Fauna and 
Flora
http://www.cites.org
IUCN (The World 
Conservation Union)
Trade in Endangered Species of Wild Fauna 
and Flora
Case Studies of 
Human Tissue 
Repositories
http://www.rand.org/pubs/
monographs/2004/RAND_MG120.pdf
Rand Corporation and the 
National Cancer Institute
Best Practices for repositories based on 
information collected from a defined number 
of U.S.-based repositories
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Chemical Safety http://www.cdc.gov/niosh/database.html
National Institute for 
Occupational Safety and 
Health (NIOSH), U.S. 
Databases and information resource links and 
publications in the United States
Chemical Safety
http://www.ilo.org/public/english/
protection/safework/cis/products/icsc/
dtasht/index.htm
International Occupational 
Safety and Health 
Information Center
Chemical database; International Chemical 
Safety Cards (ICSC) 
Chemical Safety http://www.cdc.gov/niosh/chem-inx.html
Master Index of 
Occupational Health 
Guidelines for Chemical 
Hazards (NIOSH), U.S.
U.S. National guidelines for chemical hazards 
of specific chemicals
Chemical Safety http://www.who.int/ifcs/en/
Intergovernmental Forum for 
Global Chemical Safety
Policy guidance on chemical safety
Chemicals 
Management
http://www.environment.gov.au/
settlements/chemicals/index.html
The Australian Government 
Department of the 
Environment and Water 
Resources
Chemicals management strategies to protect 
human health and the environment
Classification and 
Labelling of Chemicals
http://www.unece.org/trans/danger/
publi/ghs/ghs_rev00/00files_e.html
Globally Harmonized 
System of Classification and 
Labelling of Chemicals (GHS)
Contains harmonized classification criteria 
and hazard communication elements
Cost Modeling
https://biospecimens.cancer.gov/
resources/bemt.asp 
Biorepositories and 
Biospecimen Research 
Branch, National Cancer 
Institute, U.S. Department of 
Health & Human Services
Biobank economics modeling tool 
(BEMT) - a publicly available web-based 
financial planning tool for biobanks. BEMT 
is designed to enhance the understanding 
of the economic considerations involved 
in initiating, operating and maintaining a 
biobank to assist with long term financial 
planning and cost recovery.
Cost of User Fees
https://biobanking.org/webs/
biobankcosting
Biobank Resource Center – 
University of British Columbia 
A comprehensive and easy to use tool that 
captures annual expenses, resources, and 
biospecimen accrual and calculates the 
appropriate user fees
Calculation and 
Recovery of Costs
http://stm.sciencemag.org/
content/6/261/261fs45 
Science Translational 
Medicine 05 Nov 2014: 
Vol. 6, Issue 261, pp. 261fs45 
DOI: 10.1126/
scitranslmed.3010444
A calculation grid developed by an 
international expert group was tested across 
biobanks in six countries to evaluate costs for 
collections of various types of biospecimens
Cost Calculator
https://epi.helmholtz-muenchen.de/
tools/calc/   
Biobanking and 
Biomolecular Resources 
Research Infrastructure – 
Large Prospective Cohorts 
(BBMRI) 
Tool that enables biobanks to calculate 
their biobanking associated costs and to 
determine a price strategy for samples, data, 
and services; designed for population based 
cohorts and biobanking in clinical studies
Disinfection and 
Sterilization
https://www.cdc.gov/infectioncontrol/
guidelines/disinfection/index.html
Centers for Disease Control 
and Prevention, U.S. 
Department of Health & 
Human Services
Guideline for Disinfection and Sterilization 
in Healthcare Facilities (2008) presents 
evidence-based recommendations on 
preferred methods for cleaning, disinfection 
and sterilization of patient-care medical 
devices and for cleaning and disinfecting the 
healthcare environment
Dry Ice Safety
http://eur-lex.europa.eu/
LexUriServ/LexUriServ.
do?uri=CELEX:32008R1272:EN:NOT.
Regulation (EC) No 
1272/2008 of the European 
Parliament
European regulations for dry ice
Dry Ice Safety
http://www.ercweb.com/resources/
viewreg.aspx?id=6779
Environmental Resource 
Center
Requirements for shipping dry ice
Electrical Safety
http://www.ehs.uconn.edu/Word%20
Docs/Electrical%20Safety%20in%20
the%20Lab.pdf
University of Connecticut 
Environmental Health and 
Safety
Electrical safety in the laboratory
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Environmental Health
http://www.environment.gov.au/
approvals/index.html
The Australian Government 
Dept. of the Environment 
and Water Resources
Approvals, permits, and licensing
Environmental 
Specimen Bank 
Design
http://www.ehponline.org/
members/1995/Suppl-3/wise-full.html
U.S. National Institute of 
Standards and Technology
Paper presented at the Conference on 
Human Tissue Monitoring and Specimen 
Banking: Opportunities for Exposure 
Assessment, Risk Assessment, and 
Epidemiologic Research held 30 Mar-1 
Apr,1993 in Research Triangle Park, NC
Ethics Committee
http://www.hugo-international.org/
committee_ethics.htm
Human Genome 
Organisation
Promotes discussion and understanding of 
social, legal and ethical issues as they relate 
to the conduct of, and the use of knowledge 
derived from, human genome research
Ethics Guides
http://www.moh.govt.nz/moh.
govt.nz/moh.nsf/indexmh/
guidelines-use-human-tissue
New Zealand Ministry of 
Health
Guidelines for the Use of Human Tissue for 
Future Unspecified Research Purposes
Exposure Prevention 
Program Information
http://www.healthsystem.virginia.edu/
internet/epinet/subpage2.cfm
Exposure Prevention 
Information Network; 
University of Virginia, 
International Health Care 
Worker Safety Center
Provides standardized methods for recording 
and tracking percutaneous injuries and blood 
and body fluid contacts
General Safety http://www.osha.gov/comp-links.html
Occupational Safety and 
Health Administration, 
Department of Labor, USA
Current U.S regulations and regulations under 
development; technical, prevention and 
training information; links
General Safety http://www.lbl.gov/ehs/pub3000
Lawrence Berkeley National 
Laboratory; University of 
California, California, U.S. 
U.S.-based health and safety manual
Human Subjects
https://wcd.coe.int/ViewDoc.
jsp?id=977859
Council of Europe; 
Committee of Ministers
Recommendation Rec(2006)4  
of the Committee of Ministers to member 
states on research on biological materials of 
human origin 
Human Subjects
http://www.hhs.gov/ohrp/international/
HSPCompilation.pdf
Office of Human Research 
Protections; U.S. 
Department of Health and 
Human Services
Human subjects research legislation, 
regulations, or guidelines for 79 countries, 
two confederations and two organizations
Human Subjects
http://www.hhs.gov/ohrp/
humansubjects/guidance/45cfr46.htm
Office of Human Research 
Protections, U.S. 
Department of Health and 
Human Services
U.S. Federal Human Subjects Regulations
Human Subjects
http://www.accessdata.fda.gov/scripts/
cdrh/cfdocs/cfcfr/CFRSearch.cfm
Food and Drug 
Administration, U.S. 
Department of Health and 
Human Services
U.S.-based human subjects regulations: 21 
CFR parts 50, 56, 812
Human Subjects
http://www.hhs.gov/ohrp/policy/index.
html
Office of Human Research 
Protections, U.S. 
Department of Health and 
Human Services
Policy documents from the Office of Human 
Research Protections, U.S.
Human Subjects http://www.hhs.gov/ohrp/international/
U.S. Office of Human 
Research Protections, U.S. 
Department of Health and 
Human Services
International Compilation of Human Subjects 
Research Protections
International Statistical 
Classification of 
Diseases and Related 
Health Problems
http://apps.who.int/classifications/apps/
icd/icd10online/
World Health Organization 
(WHO)
The international standard diagnostic tool 
for epidemiology, health management, and 
clinical purposes
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Inventory System 
Evaluation
http://www.isber.org/resource/collection/
b1088675-1b3c-414c-b280-fb84327d3675/
ISBERInformationSystemEvaluationChecklist.
xlsx?hhSearchTerms
International Society for 
Biological and Environmental 
Repositories
Checklist to assist in the selection of a 
repository inventory management system
Laboratory 
Automation
http://www.slas.org/
Society for Laboratory 
Automation and Screening
Laboratory automation including liquid 
handling, sample storage and retrieval, 
specimen processing
Laboratory Design
https://www.orf.od.nih.gov/PoliciesAnd 
Guidelines/
BiomedicalandAnimalResearch 
FacilitiesDesignPoliciesandGuidelines/ 
Pages/policy-index.aspx
NIH Office of Research 
Facilities
The NIH Design Policy and Guidelines 
establishes policy, design standards, and 
technical criteria for use in programming, 
designing, and constructing new buildings, 
and major and minor alterations for the NIH
Laboratory Standards 
Development
http://www.clsi.org
Clinical and Laboratory 
Standards Institute
U.S.-based general and technical information 
for the development of laboratory standards
Microorganism and 
Culture Collection 
Resources
http://www.wfcc.info/home/
World Federation for Culture 
Collections (WFCC)
Collection, authentication, maintenance, and 
distribution of microorganisms and cultured 
cells
Natural History 
Museum Benefit 
Sharing Practices
http://www.canmexworkshop.com/
documents/papers/III.5d.2.pdf
International Expert 
Workshop on Access to 
Genetic Resources and 
Benefit Sharing
Concepts in Benefit Sharing for Museum 
Collections
Nomenclature 
Standards (human)
https://www.snomed.org/ SNOMED International
Provides global standards for health 
terminology
Nomenclature 
Standards (veterinary)
http://venomcoding.org/VeNom/
Welcome.html
Veterinary Nomenclature 
(VeNom)
A list of standardized terms used in veterinary 
practice
Nomenclature 
Standards 
(biodiversity)
https://terms.tdwg.org/wiki/
GGBN_Data_Standard
The Global Genome 
Biodiversity Network 
(GGBN) Data Standard
A set of vocabularies designed to represent 
tissue, DNA, or RNA samples associated 
to voucher specimens, tissue samples, and 
collections
Occupational Health 
and Safety
http://governance.iarc.fr/ENG/Docs/
safetymanual.pdf
International Agency for 
Research on Cancer
Health and safety manual
Occupational Health 
and Safety
http://www.ccohs.ca/
Canadian Centre for 
Occupational Health and 
Safety
Information on biological hazards, chemical 
and materials, health and safety programs 
Packing and Shipping http://www.iata.org/index.htm
International Air Transport 
Association (IATA)
Standards for shipping human specimens 
by air
Packing and Shipping http://www.icao.int/
International Civil Aviation 
Organization (ICAO)
International Transport Regulations
Packing and Shipping http://hazmat.dot.gov/hazhome.htm
U.S. Department of 
Transportation (DOT)
U.S.-based standards for shipping human 
specimens by ground
Plant Collection 
Protocols
http://www.uaf.edu/museum/herb/
howtocoll.html
University of Alaska, U.S. Guidance on collecting plant specimens
Privacy http://www.hhs.gov/ocr/hipaa/
U.S. Department of Health 
and Human Services
Health Insurance Portability and 
Accountability Act of 1996 (HIPAA)
Privacy http://privacyruleandresearch.nih.gov/
National Institutes of Health, 
U.S. Department of Health 
and Human Services
HIPAA Privacy Rule and research
Privacy http://www.usdoj.gov/oip/04_7_1.html U.S. Department of Justice Privacy Act of 1974, 5 U.S.C. § 552a 
Radiological Safety
http://www.jmu.edu/safetyplan/
radiology/advisorycommittee.shtml
James Madison University Example of U.S. radiation protection program
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Records Management
https://oma.od.nih.gov/DMS/Pages/
Records-Management.aspx
National Institutes of Health, 
U.S. Department of Health 
and Human Services
Program responsible for planning, 
controlling, directing, organizing, training, 
promoting, and conducting other managerial 
activities involved with respect to records 
creation, records maintenance and use, and 
records disposition
Resources 
for Pathology 
Laboratories 
http://www.cap.org/apps/cap.portal?_
nfpb=true&_pageLabel=reference
College of American 
Pathologists
General and Technical Information for lab 
management for U.S.-based laboratories
Specimen Tracking
http://www.leicabiosystems.com/
pathologyleaders/specimen-tracking-
helping-prevent-misdiagnosis/
Leica Biosystems Guidance on specimen labeling and tracking
Standards
http://www.aabb.org/sa/Pages/default.
aspx
American Association of 
Blood Banks (AABB)
Standards for blood banks and 
transfusion services, cellular therapies, 
perioperative services, relationship testing, 
immunohematology reference laboratories, 
molecular testing, and patient blood 
management
Standards https://clsi.org/
Clinical & Laboratory 
Standards Institute (CLSI)
Consensus-based medical laboratory 
standards 
Standards https://www.cen.eu/Pages/default.aspx
European Committee for 
Standardization (CEN, 
French: Comité Européen de 
Normalisation)
Responsible for developing and defining 
voluntary standards at European level
Standards
http://publications.iarc.fr/Book-And-
Report-Series/Iarc-Technical-Publications/
Common-Minimum-Technical-Standards-
And-Protocols-For-Biobanks-Dedicated-
To-Cancer-Research-2017
Common Minimum Technical 
Standards and Protocols 
for Biobanks Dedicated to 
Cancer Research
Guidelines and recommendations for 
biobanks based on validated and/or 
evidence-based guidelines
Temperature Mapping 
of Storage Areas
http://www.who.int/biologicals/
expert_committee/Supplement-8-TS-
mapping-storage-areas-ECSPP-ECBS.pdf
World Health Organization
Guidance for the storage and transport 
of time and temperature-sensitive 
pharmaceutical products
Tissue Procurement 
Protocols
http://www.tubafrost.org
European Human Frozen 
Tumour Tissue Bank 
(TuBaFrost) project
Collection and storage of human tissues
Tissue Procurement 
Protocols
http://www.bd.com/vacutainer/
pdfs/plus_plastic_tubes_wallchart_
orderofdraw_VS5729.pdf
Becton-Dickinson 
Wall chart on blood tube order for blood 
collection
Transnational 
Shipment of 
Chemicals
http://www.basel.int/ The Basel Convention 
Transnational boundary movements of 
hazardous wastes and their disposal
Transport of Infectious 
Substances
http://www.who.int/csr/resources/
publications/biosafety/WHO_CDS_CSR_
LYO_2004_9Final.pdf
World Health Organization
Recommendations developed by the United 
Nations Economic and Social Council’s 
Committee of Experts on the transport of 
dangerous goods
Transportation Safety
http://www.cta-otc.gc.ca/legislation/
index_e.html
Canadian Transportation 
Agency
Transportation-related legislation and other 
related matters can be found here, along 
with details of the Statutes and Regulations 
enforced by the Canadian Transportation 
Agency
Wildlife Trade 
Regulations
http://ec.europa.eu/environment/cites/
legis_wildlife_en.htm
European Council Regulation 
No. 338/97
Regulations on the protection of species of 
wild fauna and flora by regulating trade and to 
suspend the introduction into the community 
of certain species from certain countries
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APPENDIX B: GLOSSARY
Unless otherwise defined in another context in these Practices, import-
ant terms are defined below. 
ALIQUOT (Aliquoted, Aliquoting) – A process wherein a specimen is 
divided into separate parts which are typically stored in separate con-
tainers as individual samples. The term aliquot may also be used as a 
noun to denote a single sample.
ANALYTE – Component represented in the name of a measurable 
quantity. This includes any element, ion, compound, substance, factor, 
infectious agent, cell, organelle, activity, property, or other characteris-
tics which are to be determined.
ANNOTATION – Additional information associated with a particular point 
in a document or other piece of information.
ANONYMIZATION – Involves completely removing all identifying infor-
mation from specimens and data, eliminating the possibility of re-iden-
tifying the participant or re-contacting donors. This also precludes any 
return of research results, possibility for donor withdrawal, and limits the 
use of the specimens in future research.
ANONYMOUS – Identifiable personal information was not collected for 
the specimens and associated data or, if collected, was not maintained 
and cannot be retrieved, such that there is no way to trace the identity of 
the subject from whom the specimens were obtained.
ASSENT – To agree, as to a proposal; concur.
AUDIT – A documented review of procedures, records, personnel func-
tions, equipment materials, facilities, and/or vendors in order to eval-
uate adherence to written SOPs or government laws and regulations.
AUTOPSY – Postmortem examination of the organs and tissues of a body 
to determine cause of death or pathological conditions.
AXENIC STATE – State of non-contamination by or non-association with 
any other living organisms.
BANKING – The process of storing material or specimens for future use 
(see also BIOBANKING).
BIOBANK – See REPOSITORY.
BIODIVERSITY BIOBANK – A biobank holding molecular-level biodi-
versity samples (e.g., from animals, plants, fungi, microorganisms; also 
includes many types of environmental samples).
BIOHAZARD – An organism, or substance derived from an organism 
that poses a threat to (primarily) human health. This can include medical 
waste, samples of a microorganism, virus, or toxin (from a biological 
source) that can impact human health. It can also include substances 
harmful to animals.
BIOLOGICAL SAFETY CABINET (BIOSAFETY CABINET, BIOSAFETY 
HOOD) – Cabinet designed to provide microbe-free work free work 
environment which enables workers to perform work on samples in an 
isolated area.
BIOREPOSITORY – See REPOSITORY.
BIOSAFETY – The discipline addressing the safe handling and contain-
ment of infectious microorganisms and hazardous biological materials to 
prevent harm to workers, non-laboratory organisms, or the environment 
through the application of containment principles and risk assessment. 
BIOSPECIMEN RESOURCE – A collection of biological specimens 
that is acquired for a defined purpose. Management responsibility of 
the biospecimen resource is led by the custodian for the collection. 
Biospecimen resources may be stored in a repository or laboratory, 
depending on the numbers of specimens contained therein.
CALIBRATION – The process of adjusting the output or indication on a 
measurement instrument to agree with value of the applied standard, 
within a specified accuracy.
CHAIN OF CUSTODY – Refers to the chronological documentation or 
paper trail showing the full process of acquisition, transfer, handling, 
and disposition of physical or electronic materials.
COLD CHAIN – A temperature-controlled supply chain.
COLD ISCHEMIA – The time a tissue or organ is chilled during decreased 
blood perfusion or after the blood supply has been reduced or cut off.
COLLECTION – May refer to the practice or technique of collecting a 
specimen (See RETRIEVAL) or to a specific sample or group of samples 
that has been isolated for future research purposes.
CONTAINER – 1. An object that can be used to hold or transport some-
thing. 2. Enclosure for one unit or more units of specimen(s).
CRYOPROTECTANT – An additive or mixture of additives that allow living 
cells, tissues, organs, and organisms to survive exposure to cryogenic 
temperatures, of which the main type is a colligative cryoprotectant. 
This is a protective additive that must be able to penetrate the cell, 
applied to prevent damage caused by excessive cell volume changes 
and the toxic concentration of solutes (i.e., colligative injury). An osmotic 
cryoprotectant is an additive that does not penetrate the cell. It confers 
additional protection by osmotically withdrawing water from the cell 
(osmotic dehydration), consequently reducing the amount of water that 
is available to form ice. Mixtures of colligative and osmotic cryopro-
tectants are often used in plant, algal, and microbial cryoprotective solu-
tions, as well as in cryoprotective solutions for some mammalian cells. 
CULLING – Reviewing and eliminating specimens in a collection or an 
entire collection either by destruction or transfer to a new custodian.
CUSTODIAN – The individual responsible for the management of a bio-
specimen resource. The custodian works with other key stakeholders 
in the management of the resource including the tracking of all relevant 
documentation for the resource and for ensuring that policies regarding 
access to the resource are in place and implemented according to ap-
propriate guidelines.
DATABASE – A structured collection of records or data that is stored in a 
computer system so that a computer program or person using a query 
language can consult it to answer queries.
DEHYDRATION – Removal of water from a tissue.
DE-LINKING – Involves the use of unique code(s) to link specimens and 
data to donors. The repository or a third-party intermediary may act as 
an “honest broker” and hold the link between the codes and donor 
specimens and data. Researchers, receiving the specimens, receive 
the coded specimen(s). Regulations regarding de-identification may 
vary in different areas and investigators are encouraged to review 
local, state, and national/federal regulations and laws. (Also known as 
DE-IDENTIFYING.)
DESICCATION – Excessive loss of moisture; the process of drying up. 
DEVIATION – An intentional or unintentional event that is a departure 
from a procedure or a normal practice.
DEWAR – A specialized container to hold liquefied gases. A Dewar may 
also be referred to as a Dewar flask or Dewar vessel.
DISINFECTANT – An agent that reduces the number of viable 
microorganisms. 
DISPOSITION – Final destination of specimens.
DISTRIBUTION  – A process that includes receipt of request for speci-
mens, selection of appropriate specimens, and final inspection, in 
conjunction with subsequent shipment and delivery of specimens to 
another repository, specimen collection center, or laboratory.
DOCUMENT n. – A piece of written, printed, or electronic matter that 
provides information or evidence or that may serve as an official record. 
v. - Record, register, report (something) in written, photographic, or 
other form.
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DONOR – Living or deceased individual who is the source of the spec-
imen in accordance with established medical criteria, procedures and 
privacy regulations. In some countries the term SUBJECT or “individual” 
may be used in the same context as donor, especially as the context 
relates to human specimens.
DRY ICE – Solid phase carbon dioxide (CO2). CO2 solidifies at -78.5ºC.
END-USER – A health care practitioner, scientist, or laboratory staff mem-
ber who performs an appropriate procedure, test or archival function.
ENVIRONMENTAL MONITORING SYSTEM – An automated, centralized 
monitoring system that monitors environmental conditions and alarms in 
conjunction with remote access, security features, and electronic data 
storage. 
ENVIRONMENTAL SPECIMEN BANKS (ESBS) – Collect, preserve, and 
manage environmental samples (e.g., leaves, soil, water, animal or 
human tissue and fluid, ice cores, etc.), derivatives and associated data 
through standardized protocols. Samples are obtained through mon-
itoring projects and surveys in order to support research, document 
environmental change, and/or to assess the effectivity of or necessity 
for regulatory acts.
ERGONOMICS  – The science that explores human abilities and limita-
tions, and applies that knowledge to improve a person’s interactions 
with their environment, tools, products, and practice.
ETHICS REVIEW COMMITTEE – See INSTITUTIONAL REVIEW BOARD.
FEDERATED COLLECTIONS – Created when specimens are collected, 
processed, and stored at physically separated sites that each function 
as the specimen custodian for its local collection while related data is 
managed through a central database.
FIT FOR PURPOSE (var. – FITNESS FOR PURPOSE) – Suitable; appropriate, 
of a necessary standard, for its intended use.
FREEZE-DRIED – Dehydrated for storage by conversion of the water con-
tent of a frozen specimen to a gaseous state under vacuum. Also called 
lyophilized.
GLASS TRANSITION – The temperature at which a polymer transitions 
from a hard, glassy material to a soft, rubbery material.
HUMAN SUBJECTS RESEARCH – Any research or clinical investigation 
that involves human subjects about whom an investigator conducting 
research obtains (1) data through intervention or interaction with the 
individual, or (2) identifiable private information about whom includes a 
subject’s opinion on a given topic.
ICE NUCLEATION (also termed “seeding”) – The point at which ice crys-
tals are first initiated in a cryopreserved sample; usually applied in the 
context of controlled rate cooling.
IDENTIFIER/IDENTIFYING/IDENTIFIABLE INFORMATION – Information 
(e.g., name, social security number, medical record or pathology acces-
sion number, etc.) that would enable the identification of the subject. 
For some specimens this information might include the taxon name and 
collection number.
INCIDENT – Any unplanned occurrence that deviates from Standard 
Operating Procedures (SOPs) or applicable government laws and 
regulations during specimen retrieval, processing, labeling, storage, or 
distribution that may affect subsequent use of those specimens.
INFORMED CONSENT – A decision to participate in research, taken by a 
competent individual who has received the necessary information; who 
has adequately understood the information; and who, after considering 
the information, has arrived at a decision without having been subjected 
to coercion, undue influence, inducement, or intimidation.
INSTITUTIONAL REVIEW BOARD (IRB) – Any board, committee, or 
other group formally designated by an institution to review biomedical 
research involving humans as subjects, to approve the initiation of the 
research and conduct periodic review of such research.
LABEL – Any written, printed, or graphic material on or affixed to a spec-
imen container or package.
LIFECYCLE (i.e., Repository Lifecycle) – A series of stages through which 
a repository passes during its lifetime.
LIQUID NITROGEN (LN2) – Coolant used to cool and store samples. 
Nitrogen becomes liquid at -196ºC. Samples stored in the vapor phase 
of liquid nitrogen are -190ºC and warmer, depending on the distance 
from the liquid phase.
LIQUID NITROGEN DRY SHIPPER – A container used for sending samples 
in the vapor phase of liquid nitrogen.
LOT – A quantity of reagents, supplies or containers that is processed 
or manufactured at one time and identified by a unique identification 
number (see BATCH).
LYOPHILIZED – Dehydrated for storage by conversion of the water con-
tent of a frozen specimen to a gaseous state under vacuum. Also called 
freeze-dried.
MATERIAL TRANSFER AGREEMENT – An agreement that governs the 
transfer of tangible research materials and data between two organiza-
tions, when the recipient intends to use it for his or her own research 
purposes.  It defines the rights and obligations of the provider and the 
recipient with respect to the use of the materials. 
MORPHOGENETIC COMPETENCE (OR POTENTIAL) – Terms used to 
describe the state of cells that are able to respond to stimuli and in vitro 
manipulations and undergo morphogenesis, usually to produce differ-
entiated structures comprising, shoots, roots and embryos.
NATURAL HISTORY COLLECTIONS (e.g., museums, herbaria, zoological 
and botanical gardens, aquaria, etc.) – Repositories that enable and 
perform object- or specimen-based scientific research, store a diversity 
of traditional specimens (e.g., live organisms, dried skins, skeletons, 
pinned insects, herbarium sheets, whole organisms in preservative, and 
microscopes slides) and often also frozen samples.
NECROPSY – See AUTOPSY.
OPERATING MANUAL (OPERATIONS MANUAL, MANUAL OF 
OPERATIONS) – Contains procedures, instructions, and guidance 
for use by operational personnel in the execution of their duties. 
Documents the step-by-step instructions on how to complete a task or 
handle a specific situation in the workplace.
PRESERVATION – Use of chemical agents, alterations in environmental 
conditions, or other means during processing and storage to prevent or 
retard biological or physical deterioration of a specimen.
PROCESS VALIDATION STUDIES – The process of demonstrating that 
a specific procedure will consistently produce expected results within 
predetermined specifications.
PROCESSING – Any procedure employed after specimen collection but 
prior to its distribution, including preparation, testing, and releasing the 
specimen to inventory and labeling.
PROSPECTIVE – A study or collection maintained for expected or likely 
use in the future.
QUALITY ASSURANCE (QA) – An integrated system of management 
activities involving planning, implementation, documentation, assess-
ment, and improvement to ensure that a process or item is of the type 
and quality needed for the project. Same as Quality Management 
System (QMS). 
QUALITY CONTROL (QC) – Specific tests defined by the QA or QMS 
Program to be performed to monitor procurement, processing, pres-
ervation and storage; specimen quality; and test accuracy. These may 
include but are not limited to: performance evaluations, testing, and 
controls used to determine accuracy and reliability of the repository’s 
equipment and operational procedures as well as monitoring of the 
supplies, reagents, equipment and facilities.
QUALITY MANAGEMENT SYSTEM (QMS) – Same as Quality Assurance 
(QA).
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REPOSITORY – An entity that receives, stores, processes, and/or dis-
tributes specimens, as needed. It encompasses the physical location as 
well as the full range of activities associated with its operation. It may 
also be referred to as a BIOREPOSITORY or BIOBANK.
RETRIEVAL – The removal, acquisition, recovery, or harvesting of speci-
mens (or data).
RETROSPECTIVE – Relating to or being a study or collection (as of a dis-
ease) that looks back on or deals with past events or situations.
SAFETY – Processes, procedures, and technologies to ensure freedom 
from danger or harm.
SAMPLE – A single unit containing material derived from one specimen.
SHIPPING MANIFEST – A written description of the contents of the 
shipped package.
SPECIMEN – In a clinical context, a specimen is specific tissue, blood, 
urine, or other material collected for analysis or a small fragment of tissue 
for microscopic study, taken from a single subject or donor at a specific 
time. In a biodiversity context, a specimen is (usually) an individual 
animal, plant, etc., or a part thereof used as an example of its species 
/population/etc., or type (known as type specimen) collected for scien-
tific study, and/or stored as documentation of research.
STANDARD OPERATING PROCEDURE (SOP) – step-by-step instructions 
to be followed routinely for the performance of designated operations 
or in designated situations to achieve efficiency, quality output, and 
uniformity of performance. 
STERILITY – Absence of detectable, viable, contaminating 
microorganisms.
SUBJECT – Also referred to as human subject. See DONOR.
TAXON – Any recognized category in the taxonomic hierarchy. For many 
purposes, the category “species” is the most important.
TELEMETRY SYSTEM – A system that allows for measurements to be 
taken from a distance, usually via radio wave transmission and reception 
of the information.
TG – The glass transition temperature marks the temperature at which a 
fluid becomes so viscous it appears solid. The extreme viscosity reduc-
es diffusion and molecular restructuring, slowing reactions that might 
otherwise cause samples to deteriorate. The Tg for pure water is -132ºC. 
TOTIPOTENCY – In the context of plants, means that a single somatic 
(non-germ line) cell has the ability to differentiate along a developmen-
tal pathway and regenerate a plant. More generally, the potential for an 
undifferentiated cell to regenerate into a complete new plant.
VIRTUAL COLLECTIONS – Collections of virtual representations of 
specimens (e.g., digital pathology images, H&E stained slides, slides 
of tissue prepared for immunohistochemical analysis, digital images of 
specimens, molecular data) that are housed and analyzed elsewhere, or 
represent catalogs of specimens stored elsewhere.
VITRIFICATION (see also GLASS TRANSITION) - Refers to the transfor-
mation of a glass-forming liquid into a glass, which usually occurs upon 
rapid cooling. It is a dynamic phenomenon occurring between two 
distinct states of matter (liquid and glass), each with different physical 
properties.
WARM ISCHEMIA – The amount of time that an organ remains at body 
temperature after its blood supply has been stopped or reduced.
APPENDIX C: ABBREVIATIONS
Below is a list of abbreviations that are used throughout this document: 
1D – One dimensional
2D – Two dimensional
cGCP – Current Good Clinical Practices
cGLP – Current Good Laboratory Practices
cGMP – Current Good Manufacturing Practices
cGP – Current Good Practices
CO2 – Carbon dioxide
DNA – Deoxyribonucleic Acid
ESB – Environmental specimen bank
EDTA – Ethylenediaminetetraacetic Acid 
H&E – Hematoxylin and eosin
IATA – International Air Transport Association 
ICAO – International Civil Aviation Organization 
ID – Identification Reference
IRB – Institutional Review Board
ISO – International Organization for Standardization 
LN2 – Liquid Nitrogen
MSDS – Material Safety Data Sheet
PBMC – Peripheral Blood Mononuclear Cell
PEL – Permissible Exposure Limit
PHI – Protected Health Information
QA – Quality Assurance 
QC – Quality Control
QMS – Quality Management System 
RBC – Red Blood Cell
RNA – Ribonucleic Acid
SOP – Standard Operating Procedures
Tg – Glass Transition Temperature
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